data_2jr0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jr0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.857 0.36 . . . . 1.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.512 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.6 m120 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 52' ' ' ASP . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' HIS . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 64' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.615 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.431 ' OG ' ' OD2' ' A' ' 75' ' ' ASP . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.485 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.526 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 130' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.406 ' HD3' ' HE2' ' A' ' 68' ' ' HIS . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.546 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.835 0.35 . . . . 1.0 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.614 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' HIS . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' CG2' HG13 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 64' ' ' ILE . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 70' ' ' LYS . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.646 ' HG ' ' H ' ' A' ' 75' ' ' ASP . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.646 ' H ' ' HG ' ' A' ' 73' ' ' SER . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 74' ' ' ILE . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.801 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.801 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.554 ' H ' ' HG ' ' A' ' 97' ' ' SER . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 130' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.568 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 29.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.763 0.316 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.65 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' PHE . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' CG ' HH21 ' A' ' 82' ' ' ARG . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 57' ' ' HIS . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' NE2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 64' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.5 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' OD1' ' OD2' ' A' ' 19' ' ' ASP . 28.7 m120 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 86' ' ' ARG . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.474 ' H ' ' HG ' ' A' ' 97' ' ' SER . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' CD1' HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.748 0.309 . . . . 1.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.432 ' HZ2' ' CG ' ' A' ' 106' ' ' ASP . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.527 ' CG ' HD21 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 64' ' ' ILE . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.655 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.527 HD21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.522 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 86' ' ' ARG . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.934 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.934 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.432 ' CG ' ' HZ2' ' A' ' 5' ' ' LYS . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.552 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 130' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.783 0.325 . . . . 1.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 27' ' ' GLU . 13.7 t30 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' H ' HD21 ' A' ' 24' ' ' ASN . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' O ' ' A' ' 37' ' ' ASN . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.415 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' H ' HG21 ' A' ' 58' ' ' ILE . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' HG12 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' O ' ' C ' ' A' ' 69' ' ' LEU . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 68' ' ' HIS . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.491 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD11 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 86' ' ' ARG . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' C ' ' O ' ' A' ' 91' ' ' GLU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.85 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.413 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.902 0.382 . . . . 1.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.649 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 20.8 m120 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.568 ' O ' HG11 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG2' ' CG1' ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG21 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' LYS . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.567 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.408 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CD1' HG12 ' A' ' 103' ' ' VAL . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 107' ' ' ILE . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.438 ' CG2' ' OE1' ' A' ' 81' ' ' GLU . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.452 ' CB ' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 130' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.524 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.841 0.353 . . . . 1.0 110.325 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 11' ' ' ALA . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.423 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.592 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 51' ' ' VAL . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 54' ' ' ALA . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 64' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' N ' HG23 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' CE1' ' O ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 77' ' ' LEU . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD1' ' CD2' ' A' ' 127' ' ' LEU . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.446 ' O ' ' CE1' ' A' ' 68' ' ' HIS . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 130' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 131' ' ' TYR . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.437 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.613 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.884 0.373 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.637 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.614 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.614 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 54' ' ' ALA . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 64' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.573 ' N ' HG23 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.694 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' GLU . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.451 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.459 HG13 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.527 ' HG ' ' H ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' H ' ' HG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.557 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 107' ' ' ILE . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.472 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.443 HD12 HG23 ' A' ' 130' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.602 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.774 0.321 . . . . 1.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.477 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 57' ' ' HIS . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.715 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.715 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 64' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' N ' HG21 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.639 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 107' ' ' ILE . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.494 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.504 HG23 HD13 ' A' ' 130' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.757 0.313 . . . . 1.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.646 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' O ' HD13 ' A' ' 61' ' ' ILE . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.468 ' CG2' HG12 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.595 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.486 HH11 ' NH1' ' A' ' 82' ' ' ARG . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.738 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.738 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 127' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 126' ' ' VAL . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 123' ' ' VAL . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.595 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 130' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.56 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 1.0 110.48 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.66 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.2 m-80 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' O ' HG11 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.583 HG11 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 ' CG2' HG13 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 64' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.483 ' N ' HG23 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.591 ' HE2' ' HZ1' ' A' ' 132' ' ' LYS . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.445 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD2' ' CE1' ' A' ' 122' ' ' PHE . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.525 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.645 ' NH2' ' CE3' ' A' ' 18' ' ' TRP . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG13 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.833 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.833 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.575 ' O ' HD13 ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.656 ' O ' ' CD2' ' A' ' 110' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.726 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.581 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.591 ' HZ1' ' HE2' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.55 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CG ' ' OD1' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLU . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.529 ' H ' ' C ' ' A' ' 70' ' ' LYS . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 83' ' ' ASN . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.458 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' HG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.581 ' N ' ' HG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' A' ' 68' ' ' HIS . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 130' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.607 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.756 0.312 . . . . 1.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.773 HD21 ' H ' ' A' ' 27' ' ' GLU . 10.2 t30 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.773 ' H ' HD21 ' A' ' 24' ' ' ASN . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' ASN . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.458 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.2 m-80 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.697 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.697 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' CG2' HG13 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 64' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.544 ' HB ' HG23 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.494 ' C ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.507 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' VAL . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.577 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' PHE . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' OE1' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' CE1' ' A' ' 68' ' ' HIS . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 130' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.55 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.853 0.359 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.584 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 57' ' ' HIS . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 64' ' ' ILE . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.581 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.581 ' N ' HG21 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.438 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' H ' HG11 ' A' ' 89' ' ' VAL . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.954 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HZ2' ' HG2' ' A' ' 113' ' ' LYS . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.436 ' O ' ' OE2' ' A' ' 81' ' ' GLU . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.477 HD12 HG21 ' A' ' 130' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 1.7 p90 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.828 0.347 . . . . 1.0 110.663 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.602 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.465 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 ' CG2' HG13 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 64' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.597 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 89' ' ' VAL . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 86' ' ' ARG . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.752 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 130' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.541 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.771 0.32 . . . . 1.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.59 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.477 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.463 ' CG2' HG13 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.521 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.521 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.501 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.878 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.403 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 121' ' ' LYS . 2.7 p30 -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.548 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 130' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.545 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.756 0.313 . . . . 1.0 110.633 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 21.2 m120 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.654 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.6 m-80 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 64' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.623 ' N ' HG23 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' GLY . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.504 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.504 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.651 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.422 ' HZ1' ' CB ' ' A' ' 117' ' ' GLU . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' CB ' ' HZ1' ' A' ' 112' ' ' LYS . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 126' ' ' VAL . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 123' ' ' VAL . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 130' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.553 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 9' ' ' ASP . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.408 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG12 ' N ' ' A' ' 52' ' ' ASP . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.579 ' N ' HG12 ' A' ' 51' ' ' VAL . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' ILE . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 64' ' ' ILE . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 64' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 70' ' ' LYS . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 130' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.737 0.303 . . . . 1.0 110.468 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.722 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.639 ' HH ' ' HZ1' ' A' ' 48' ' ' LYS . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HZ1' ' HH ' ' A' ' 44' ' ' TYR . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 61' ' ' ILE . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.759 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.759 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 64' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.584 HG23 ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 71' ' ' GLY . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.511 ' H ' HG13 ' A' ' 89' ' ' VAL . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.619 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.475 ' H ' ' HG ' ' A' ' 97' ' ' SER . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.515 HG13 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 130' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 5' ' ' LYS . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.478 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.417 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' H ' ' ND2' ' A' ' 24' ' ' ASN . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' ASN . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' LYS . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 57' ' ' HIS . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CG2' HG12 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 64' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.633 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.607 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.541 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.633 ' HB ' HG21 ' A' ' 65' ' ' ILE . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.433 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.491 ' H ' HG11 ' A' ' 89' ' ' VAL . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.758 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.758 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' HG ' ' A' ' 97' ' ' SER . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.634 ' H ' ' HG ' ' A' ' 97' ' ' SER . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.465 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 130' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.59 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -76.23 74.78 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.373 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 -58.2 -36.01 72.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.678 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.512 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.6 m120 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 52' ' ' ASP . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' HIS . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 64' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.615 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.431 ' OG ' ' OD2' ' A' ' 75' ' ' ASP . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.485 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.712 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.526 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 130' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.406 ' HD3' ' HE2' ' A' ' 68' ' ' HIS . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.546 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.02 -32.25 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 9.0 p -82.4 -33.43 28.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 1.0 110.232 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 138' ' ' SER . 32.7 t -80.97 -3.01 50.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.68 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 137' ' ' SER . 6.8 t -33.52 -97.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.068 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 138' ' ' SER . 18.5 tptm -174.59 149.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.612 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -117.66 -22.3 8.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.263 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 51.02 87.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -74.67 154.14 87.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.06 146.38 90.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.534 2.156 . . . . 1.0 111.912 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.5 t -45.76 -53.86 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 147' ' ' SER . 0.7 OUTLIER -173.86 -19.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.309 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER 47.93 -94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.493 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 145' ' ' LEU . 27.3 t 54.76 9.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.803 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 146' ' ' LYS . 55.8 mt-10 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.497 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -146.54 -73.03 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.626 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 -63.51 -47.14 82.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.506 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.614 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' HIS . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' CG2' HG13 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 64' ' ' ILE . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 70' ' ' LYS . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.646 ' HG ' ' H ' ' A' ' 75' ' ' ASP . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.646 ' H ' ' HG ' ' A' ' 73' ' ' SER . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 74' ' ' ILE . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.801 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.801 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.554 ' H ' ' HG ' ' A' ' 97' ' ' SER . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 130' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.568 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.08 128.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 19.2 p -104.1 -39.59 6.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.182 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 138' ' ' SER . 97.6 p -111.67 -20.47 12.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.192 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.5 OUTLIER 83.37 -157.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.62 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -132.2 128.7 38.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.434 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -140.7 -147.38 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 141' ' ' GLU . 24.8 mp0 -133.69 -42.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.427 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -85.52 147.9 47.88 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.166 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 145.55 80.96 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.4 2.067 . . . . 1.0 111.887 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.4 p -86.91 87.03 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.4 tp -156.73 86.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.627 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' CD ' ' N ' ' A' ' 146' ' ' LYS . 12.0 mptt -88.27 99.86 12.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.407 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 146' ' ' LYS . 11.0 p 60.63 165.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.524 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' TYR . 24.6 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ttp85 52.42 9.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 1' ' ' MET . 29.8 p90 -60.0 -35.6 75.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.65 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' PHE . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' CG ' HH21 ' A' ' 82' ' ' ARG . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 57' ' ' HIS . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' NE2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 64' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.5 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' OD1' ' OD2' ' A' ' 19' ' ' ASP . 28.7 m120 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.516 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 86' ' ' ARG . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.474 ' H ' ' HG ' ' A' ' 97' ' ' SER . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' CD1' HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -84.21 121.15 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.1 p -101.43 -24.58 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 139' ' ' LYS . 24.9 p -73.54 -7.22 50.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.591 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.3 p -65.63 4.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 137' ' ' SER . 7.3 mtpm? -124.23 166.46 15.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.505 ' H ' ' CD ' ' A' ' 140' ' ' GLU . 17.7 mp0 -86.89 -5.32 59.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -74.03 138.21 43.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.601 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -80.8 146.64 60.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.279 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.84 150.92 85.49 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.419 2.08 . . . . 1.0 112.049 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 m -155.51 85.35 1.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.42 ' H ' ' CD2' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -86.46 2.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.647 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -73.7 83.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.5 t -54.31 167.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.972 -1.014 . . . . 1.0 110.523 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' H3 ' ' H ' ' A' ' 2' ' ' ARG . 32.6 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 8.6 ptp85 -88.92 41.23 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.656 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 -64.7 -44.49 90.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.891 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.432 ' HZ2' ' CG ' ' A' ' 106' ' ' ASP . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.527 ' CG ' HD21 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 64' ' ' ILE . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.655 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.527 HD21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.522 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 86' ' ' ARG . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.934 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.934 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.432 ' CG ' ' HZ2' ' A' ' 5' ' ' LYS . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.552 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 HG22 HD13 ' A' ' 130' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -85.39 79.75 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.64 -27.13 12.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.569 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.9 t -75.33 -20.7 58.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.86 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.7 p -45.09 -86.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.73 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -44.65 -70.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.795 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.48 110.2 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.86 -60.5 2.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.651 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.46 159.45 55.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.78 139.01 55.75 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.757 2.305 . . . . 1.0 111.994 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 145' ' ' LEU . 9.4 t -93.51 -147.79 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.55 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.619 ' H ' ' HG ' ' A' ' 144' ' ' SER . 2.9 mm? -66.25 107.96 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.437 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -93.86 138.97 31.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.492 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 p -80.45 160.53 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.602 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -157.54 -21.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 -65.8 -39.33 90.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.342 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 27' ' ' GLU . 13.7 t30 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' H ' HD21 ' A' ' 24' ' ' ASN . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' O ' ' A' ' 37' ' ' ASN . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' H ' HG21 ' A' ' 58' ' ' ILE . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' HG12 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' O ' ' C ' ' A' ' 69' ' ' LEU . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 68' ' ' HIS . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.491 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD11 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 86' ' ' ARG . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.85 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' C ' ' O ' ' A' ' 91' ' ' GLU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.85 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.413 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.589 ' C ' ' H ' ' A' ' 136' ' ' THR . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -46.83 -6.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 134' ' ' TYR . 17.0 p -68.06 -32.18 72.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.789 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -83.27 -36.47 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.5 m -76.23 5.39 7.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.536 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -132.22 -176.44 4.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.382 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -159.71 -23.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' CG ' ' H ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER 47.49 -141.79 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.487 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.547 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -72.44 148.16 90.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.326 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.4 151.9 83.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.377 2.052 . . . . 1.0 112.013 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -138.93 106.59 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mt -105.7 -169.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.43 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -55.92 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.6 p -144.61 114.2 7.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.529 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.608 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -168.94 23.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.695 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 -65.69 -35.72 81.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.415 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.649 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 20.8 m120 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.568 ' O ' HG11 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG2' ' CG1' ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG21 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' LYS . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.567 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.408 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.436 ' CD1' HG12 ' A' ' 103' ' ' VAL . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 107' ' ' ILE . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.47 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.438 ' CG2' ' OE1' ' A' ' 81' ' ' GLU . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' CB ' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 130' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.524 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.8 -25.16 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -30.12 71.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.339 . . . . 1.0 110.515 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.588 ' HG ' ' N ' ' A' ' 138' ' ' SER . 53.5 p -106.63 -36.52 6.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.292 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.588 ' N ' ' HG ' ' A' ' 137' ' ' SER . 70.7 p 41.81 -98.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -124.0 165.44 17.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm-20 -47.78 -37.63 13.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 16.5 tp10 66.53 158.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.655 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -69.03 146.75 97.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.172 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.75 154.94 71.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.374 2.05 . . . . 1.0 112.032 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t 58.37 17.88 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.618 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.445 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 4.2 tp 50.47 -139.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 145' ' ' LEU . 35.3 mttp -69.54 152.77 44.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.642 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.51 ' HG ' ' H ' ' A' ' 148' ' ' GLU . 14.0 t 56.66 177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.625 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' H ' ' HG ' ' A' ' 147' ' ' SER . 33.4 mp0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.567 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -164.52 6.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.582 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 -59.25 -42.02 90.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.325 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 11' ' ' ALA . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.423 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.592 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 51' ' ' VAL . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 54' ' ' ALA . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 64' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' N ' HG23 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.446 ' CE1' ' O ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.598 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 77' ' ' LEU . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CD1' ' CD2' ' A' ' 127' ' ' LEU . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' O ' ' CE1' ' A' ' 68' ' ' HIS . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 130' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 131' ' ' TYR . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.437 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 136' ' ' THR . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.613 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -46.89 -5.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.607 ' H ' ' C ' ' A' ' 134' ' ' TYR . 34.1 p -76.02 -38.65 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 1.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -17.4 43.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.65 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -44.94 -27.58 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.583 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 140' ' ' GLU . 14.2 ttmt -106.44 -157.74 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.402 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.18 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.35 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 49.84 42.21 23.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.763 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 2.2 mtmp? -69.79 151.42 96.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 1.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 144' ' ' SER . 17.9 Cg_endo -60.83 148.58 91.7 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.298 1.999 . . . . 1.0 111.922 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 143' ' ' PRO . 15.4 m -43.87 170.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.68 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 145' ' ' LEU . 2.2 mm? -89.08 -58.81 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -54.28 149.08 10.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.556 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.685 ' HG ' ' H ' ' A' ' 148' ' ' GLU . 92.9 p -167.81 -84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.583 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.685 ' H ' ' HG ' ' A' ' 147' ' ' SER . 44.9 mm-40 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' H2 ' ' H ' ' A' ' 2' ' ' ARG . 66.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.443 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 26.6 ttm180 -163.76 -26.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.668 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 -54.88 -39.4 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.637 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.614 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.614 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 54' ' ' ALA . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 64' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.573 ' N ' HG23 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.694 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' GLU . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.459 HG13 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.527 ' HG ' ' H ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' H ' ' HG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.557 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 107' ' ' ILE . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.472 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.443 HD12 HG23 ' A' ' 130' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.602 ' C ' ' H ' ' A' ' 136' ' ' THR . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.602 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -47.23 -6.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 134' ' ' TYR . 16.0 p -64.58 -21.34 66.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.901 0.381 . . . . 1.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 138' ' ' SER . 25.9 m -73.15 -15.13 61.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 137' ' ' SER . 11.5 p 59.22 120.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.431 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -159.44 -27.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.317 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.55 -54.69 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.326 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -50.71 154.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.455 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -74.69 146.78 83.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.101 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.51 154.92 71.56 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.347 2.031 . . . . 1.0 112.296 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.7 m -56.28 112.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.62 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 147' ' ' SER . 13.2 mt -122.29 104.09 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.411 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.4 mttt 63.36 -72.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 145' ' ' LEU . 16.1 m -66.64 -173.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.607 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.2 pm0 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.494 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -101.58 174.7 5.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.639 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -66.37 -43.59 85.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.94 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.477 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 57' ' ' HIS . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.715 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.715 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 64' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' N ' HG21 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.639 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 107' ' ' ILE . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.494 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.504 HG23 HD13 ' A' ' 130' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 136' ' ' THR . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -53.87 -21.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -62.6 -20.22 64.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 1.0 110.837 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 138' ' ' SER . 69.2 m -73.1 -36.28 66.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.674 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 137' ' ' SER . 17.2 p 59.64 143.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.43 -58.26 2.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.45 -80.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.666 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -42.89 115.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -83.06 146.42 51.64 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.427 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.94 136.08 43.59 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.422 2.082 . . . . 1.0 111.969 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.1 m -62.2 88.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.565 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.564 ' C ' ' H ' ' A' ' 147' ' ' SER . 7.0 tp -47.09 157.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.447 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.51 14.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.76 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 145' ' ' LEU . 51.1 m -56.72 -32.73 65.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 1.0 110.494 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.655 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -160.41 -19.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.433 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 -65.53 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.646 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' O ' HD13 ' A' ' 61' ' ' ILE . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' CG2' HG12 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.539 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.595 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.486 HH11 ' NH1' ' A' ' 82' ' ' ARG . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.738 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.738 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 127' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 126' ' ' VAL . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 123' ' ' VAL . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.595 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 130' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.56 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -63.98 -36.03 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.6 t -82.24 -20.09 38.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.766 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -72.9 -5.58 39.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.557 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m 63.22 -139.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.701 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 3.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.394 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -162.36 167.67 23.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 142' ' ' LYS . 5.5 tt0 -107.24 172.8 6.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.396 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 141' ' ' GLU . 13.0 ptpt -68.92 149.58 97.83 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.84 131.31 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.381 2.054 . . . . 1.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.2 t -97.15 105.51 17.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.27 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 145' ' ' LEU . 3.7 mm? -56.27 136.23 53.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.252 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 148' ' ' GLU . 61.9 mttp -46.08 117.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.414 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 t -76.95 17.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.658 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -168.27 -1.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.472 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 -61.5 -35.8 78.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.66 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.2 m-80 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' O ' HG11 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG11 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' CG2' HG13 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 64' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.483 ' N ' HG23 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.591 ' HE2' ' HZ1' ' A' ' 132' ' ' LYS . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CD2' ' O ' ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.445 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD2' ' CE1' ' A' ' 122' ' ' PHE . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.525 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.645 ' NH2' ' CE3' ' A' ' 18' ' ' TRP . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.477 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG13 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.833 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.833 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.575 ' O ' HD13 ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.656 ' O ' ' CD2' ' A' ' 110' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.581 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.591 ' HZ1' ' HE2' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.55 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.68 -34.7 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 21.4 p -79.33 -27.45 42.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.426 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.0 p -91.48 -7.02 51.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 139' ' ' LYS . 42.4 m -78.58 155.94 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.699 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 138' ' ' SER . 6.7 tptm 58.2 153.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 20.2 mp0 -125.14 -178.78 4.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLU . 21.2 mt-10 59.56 123.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.602 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.31 146.8 78.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.744 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.29 155.31 70.55 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.375 2.05 . . . . 1.0 111.417 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m 56.25 90.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.613 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.65 -41.02 4.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -82.32 82.95 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.562 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 76.7 p -116.23 -58.25 2.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.483 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.631 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -161.16 -16.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -63.8 -38.04 89.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CG ' ' OD1' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLU . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.529 ' H ' ' C ' ' A' ' 70' ' ' LYS . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 83' ' ' ASN . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' HG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.581 ' N ' ' HG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' A' ' 68' ' ' HIS . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 130' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 136' ' ' THR . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.607 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -46.38 -7.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.611 ' H ' ' C ' ' A' ' 134' ' ' TYR . 12.5 t -69.16 -25.95 64.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 1.0 110.343 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 14.6 t -81.62 -31.98 32.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 139' ' ' LYS . 87.3 p -54.91 -107.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.71 ' H ' ' HG ' ' A' ' 138' ' ' SER . 52.6 pttt -84.39 168.37 15.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -168.94 150.83 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.45 -155.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -85.76 152.22 56.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.54 142.67 85.3 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.458 2.105 . . . . 1.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 145' ' ' LEU . 46.7 t -142.44 -171.95 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.652 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.416 ' N ' ' OG ' ' A' ' 144' ' ' SER . 0.5 OUTLIER -163.58 153.59 15.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.307 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt 60.37 101.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -156.13 140.07 16.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.448 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H2 ' ' H ' ' A' ' 2' ' ' ARG . 23.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.411 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 11.5 ptt180 -164.28 11.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 -60.29 -36.13 77.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.509 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.773 HD21 ' H ' ' A' ' 27' ' ' GLU . 10.2 t30 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.773 ' H ' HD21 ' A' ' 24' ' ' ASN . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' ASN . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.458 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.2 m-80 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.697 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.697 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' CG2' HG13 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 64' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.544 ' HB ' HG23 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' C ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.507 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' VAL . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.577 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' PHE . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' OE1' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' CE1' ' A' ' 68' ' ' HIS . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 130' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.55 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -60.87 -32.52 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 25.9 p -72.43 -23.79 61.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 1.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.8 m -75.53 -18.25 59.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 t -83.84 107.48 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.49 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -41.27 -69.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.68 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 142' ' ' LYS . 5.6 pt-20 -172.24 72.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.816 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.88 -81.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 140' ' ' GLU . 2.0 mmmm -87.25 157.49 53.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.496 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.28 153.68 32.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.215 1.943 . . . . 1.0 112.059 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.1 m -156.82 92.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.458 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.8 mt 47.95 96.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 148' ' ' GLU . 21.5 tptt -149.04 52.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 146' ' ' LYS . 2.9 p 75.13 -35.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.757 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 146' ' ' LYS . 11.4 pt-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.717 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.633 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -151.33 4.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.529 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 -52.65 -35.87 55.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.584 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 57' ' ' HIS . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 64' ' ' ILE . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.581 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.581 ' N ' HG21 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.438 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' H ' HG11 ' A' ' 89' ' ' VAL . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.954 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.954 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HZ2' ' HG2' ' A' ' 113' ' ' LYS . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.436 ' O ' ' OE2' ' A' ' 81' ' ' GLU . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.477 HD12 HG21 ' A' ' 130' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 136' ' ' THR . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -88.83 26.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 133' ' ' ALA . 11.8 t -81.11 -21.78 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.6 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.1 p -74.85 -3.78 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.64 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 p -55.98 109.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -84.25 158.06 21.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.505 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.51 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.92 -172.77 2.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.657 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -69.56 149.68 96.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.449 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.66 153.03 79.95 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.474 2.116 . . . . 1.0 111.771 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.7 m -156.27 -15.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 mt 42.87 91.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.666 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -76.3 66.0 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.47 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -144.77 -19.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.556 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.03 20.39 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 1.7 p90 -54.26 -42.65 70.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.663 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.602 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' CG2' HG13 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 64' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.597 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 89' ' ' VAL . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 86' ' ' ARG . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.752 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 130' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.541 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -47.21 -33.35 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.02 -21.19 18.14 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.939 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.9 t -73.42 -23.09 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.66 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.1 m -76.25 57.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -152.74 -165.2 2.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -42.18 130.48 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.94 -84.22 0.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -85.36 130.24 52.34 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.314 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.7 145.75 76.57 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.115 1.877 . . . . 1.0 111.685 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.1 t -171.8 88.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.672 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 145' ' ' LEU . 9.3 mp -94.01 100.59 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -166.98 163.72 16.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m 53.04 33.33 14.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.654 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.553 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.443 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 87.9 mtt180 -76.68 -56.91 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.52 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 -63.98 -36.76 85.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.492 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.59 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.477 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' CG2' HG13 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.521 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.521 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.501 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.878 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.403 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 121' ' ' LYS . 2.7 p30 -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.548 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 130' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.545 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -50.24 -32.95 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 2.5 p -83.49 -30.05 27.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 1.0 110.394 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -77.05 -22.91 52.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.656 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -71.34 -43.57 66.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -76.94 149.51 36.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.664 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 17.0 mp0 -79.59 126.74 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.401 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -91.86 -10.56 39.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.581 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' N ' ' OE1' ' A' ' 141' ' ' GLU . 1.3 pttp -84.59 152.53 60.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.88 155.11 71.05 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.657 2.238 . . . . 1.0 112.257 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 146' ' ' LYS . 54.1 p -127.15 112.95 15.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.5 mt 55.93 5.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 144' ' ' SER . 83.8 mttt -92.55 -45.83 7.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.44 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.1 p -172.87 174.65 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.56 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.068 -0.968 . . . . 1.0 110.497 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 55.53 50.04 15.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.511 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 -64.65 -35.18 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.633 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 21.2 m120 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.654 HD21 ' H ' ' A' ' 40' ' ' ASN . 1.6 m-80 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 64' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.623 ' N ' HG23 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' GLY . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.504 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.504 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.651 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.467 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.422 ' HZ1' ' CB ' ' A' ' 117' ' ' GLU . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' CB ' ' HZ1' ' A' ' 112' ' ' LYS . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 126' ' ' VAL . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 123' ' ' VAL . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 130' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' O ' ' OG ' ' A' ' 137' ' ' SER . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.553 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -51.94 -30.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.9 p -85.16 -30.87 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.212 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 133' ' ' ALA . 6.8 m -73.46 -36.63 65.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.627 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 82.9 p -79.74 161.67 25.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.515 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -152.6 149.23 28.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -44.74 -31.03 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -166.63 -179.88 5.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -69.91 154.83 94.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.99 154.49 73.09 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.498 2.132 . . . . 1.0 111.84 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' A' ' 145' ' ' LEU . 93.0 p -151.77 -131.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.639 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.59 ' N ' ' HG ' ' A' ' 144' ' ' SER . 10.1 mp -77.8 -102.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.554 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 -172.08 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.453 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t 50.29 55.6 9.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.442 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.547 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 48.42 41.1 16.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.622 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 -66.43 -40.17 89.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 9' ' ' ASP . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG12 ' N ' ' A' ' 52' ' ' ASP . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.579 ' N ' HG12 ' A' ' 51' ' ' VAL . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' ILE . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 64' ' ' ILE . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 64' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 70' ' ' LYS . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 130' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 137' ' ' SER . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -30.84 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.5 p -87.82 -20.47 26.04 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 133' ' ' ALA . 35.1 t -80.22 -36.37 34.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 1.0 110.377 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.0 t -49.53 100.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.498 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -69.28 107.69 3.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.35 82.69 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -134.82 140.13 45.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.346 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 11.9 mtpp -69.05 147.25 97.64 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.541 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' SER . 33.3 Cg_endo -65.74 131.41 27.45 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.391 2.061 . . . . 1.0 112.03 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PRO . 4.9 m 41.13 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.645 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.72 -98.04 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.479 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 147' ' ' SER . 52.6 pttt -88.67 -13.39 39.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.494 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 146' ' ' LYS . 70.3 p 48.5 101.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.687 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.529 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 2' ' ' ARG . 3.5 mmt180 -44.42 110.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.302 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 -53.1 -37.29 61.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.468 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.722 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.639 ' HH ' ' HZ1' ' A' ' 48' ' ' LYS . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HZ1' ' HH ' ' A' ' 44' ' ' TYR . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 61' ' ' ILE . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.759 ' CG2' ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.759 ' H ' ' CG2' ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 64' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.584 HG23 ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 71' ' ' GLY . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 81' ' ' GLU . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.511 ' H ' HG13 ' A' ' 89' ' ' VAL . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.619 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.475 ' H ' ' HG ' ' A' ' 97' ' ' SER . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.515 HG13 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 100' ' ' PRO . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 130' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 136' ' ' THR . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' THR . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -42.98 -23.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 133' ' ' ALA . 1.6 t -62.92 -25.71 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.0 110.723 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -74.83 -24.52 58.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.629 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 139' ' ' LYS . 4.1 t 54.69 174.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.419 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 138' ' ' SER . 28.3 ttmt -136.19 138.43 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.391 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 47.57 79.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.455 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -89.14 172.08 9.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -68.87 147.51 97.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.084 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.42 131.46 30.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.236 1.958 . . . . 1.0 111.724 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 m -54.94 177.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.624 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.1 tp -143.7 -12.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.308 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.64 -44.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.34 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m 44.82 35.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.802 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.043 -0.98 . . . . 1.0 110.425 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.636 ' H ' ' NE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 47.5 91.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.727 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 -66.11 -35.26 80.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 5' ' ' LYS . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.478 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.417 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' H ' ' ND2' ' A' ' 24' ' ' ASN . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 33' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 37' ' ' ASN . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' LYS . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 57' ' ' HIS . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CG2' HG12 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 64' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.633 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.541 ' ND1' ' O ' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.633 ' HB ' HG21 ' A' ' 65' ' ' ILE . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.433 ' O ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.491 ' H ' HG11 ' A' ' 89' ' ' VAL . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.758 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.758 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 99' ' ' GLU . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' HG ' ' A' ' 97' ' ' SER . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.634 ' H ' ' HG ' ' A' ' 97' ' ' SER . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' ND1' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 130' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.589 ' C ' ' H ' ' A' ' 136' ' ' THR . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.59 ' C ' ' CD1' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -46.23 -8.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 134' ' ' TYR . 41.4 p -72.12 -34.27 68.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 1.0 110.477 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.8 m -73.11 -36.07 66.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.36 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.5 m -75.61 142.7 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.417 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.6 mttm 51.36 -120.88 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 141' ' ' GLU . 57.6 tt0 -166.65 161.14 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.589 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 5.8 mp0 -46.42 160.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.743 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -69.39 150.98 96.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.39 154.67 72.57 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.428 2.086 . . . . 1.0 111.878 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 m -163.65 144.36 8.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -81.85 82.14 7.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.413 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -113.28 -20.85 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.695 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -159.91 119.24 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.689 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.522 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.857 0.36 . . . . 1.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG2' HD11 ' A' ' 107' ' ' ILE . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' HD13 ' A' ' 110' ' ' LEU . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.648 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ILE . 18.4 m-20 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.789 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 48' ' ' LYS . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 90' ' ' ALA . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG23 ' H ' ' A' ' 59' ' ' GLU . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG23 ' A' ' 58' ' ' ILE . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.781 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.574 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 69' ' ' LEU . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.713 HD21 HG11 ' A' ' 126' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.781 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.713 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.713 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 8' ' ' ARG . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.892 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 119' ' ' ALA . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.713 HG11 HD21 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 65' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.835 0.35 . . . . 1.0 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' THR . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 6' ' ' GLY . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.664 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 28' ' ' LEU . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.408 ' NE1' HD13 ' A' ' 58' ' ' ILE . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 28' ' ' LEU . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.653 HD11 ' HG3' ' A' ' 21' ' ' ARG . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 38' ' ' ILE . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 3.6 m120 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.424 ' OG1' HD23 ' A' ' 95' ' ' LEU . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 HH21 ' A' ' 86' ' ' ARG . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.803 ' CG2' HG11 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.586 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 76' ' ' ARG . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.667 ' CG ' HG22 ' A' ' 123' ' ' VAL . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.553 HH21 HD11 ' A' ' 58' ' ' ILE . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.803 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 100' ' ' PRO . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 87' ' ' LEU . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.978 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 65' ' ' ILE . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 65' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.832 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 29.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.763 0.316 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 51' ' ' VAL . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 HD21 ' A' ' 15' ' ' LEU . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.518 HG22 ' HB1' ' A' ' 90' ' ' ALA . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' VAL . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 89' ' ' VAL . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.854 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 115' ' ' ALA . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.699 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.518 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.539 ' ND2' ' OD2' ' A' ' 19' ' ' ASP . 70.8 m-80 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.601 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.679 HG21 HG23 ' A' ' 61' ' ' ILE . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 53' ' ' THR . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.505 ' CE1' HD12 ' A' ' 127' ' ' LEU . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 115' ' ' ALA . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 135' ' ' ILE . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.748 0.309 . . . . 1.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 107' ' ' ILE . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.571 ' HA ' HD22 ' A' ' 110' ' ' LEU . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.683 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.55 ' CG ' HD22 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 15' ' ' LEU . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.678 HG21 ' HG ' ' A' ' 95' ' ' LEU . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.807 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 65' ' ' ILE . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.614 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 80' ' ' VAL . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.55 HD22 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.946 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.946 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.678 ' HG ' HG21 ' A' ' 53' ' ' THR . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 8' ' ' ARG . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.449 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.492 ' O ' HG12 ' A' ' 126' ' ' VAL . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 119' ' ' ALA . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HG12 ' A' ' 65' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.783 0.325 . . . . 1.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 110' ' ' LEU . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.441 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' GLU . 11.2 t-20 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 32' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' LYS . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 38' ' ' ILE . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HG ' ' A' ' 95' ' ' LEU . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.416 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 123' ' ' VAL . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.899 ' N ' HD13 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.627 ' OE2' HD11 ' A' ' 107' ' ' ILE . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 127' ' ' LEU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 53' ' ' THR . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.412 ' HB2' HG11 ' A' ' 108' ' ' VAL . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 92' ' ' LEU . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.676 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.986 ' O ' HD12 ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.986 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.902 0.382 . . . . 1.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 17' ' ' ARG . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 89.2 m-20 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.734 ' O ' HG12 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.557 HG22 ' HB1' ' A' ' 90' ' ' ALA . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.744 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.968 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.664 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.597 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 95' ' ' LEU . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 104' ' ' PHE . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 119' ' ' ALA . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.968 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.688 HD11 HG12 ' A' ' 65' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.841 0.353 . . . . 1.0 110.325 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.556 ' OD1' HD13 ' A' ' 110' ' ' LEU . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 51' ' ' VAL . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HG2' HG21 ' A' ' 55' ' ' VAL . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 HD12 ' HG2' ' A' ' 17' ' ' ARG . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.904 ' CD2' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG23 HD21 ' A' ' 15' ' ' LEU . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' HB1' ' A' ' 90' ' ' ALA . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 59' ' ' GLU . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 58' ' ' ILE . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.735 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.638 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 12' ' ' PHE . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.661 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 50' ' ' LEU . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.735 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 104' ' ' PHE . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 119' ' ' ALA . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.7 HD11 HG12 ' A' ' 65' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.483 ' HB2' HD11 ' A' ' 92' ' ' LEU . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.973 ' O ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.884 0.373 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.569 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.414 ' CG2' HD13 ' A' ' 95' ' ' LEU . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 130' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.539 ' N ' HG22 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 69' ' ' LEU . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 115' ' ' ALA . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 HG11 ' A' ' 126' ' ' VAL . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.77 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.569 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.77 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' PHE . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.49 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 119' ' ' ALA . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 85' ' ' LEU . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.594 HD11 HG12 ' A' ' 65' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.976 ' O ' HD12 ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.976 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.774 0.321 . . . . 1.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' HA ' HD22 ' A' ' 110' ' ' LEU . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.669 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.758 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD3' ' H ' ' A' ' 24' ' ' ASN . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.758 HG13 ' CD1' ' A' ' 15' ' ' LEU . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.643 HG21 HD23 ' A' ' 95' ' ' LEU . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 51' ' ' VAL . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.654 ' CE1' ' OE1' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.049 HG23 ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.049 ' H ' HG23 ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.654 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.799 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 130' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.729 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG22 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.825 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.592 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 123' ' ' VAL . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 123' ' ' VAL . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.736 ' CD2' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 92' ' ' LEU . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.799 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 88' ' ' GLY . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 119' ' ' ALA . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 HG12 ' A' ' 65' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.568 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.969 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.757 0.313 . . . . 1.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' LYS . 3.1 m-20 -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.5 m120 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' HD21 ' A' ' 95' ' ' LEU . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 15' ' ' LEU . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 ' OG1' HD23 ' A' ' 95' ' ' LEU . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.826 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.681 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.588 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 126' ' ' VAL . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.564 ' O ' HG13 ' A' ' 89' ' ' VAL . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.748 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' PHE . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.464 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.717 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 119' ' ' ALA . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 85' ' ' LEU . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.681 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.785 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 1.0 110.48 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 10' ' ' THR . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLY . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.677 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' CG ' HG11 ' A' ' 33' ' ' VAL . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 95' ' ' LEU . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.762 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.459 ' CG2' HG23 ' A' ' 130' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.649 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD11 ' H ' ' A' ' 74' ' ' ILE . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.468 ' C ' HD13 ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.656 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 77' ' ' LEU . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.754 ' N ' HD13 ' A' ' 85' ' ' LEU . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.762 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 53' ' ' THR . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.851 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 104' ' ' PHE . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.048 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.596 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.774 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 110' ' ' LEU . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 6' ' ' GLY . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' CG ' ' ND2' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 15' ' ' LEU . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.569 HG21 HD23 ' A' ' 95' ' ' LEU . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.725 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.814 ' CG2' HG11 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 65' ' ' ILE . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.518 ' C ' HD23 ' A' ' 69' ' ' LEU . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' HD21 ' A' ' 69' ' ' LEU . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 123' ' ' VAL . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.573 ' ND2' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.469 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.814 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' CE1' ' A' ' 134' ' ' TYR . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 107' ' ' ILE . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 105' ' ' ILE . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.997 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.604 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 HG12 ' A' ' 65' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.998 ' O ' HD12 ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CE1' HG21 ' A' ' 93' ' ' ILE . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.756 0.312 . . . . 1.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.722 ' HA ' HD22 ' A' ' 110' ' ' LEU . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' GLY . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 23' ' ' GLU . 7.5 t-20 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 10' ' ' THR . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 39' ' ' LYS . 3.1 m120 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.593 HG21 ' HG ' ' A' ' 95' ' ' LEU . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.572 ' CE1' ' OE1' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.01 ' H ' HG23 ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.572 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.561 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 69' ' ' LEU . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' N ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 83' ' ' ASN . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.636 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 85' ' ' LEU . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 107' ' ' ILE . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.897 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 107' ' ' ILE . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 53' ' ' THR . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.745 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.636 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 65' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 92' ' ' LEU . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.531 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.853 0.359 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 10' ' ' THR . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HA ' HD22 ' A' ' 110' ' ' LEU . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' GLY . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.686 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 51' ' ' VAL . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 54.5 t-20 -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 33.7 t-20 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 38' ' ' ILE . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 15' ' ' LEU . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.65 HG21 ' HG ' ' A' ' 95' ' ' LEU . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.467 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.782 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.563 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 69' ' ' LEU . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.537 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.782 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.957 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.957 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.65 ' HG ' HG21 ' A' ' 53' ' ' THR . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 107' ' ' ILE . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.601 ' HA ' HD23 ' A' ' 110' ' ' LEU . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 119' ' ' ALA . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 65' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 135' ' ' ILE . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.523 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.7 p90 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.828 0.347 . . . . 1.0 110.663 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.61 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.753 HD13 HG22 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.753 HG22 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' HD23 ' A' ' 95' ' ' LEU . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.779 ' CG2' HG11 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.466 ' CG2' HG23 ' A' ' 130' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.575 HD12 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.528 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.779 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.755 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.632 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.771 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.771 0.32 . . . . 1.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.463 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.727 ' CD1' HG13 ' A' ' 51' ' ' VAL . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 m-20 -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 15' ' ' LEU . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 95' ' ' LEU . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 59' ' ' GLU . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' ILE . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.57 HG22 HG12 ' A' ' 130' ' ' ILE . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.631 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.69 ' CG ' ' HB1' ' A' ' 119' ' ' ALA . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.607 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 53' ' ' THR . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 105' ' ' ILE . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.925 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.507 ' CG ' ' N ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 104' ' ' PHE . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.631 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 65' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.756 0.313 . . . . 1.0 110.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 110' ' ' LEU . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 17' ' ' ARG . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 78.7 m-20 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' NZ ' HD11 ' A' ' 95' ' ' LEU . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.715 HG22 ' HB1' ' A' ' 90' ' ' ALA . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.784 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.624 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 69' ' ' LEU . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.518 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.784 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB1' HG22 ' A' ' 53' ' ' THR . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.796 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.722 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 104' ' ' PHE . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.447 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.613 ' HB1' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.428 HG23 ' OE2' ' A' ' 81' ' ' GLU . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 65' ' ' ILE . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.598 HD11 HG12 ' A' ' 65' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' THR . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' HD13 ' A' ' 110' ' ' LEU . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' GLY . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.571 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.942 ' O ' HG12 ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 48' ' ' LYS . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.44 ' CG2' HD13 ' A' ' 95' ' ' LEU . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 130' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.76 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 69' ' ' LEU . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.499 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.598 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 95' ' ' LEU . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 104' ' ' PHE . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 119' ' ' ALA . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.604 HG13 HD21 ' A' ' 85' ' ' LEU . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.598 HD11 ' HA3' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.672 HD11 HG12 ' A' ' 65' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HB2' HD11 ' A' ' 92' ' ' LEU . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.737 0.303 . . . . 1.0 110.468 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 110' ' ' LEU . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.65 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.408 ' CE2' HD11 ' A' ' 58' ' ' ILE . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.7 m-20 -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' O ' HG12 ' A' ' 51' ' ' VAL . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.653 HG21 ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' HD23 ' A' ' 95' ' ' LEU . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.033 ' H ' HG23 ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.832 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.432 ' CG2' HG23 ' A' ' 130' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 69' ' ' LEU . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 12' ' ' PHE . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' OE1' HG21 ' A' ' 123' ' ' VAL . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.626 ' C ' HD11 ' A' ' 127' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.832 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.812 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.884 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 107' ' ' ILE . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.771 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 119' ' ' ALA . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 65' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 51' ' ' VAL . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.566 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.463 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 23' ' ' GLU . 48.0 t-20 -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 36' ' ' LYS . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB2' HG21 ' A' ' 38' ' ' ILE . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 55' ' ' VAL . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.631 HG22 ' HB1' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' VAL . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG23 ' A' ' 130' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.797 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 77' ' ' LEU . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.566 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.76 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.76 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.555 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 104' ' ' PHE . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 119' ' ' ALA . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.463 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.797 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.953 ' O ' HD12 ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.953 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -76.23 74.78 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.373 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 -58.2 -36.01 72.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.678 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG2' HD11 ' A' ' 107' ' ' ILE . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' HD13 ' A' ' 110' ' ' LEU . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.648 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ILE . 18.4 m-20 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.789 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 48' ' ' LYS . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 90' ' ' ALA . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG23 ' H ' ' A' ' 59' ' ' GLU . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG23 ' A' ' 58' ' ' ILE . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.781 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.574 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 69' ' ' LEU . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.648 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.713 HD21 HG11 ' A' ' 126' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.781 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.713 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.713 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 8' ' ' ARG . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.892 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 119' ' ' ALA . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.713 HG11 HD21 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 65' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.02 -32.25 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 9.0 p -82.4 -33.43 28.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 1.0 110.232 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 138' ' ' SER . 32.7 t -80.97 -3.01 50.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.68 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 137' ' ' SER . 6.8 t -33.52 -97.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.068 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 138' ' ' SER . 18.5 tptm -174.59 149.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.612 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -117.66 -22.3 8.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.263 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 51.02 87.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -74.67 154.14 87.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.06 146.38 90.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.534 2.156 . . . . 1.0 111.912 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.5 t -45.76 -53.86 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 147' ' ' SER . 0.7 OUTLIER -173.86 -19.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.309 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER 47.93 -94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.493 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 145' ' ' LEU . 27.3 t 54.76 9.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.803 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 146' ' ' LYS . 55.8 mt-10 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.497 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -146.54 -73.03 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.626 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 -63.51 -47.14 82.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.506 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' THR . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 6' ' ' GLY . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.664 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 28' ' ' LEU . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.408 ' NE1' HD13 ' A' ' 58' ' ' ILE . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 28' ' ' LEU . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.653 HD11 ' HG3' ' A' ' 21' ' ' ARG . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 38' ' ' ILE . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 3.6 m120 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.424 ' OG1' HD23 ' A' ' 95' ' ' LEU . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 HH21 ' A' ' 86' ' ' ARG . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.803 ' CG2' HG11 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.586 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 76' ' ' ARG . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.667 ' CG ' HG22 ' A' ' 123' ' ' VAL . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.553 HH21 HD11 ' A' ' 58' ' ' ILE . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.803 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 100' ' ' PRO . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 87' ' ' LEU . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.978 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 65' ' ' ILE . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 65' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.832 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.08 128.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.51 ' N ' HD12 ' A' ' 135' ' ' ILE . 19.2 p -104.1 -39.59 6.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.182 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 138' ' ' SER . 97.6 p -111.67 -20.47 12.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.192 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.601 ' CA ' HD13 ' A' ' 135' ' ' ILE . 0.5 OUTLIER 83.37 -157.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.62 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -132.2 128.7 38.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.434 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -140.7 -147.38 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 141' ' ' GLU . 24.8 mp0 -133.69 -42.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.427 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -85.52 147.9 47.88 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.166 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 145.55 80.96 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.4 2.067 . . . . 1.0 111.887 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.4 p -86.91 87.03 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.4 tp -156.73 86.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.627 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' CD ' ' N ' ' A' ' 146' ' ' LYS . 12.0 mptt -88.27 99.86 12.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.407 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p 60.63 165.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.386 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.524 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' C ' ' H ' ' A' ' 3' ' ' TYR . 24.6 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ttp85 52.42 9.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 1' ' ' MET . 29.8 p90 -60.0 -35.6 75.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 51' ' ' VAL . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 HD21 ' A' ' 15' ' ' LEU . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.518 HG22 ' HB1' ' A' ' 90' ' ' ALA . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' VAL . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 89' ' ' VAL . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.854 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 115' ' ' ALA . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.699 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.539 ' ND2' ' OD2' ' A' ' 19' ' ' ASP . 70.8 m-80 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.601 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.679 HG21 HG23 ' A' ' 61' ' ' ILE . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 53' ' ' THR . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.505 ' CE1' HD12 ' A' ' 127' ' ' LEU . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 115' ' ' ALA . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 135' ' ' ILE . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -84.21 121.15 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.1 p -101.43 -24.58 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 139' ' ' LYS . 24.9 p -73.54 -7.22 50.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.591 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.3 p -65.63 4.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 137' ' ' SER . 7.3 mtpm? -124.23 166.46 15.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 140' ' ' GLU . 17.7 mp0 -86.89 -5.32 59.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -74.03 138.21 43.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.601 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -80.8 146.64 60.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.279 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.84 150.92 85.49 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.419 2.08 . . . . 1.0 112.049 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 m -155.51 85.35 1.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -86.46 2.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.647 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -73.7 83.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.5 t -54.31 167.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.972 -1.014 . . . . 1.0 110.523 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.6 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -88.92 41.23 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 -64.7 -44.49 90.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.891 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 107' ' ' ILE . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.571 ' HA ' HD22 ' A' ' 110' ' ' LEU . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.683 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.55 ' CG ' HD22 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 15' ' ' LEU . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.678 HG21 ' HG ' ' A' ' 95' ' ' LEU . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.807 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 65' ' ' ILE . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.614 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 80' ' ' VAL . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.55 HD22 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.946 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.946 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.678 ' HG ' HG21 ' A' ' 53' ' ' THR . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 8' ' ' ARG . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.492 ' O ' HG12 ' A' ' 126' ' ' VAL . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 119' ' ' ALA . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HG12 ' A' ' 65' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -85.39 79.75 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.64 -27.13 12.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.569 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.9 t -75.33 -20.7 58.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.86 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.7 p -45.09 -86.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.73 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -44.65 -70.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.795 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.48 110.2 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.86 -60.5 2.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.651 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.46 159.45 55.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.78 139.01 55.75 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.757 2.305 . . . . 1.0 111.994 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.4 t -93.51 -147.79 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.25 107.96 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.437 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -93.86 138.97 31.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.492 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 p -80.45 160.53 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.602 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -157.54 -21.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 -65.8 -39.33 90.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.342 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 110' ' ' LEU . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.441 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' GLU . 11.2 t-20 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 32' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' LYS . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 38' ' ' ILE . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HG ' ' A' ' 95' ' ' LEU . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.416 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 123' ' ' VAL . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.899 ' N ' HD13 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.627 ' OE2' HD11 ' A' ' 107' ' ' ILE . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 127' ' ' LEU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 53' ' ' THR . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.412 ' HB2' HG11 ' A' ' 108' ' ' VAL . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 92' ' ' LEU . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.676 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.986 ' O ' HD12 ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 136' ' ' THR . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.83 -6.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.011 ' N ' HD13 ' A' ' 135' ' ' ILE . 17.0 p -68.06 -32.18 72.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.789 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -83.27 -36.47 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.5 m -76.23 5.39 7.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.536 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -132.22 -176.44 4.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.382 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -159.71 -23.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' CG ' ' H ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER 47.49 -141.79 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.487 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.547 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -72.44 148.16 90.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.326 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.4 151.9 83.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.377 2.052 . . . . 1.0 112.013 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -138.93 106.59 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mt -105.7 -169.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.43 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -55.92 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.6 p -144.61 114.2 7.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.529 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.608 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -168.94 23.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.695 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 -65.69 -35.72 81.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.415 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 17' ' ' ARG . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 89.2 m-20 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.734 ' O ' HG12 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.557 HG22 ' HB1' ' A' ' 90' ' ' ALA . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.744 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.968 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.664 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.597 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 95' ' ' LEU . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 104' ' ' PHE . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 119' ' ' ALA . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.968 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.688 HD11 HG12 ' A' ' 65' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 136' ' ' THR . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.8 -25.16 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -62.82 -30.12 71.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.339 . . . . 1.0 110.515 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.5 p -106.63 -36.52 6.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.292 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 p 41.81 -98.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -124.0 165.44 17.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm-20 -47.78 -37.63 13.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 16.5 tp10 66.53 158.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.655 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -69.03 146.75 97.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.172 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.75 154.94 71.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.374 2.05 . . . . 1.0 112.032 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t 58.37 17.88 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.618 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.405 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 4.2 tp 50.47 -139.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 145' ' ' LEU . 35.3 mttp -69.54 152.77 44.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.642 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.0 t 56.66 177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.625 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 148' ' ' GLU . 33.4 mp0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.567 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -164.52 6.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.582 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 -59.25 -42.02 90.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.325 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.556 ' OD1' HD13 ' A' ' 110' ' ' LEU . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 51' ' ' VAL . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HG2' HG21 ' A' ' 55' ' ' VAL . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 HD12 ' HG2' ' A' ' 17' ' ' ARG . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.904 ' CD2' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG23 HD21 ' A' ' 15' ' ' LEU . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' HB1' ' A' ' 90' ' ' ALA . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 59' ' ' GLU . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 58' ' ' ILE . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.735 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.638 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 12' ' ' PHE . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.661 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 50' ' ' LEU . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.735 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 104' ' ' PHE . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 119' ' ' ALA . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.7 HD11 HG12 ' A' ' 65' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.483 ' HB2' HD11 ' A' ' 92' ' ' LEU . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.973 ' O ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' O ' ' N ' ' A' ' 136' ' ' THR . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.018 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.89 -5.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.018 ' N ' HD13 ' A' ' 135' ' ' ILE . 34.1 p -76.02 -38.65 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 1.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -17.4 43.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.65 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -44.94 -27.58 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.583 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 140' ' ' GLU . 14.2 ttmt -106.44 -157.74 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.402 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.18 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.35 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 49.84 42.21 23.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.763 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 2.2 mtmp? -69.79 151.42 96.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 1.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 144' ' ' SER . 17.9 Cg_endo -60.83 148.58 91.7 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.298 1.999 . . . . 1.0 111.922 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 143' ' ' PRO . 15.4 m -43.87 170.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.68 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.829 ' N ' HD22 ' A' ' 145' ' ' LEU . 2.2 mm? -89.08 -58.81 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -54.28 149.08 10.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.556 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 148' ' ' GLU . 92.9 p -167.81 -84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.583 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' ' OG ' ' A' ' 147' ' ' SER . 44.9 mm-40 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -163.76 -26.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.668 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 -54.88 -39.4 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.569 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.414 ' CG2' HD13 ' A' ' 95' ' ' LEU . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 130' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.539 ' N ' HG22 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 69' ' ' LEU . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 115' ' ' ALA . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 HG11 ' A' ' 126' ' ' VAL . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.77 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.569 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.77 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' PHE . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.49 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 119' ' ' ALA . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 85' ' ' LEU . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.594 HD11 HG12 ' A' ' 65' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.976 ' O ' HD12 ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 136' ' ' THR . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.013 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -47.23 -6.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.013 ' N ' HD13 ' A' ' 135' ' ' ILE . 16.0 p -64.58 -21.34 66.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.901 0.381 . . . . 1.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 138' ' ' SER . 25.9 m -73.15 -15.13 61.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 137' ' ' SER . 11.5 p 59.22 120.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.431 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -159.44 -27.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.317 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.55 -54.69 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.326 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -50.71 154.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.455 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -74.69 146.78 83.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.101 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.51 154.92 71.56 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.347 2.031 . . . . 1.0 112.296 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.7 m -56.28 112.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.62 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 147' ' ' SER . 13.2 mt -122.29 104.09 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.411 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.4 mttt 63.36 -72.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 145' ' ' LEU . 16.1 m -66.64 -173.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.607 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.2 pm0 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.494 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -101.58 174.7 5.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.639 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -66.37 -43.59 85.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.94 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' HA ' HD22 ' A' ' 110' ' ' LEU . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.669 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.758 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD3' ' H ' ' A' ' 24' ' ' ASN . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.758 HG13 ' CD1' ' A' ' 15' ' ' LEU . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.643 HG21 HD23 ' A' ' 95' ' ' LEU . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 51' ' ' VAL . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.654 ' CE1' ' OE1' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.049 HG23 ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.049 ' H ' HG23 ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.654 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.799 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 130' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.729 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG22 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.825 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.592 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 123' ' ' VAL . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 123' ' ' VAL . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.736 ' CD2' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 92' ' ' LEU . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.799 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 88' ' ' GLY . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 119' ' ' ALA . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 HG12 ' A' ' 65' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.65 ' O ' HG22 ' A' ' 136' ' ' THR . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.969 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -53.87 -21.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -62.6 -20.22 64.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 1.0 110.837 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 138' ' ' SER . 69.2 m -73.1 -36.28 66.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.674 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 137' ' ' SER . 17.2 p 59.64 143.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.43 -58.26 2.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.45 -80.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.666 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -42.89 115.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -83.06 146.42 51.64 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.427 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.94 136.08 43.59 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.422 2.082 . . . . 1.0 111.969 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.1 m -62.2 88.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.565 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 147' ' ' SER . 7.0 tp -47.09 157.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.447 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.51 14.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.76 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 145' ' ' LEU . 51.1 m -56.72 -32.73 65.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 1.0 110.494 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.655 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -160.41 -19.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.433 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 -65.53 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' LYS . 3.1 m-20 -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.5 m120 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' HD21 ' A' ' 95' ' ' LEU . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 15' ' ' LEU . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 ' OG1' HD23 ' A' ' 95' ' ' LEU . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.826 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.681 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.588 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 126' ' ' VAL . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.564 ' O ' HG13 ' A' ' 89' ' ' VAL . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.748 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' PHE . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.717 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 119' ' ' ALA . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 85' ' ' LEU . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.681 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.785 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -63.98 -36.03 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.6 t -82.24 -20.09 38.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.766 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -72.9 -5.58 39.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.557 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m 63.22 -139.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.701 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 3.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.394 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -162.36 167.67 23.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 142' ' ' LYS . 5.5 tt0 -107.24 172.8 6.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.396 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 141' ' ' GLU . 13.0 ptpt -68.92 149.58 97.83 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.84 131.31 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.381 2.054 . . . . 1.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.2 t -97.15 105.51 17.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.27 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.579 ' N ' HD22 ' A' ' 145' ' ' LEU . 3.7 mm? -56.27 136.23 53.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.252 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 148' ' ' GLU . 61.9 mttp -46.08 117.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.414 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 t -76.95 17.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.658 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -168.27 -1.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.472 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 -61.5 -35.8 78.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 10' ' ' THR . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLY . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.677 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' CG ' HG11 ' A' ' 33' ' ' VAL . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 95' ' ' LEU . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.762 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.459 ' CG2' HG23 ' A' ' 130' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.649 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD11 ' H ' ' A' ' 74' ' ' ILE . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.468 ' C ' HD13 ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.656 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 77' ' ' LEU . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.754 ' N ' HD13 ' A' ' 85' ' ' LEU . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.762 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 53' ' ' THR . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.851 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 104' ' ' PHE . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.048 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.596 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.774 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.68 -34.7 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 21.4 p -79.33 -27.45 42.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.426 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.0 p -91.48 -7.02 51.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 139' ' ' LYS . 42.4 m -78.58 155.94 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.699 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 138' ' ' SER . 6.7 tptm 58.2 153.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 20.2 mp0 -125.14 -178.78 4.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLU . 21.2 mt-10 59.56 123.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.602 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.31 146.8 78.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.744 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.29 155.31 70.55 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.375 2.05 . . . . 1.0 111.417 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m 56.25 90.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.613 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.65 -41.02 4.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -82.32 82.95 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.562 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 76.7 p -116.23 -58.25 2.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.483 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.631 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -161.16 -16.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -63.8 -38.04 89.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 110' ' ' LEU . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 6' ' ' GLY . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' CG ' ' ND2' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 15' ' ' LEU . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.569 HG21 HD23 ' A' ' 95' ' ' LEU . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.725 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.814 ' CG2' HG11 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 65' ' ' ILE . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.518 ' C ' HD23 ' A' ' 69' ' ' LEU . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' HD21 ' A' ' 69' ' ' LEU . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 123' ' ' VAL . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.573 ' ND2' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.469 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.814 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' CE1' ' A' ' 134' ' ' TYR . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 107' ' ' ILE . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 105' ' ' ILE . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.997 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.604 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 HG12 ' A' ' 65' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.998 ' O ' HD12 ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 136' ' ' THR . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 136' ' ' THR . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.043 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.38 -7.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.043 ' N ' HD13 ' A' ' 135' ' ' ILE . 12.5 t -69.16 -25.95 64.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 1.0 110.343 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 14.6 t -81.62 -31.98 32.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 139' ' ' LYS . 87.3 p -54.91 -107.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.532 ' N ' ' OG ' ' A' ' 138' ' ' SER . 52.6 pttt -84.39 168.37 15.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -168.94 150.83 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.45 -155.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -85.76 152.22 56.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.54 142.67 85.3 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.458 2.105 . . . . 1.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 145' ' ' LEU . 46.7 t -142.44 -171.95 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.652 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 146' ' ' LYS . 0.5 OUTLIER -163.58 153.59 15.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.307 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 145' ' ' LEU . 29.5 ttmt 60.37 101.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -156.13 140.07 16.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.448 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -164.28 11.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.548 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 -60.29 -36.13 77.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.509 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.722 ' HA ' HD22 ' A' ' 110' ' ' LEU . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' GLY . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 23' ' ' GLU . 7.5 t-20 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 10' ' ' THR . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 39' ' ' LYS . 3.1 m120 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.593 HG21 ' HG ' ' A' ' 95' ' ' LEU . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.572 ' CE1' ' OE1' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.01 ' H ' HG23 ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.572 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.561 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 69' ' ' LEU . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' N ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 83' ' ' ASN . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.636 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 85' ' ' LEU . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 107' ' ' ILE . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.897 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 107' ' ' ILE . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 53' ' ' THR . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.745 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.636 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 65' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 92' ' ' LEU . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.531 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -60.87 -32.52 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 25.9 p -72.43 -23.79 61.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 1.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.8 m -75.53 -18.25 59.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 t -83.84 107.48 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.49 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -41.27 -69.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.68 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 142' ' ' LYS . 5.6 pt-20 -172.24 72.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.816 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.88 -81.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 140' ' ' GLU . 2.0 mmmm -87.25 157.49 53.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.496 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.28 153.68 32.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.215 1.943 . . . . 1.0 112.059 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.1 m -156.82 92.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.458 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.8 mt 47.95 96.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 148' ' ' GLU . 21.5 tptt -149.04 52.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.9 p 75.13 -35.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.757 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 146' ' ' LYS . 11.4 pt-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.717 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -151.33 4.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.529 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 -52.65 -35.87 55.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 10' ' ' THR . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HA ' HD22 ' A' ' 110' ' ' LEU . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' GLY . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.686 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 51' ' ' VAL . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 54.5 t-20 -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 33.7 t-20 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 38' ' ' ILE . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 15' ' ' LEU . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.65 HG21 ' HG ' ' A' ' 95' ' ' LEU . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.467 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.782 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.563 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 69' ' ' LEU . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.537 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.782 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.957 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.957 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.65 ' HG ' HG21 ' A' ' 53' ' ' THR . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 107' ' ' ILE . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.601 ' HA ' HD23 ' A' ' 110' ' ' LEU . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 119' ' ' ALA . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 65' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 135' ' ' ILE . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.523 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -88.83 26.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 133' ' ' ALA . 11.8 t -81.11 -21.78 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.6 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.1 p -74.85 -3.78 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.64 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 p -55.98 109.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -84.25 158.06 21.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.505 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.51 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.92 -172.77 2.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.657 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -69.56 149.68 96.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.449 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.66 153.03 79.95 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.474 2.116 . . . . 1.0 111.771 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.7 m -156.27 -15.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 mt 42.87 91.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.666 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -76.3 66.0 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.47 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -144.77 -19.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.556 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.03 20.39 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.7 p90 -54.26 -42.65 70.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.663 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.61 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.753 HD13 HG22 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.753 HG22 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' HD23 ' A' ' 95' ' ' LEU . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.779 ' CG2' HG11 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.466 ' CG2' HG23 ' A' ' 130' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.575 HD12 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.528 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.779 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.755 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.632 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.771 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -47.21 -33.35 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.02 -21.19 18.14 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.939 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.9 t -73.42 -23.09 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.66 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.1 m -76.25 57.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -152.74 -165.2 2.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -42.18 130.48 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.94 -84.22 0.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -85.36 130.24 52.34 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.314 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.7 145.75 76.57 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.115 1.877 . . . . 1.0 111.685 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.405 ' HG ' ' HZ2' ' A' ' 146' ' ' LYS . 33.1 t -171.8 88.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.672 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 145' ' ' LEU . 9.3 mp -94.01 100.59 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HZ2' ' HG ' ' A' ' 144' ' ' SER . 23.6 pttm -166.98 163.72 16.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.651 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m 53.04 33.33 14.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.654 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.553 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -76.68 -56.91 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.52 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 -63.98 -36.76 85.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.492 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.727 ' CD1' HG13 ' A' ' 51' ' ' VAL . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 m-20 -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 15' ' ' LEU . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 95' ' ' LEU . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 59' ' ' GLU . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' ILE . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.57 HG22 HG12 ' A' ' 130' ' ' ILE . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.631 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.69 ' CG ' ' HB1' ' A' ' 119' ' ' ALA . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.607 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 53' ' ' THR . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 105' ' ' ILE . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.925 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.507 ' CG ' ' N ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 104' ' ' PHE . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.631 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 65' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -50.24 -32.95 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 2.5 p -83.49 -30.05 27.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 1.0 110.394 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -77.05 -22.91 52.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.656 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -71.34 -43.57 66.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -76.94 149.51 36.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.664 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 17.0 mp0 -79.59 126.74 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.401 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -91.86 -10.56 39.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.581 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' N ' ' OE1' ' A' ' 141' ' ' GLU . 1.3 pttp -84.59 152.53 60.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.88 155.11 71.05 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.657 2.238 . . . . 1.0 112.257 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 146' ' ' LYS . 54.1 p -127.15 112.95 15.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.5 mt 55.93 5.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 144' ' ' SER . 83.8 mttt -92.55 -45.83 7.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.44 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.1 p -172.87 174.65 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.56 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.068 -0.968 . . . . 1.0 110.497 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 55.53 50.04 15.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.511 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 -64.65 -35.18 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.633 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 110' ' ' LEU . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 17' ' ' ARG . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 78.7 m-20 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' NZ ' HD11 ' A' ' 95' ' ' LEU . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.715 HG22 ' HB1' ' A' ' 90' ' ' ALA . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.784 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.624 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 69' ' ' LEU . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.518 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.784 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB1' HG22 ' A' ' 53' ' ' THR . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.796 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.722 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 104' ' ' PHE . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.447 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.613 ' HB1' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.428 HG23 ' OE2' ' A' ' 81' ' ' GLU . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 65' ' ' ILE . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.598 HD11 HG12 ' A' ' 65' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -51.94 -30.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.9 p -85.16 -30.87 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.212 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -73.46 -36.63 65.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.627 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 82.9 p -79.74 161.67 25.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.515 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 148' ' ' GLU . 22.0 tttm -152.6 149.23 28.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -44.74 -31.03 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -166.63 -179.88 5.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -69.91 154.83 94.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.99 154.49 73.09 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.498 2.132 . . . . 1.0 111.84 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 93.0 p -151.77 -131.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.639 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 145' ' ' LEU . 10.1 mp -77.8 -102.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.554 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -145.47 -172.08 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.453 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t 50.29 55.6 9.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.442 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 139' ' ' LYS . 12.3 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.547 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 48.42 41.1 16.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.622 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 -66.43 -40.17 89.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' THR . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' HD13 ' A' ' 110' ' ' LEU . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' GLY . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.571 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.942 ' O ' HG12 ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 48' ' ' LYS . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.44 ' CG2' HD13 ' A' ' 95' ' ' LEU . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 130' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.76 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 69' ' ' LEU . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.499 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.598 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 95' ' ' LEU . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 104' ' ' PHE . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 119' ' ' ALA . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.604 HG13 HD21 ' A' ' 85' ' ' LEU . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.598 HD11 ' HA3' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.672 HD11 HG12 ' A' ' 65' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HB2' HD11 ' A' ' 92' ' ' LEU . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 137' ' ' SER . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -98.68 -30.84 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.5 p -87.82 -20.47 26.04 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 133' ' ' ALA . 35.1 t -80.22 -36.37 34.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 1.0 110.377 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.0 t -49.53 100.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.498 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -69.28 107.69 3.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.35 82.69 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -134.82 140.13 45.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.346 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 11.9 mtpp -69.05 147.25 97.64 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.541 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' SER . 33.3 Cg_endo -65.74 131.41 27.45 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.391 2.061 . . . . 1.0 112.03 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PRO . 4.9 m 41.13 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.645 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.72 -98.04 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.479 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 147' ' ' SER . 52.6 pttt -88.67 -13.39 39.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.494 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 146' ' ' LYS . 70.3 p 48.5 101.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.687 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.529 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 3.5 mmt180 -44.42 110.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.302 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 -53.1 -37.29 61.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.468 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 110' ' ' LEU . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.65 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.408 ' CE2' HD11 ' A' ' 58' ' ' ILE . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.7 m-20 -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' O ' HG12 ' A' ' 51' ' ' VAL . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.653 HG21 ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' HD23 ' A' ' 95' ' ' LEU . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.033 ' H ' HG23 ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.832 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.432 ' CG2' HG23 ' A' ' 130' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 69' ' ' LEU . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 12' ' ' PHE . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' OE1' HG21 ' A' ' 123' ' ' VAL . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.626 ' C ' HD11 ' A' ' 127' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.832 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.812 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.884 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 107' ' ' ILE . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.771 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 119' ' ' ALA . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 65' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 136' ' ' THR . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' THR . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -42.98 -23.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 133' ' ' ALA . 1.6 t -62.92 -25.71 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.0 110.723 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -74.83 -24.52 58.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.629 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 139' ' ' LYS . 4.1 t 54.69 174.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.419 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 138' ' ' SER . 28.3 ttmt -136.19 138.43 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.391 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 47.57 79.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.455 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -89.14 172.08 9.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -68.87 147.51 97.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.084 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.42 131.46 30.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.236 1.958 . . . . 1.0 111.724 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 m -54.94 177.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.624 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.1 tp -143.7 -12.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.308 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.64 -44.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.34 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m 44.82 35.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.802 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.043 -0.98 . . . . 1.0 110.425 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' H ' ' NE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 47.5 91.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.727 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 -66.11 -35.26 80.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 51' ' ' VAL . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.566 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.463 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 23' ' ' GLU . 48.0 t-20 -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 36' ' ' LYS . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB2' HG21 ' A' ' 38' ' ' ILE . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 55' ' ' VAL . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.631 HG22 ' HB1' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' VAL . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG23 ' A' ' 130' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.797 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 77' ' ' LEU . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.566 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.76 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.76 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.555 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 104' ' ' PHE . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 119' ' ' ALA . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.463 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.797 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.953 ' O ' HD12 ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 136' ' ' THR . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.23 -8.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 135' ' ' ILE . 41.4 p -72.12 -34.27 68.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 1.0 110.477 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.8 m -73.11 -36.07 66.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.36 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.5 m -75.61 142.7 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.417 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.6 mttm 51.36 -120.88 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 141' ' ' GLU . 57.6 tt0 -166.65 161.14 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.589 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 5.8 mp0 -46.42 160.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.743 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -69.39 150.98 96.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.39 154.67 72.57 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.428 2.086 . . . . 1.0 111.878 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 m -163.65 144.36 8.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -81.85 82.14 7.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.413 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -113.28 -20.85 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.695 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -159.91 119.24 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.689 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.522 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.857 0.36 . . . . 1.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG2' HD11 ' A' ' 107' ' ' ILE . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' HD13 ' A' ' 110' ' ' LEU . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.512 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' ASN . 1.6 m120 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.789 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 48' ' ' LYS . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 90' ' ' ALA . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG23 ' H ' ' A' ' 59' ' ' GLU . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG23 ' A' ' 58' ' ' ILE . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.781 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.574 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 69' ' ' LEU . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.713 HD21 HG11 ' A' ' 126' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.781 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.713 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.713 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 8' ' ' ARG . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.892 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 119' ' ' ALA . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.713 HG11 HD21 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 65' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.835 0.35 . . . . 1.0 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' THR . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 6' ' ' GLY . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.664 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 28' ' ' LEU . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.408 ' NE1' HD13 ' A' ' 58' ' ' ILE . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 28' ' ' LEU . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.653 HD11 ' HG3' ' A' ' 21' ' ' ARG . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 38' ' ' ILE . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.4 m-80 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.424 ' OG1' HD23 ' A' ' 95' ' ' LEU . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 HH21 ' A' ' 86' ' ' ARG . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.803 ' CG2' HG11 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.586 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 76' ' ' ARG . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.667 ' CG ' HG22 ' A' ' 123' ' ' VAL . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.553 HH21 HD11 ' A' ' 58' ' ' ILE . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.803 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 100' ' ' PRO . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 87' ' ' LEU . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.978 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 65' ' ' ILE . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 65' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.832 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 29.8 p90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.763 0.316 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 51' ' ' VAL . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' CG ' HH21 ' A' ' 82' ' ' ARG . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 HD21 ' A' ' 15' ' ' LEU . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.518 HG22 ' HB1' ' A' ' 90' ' ' ALA . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' VAL . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 89' ' ' VAL . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.854 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 115' ' ' ALA . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.699 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.518 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' OD1' ' OD2' ' A' ' 19' ' ' ASP . 28.7 m120 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.601 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.679 HG21 HG23 ' A' ' 61' ' ' ILE . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 53' ' ' THR . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.505 ' CE1' HD12 ' A' ' 127' ' ' LEU . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 115' ' ' ALA . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 135' ' ' ILE . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.748 0.309 . . . . 1.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 107' ' ' ILE . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.571 ' HA ' HD22 ' A' ' 110' ' ' LEU . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.683 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.55 ' CG ' HD22 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 15' ' ' LEU . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.678 HG21 ' HG ' ' A' ' 95' ' ' LEU . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.807 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 65' ' ' ILE . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.614 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 80' ' ' VAL . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.55 HD22 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.946 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.946 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.678 ' HG ' HG21 ' A' ' 53' ' ' THR . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 8' ' ' ARG . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.449 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.492 ' O ' HG12 ' A' ' 126' ' ' VAL . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 119' ' ' ALA . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HG12 ' A' ' 65' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.783 0.325 . . . . 1.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 110' ' ' LEU . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.441 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.851 HD22 ' H ' ' A' ' 27' ' ' GLU . 13.7 t30 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.851 ' H ' HD22 ' A' ' 24' ' ' ASN . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 32' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' LYS . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 38' ' ' ILE . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HG ' ' A' ' 95' ' ' LEU . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.416 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 123' ' ' VAL . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.899 ' N ' HD13 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.627 ' OE2' HD11 ' A' ' 107' ' ' ILE . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 127' ' ' LEU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 53' ' ' THR . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.412 ' HB2' HG11 ' A' ' 108' ' ' VAL . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 92' ' ' LEU . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.676 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.986 ' O ' HD12 ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.986 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.902 0.382 . . . . 1.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 17' ' ' ARG . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 20.8 m120 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.734 ' O ' HG12 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.557 HG22 ' HB1' ' A' ' 90' ' ' ALA . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.744 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.968 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.664 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.597 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 95' ' ' LEU . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 104' ' ' PHE . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 119' ' ' ALA . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.968 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.688 HD11 HG12 ' A' ' 65' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.841 0.353 . . . . 1.0 110.325 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.556 ' OD1' HD13 ' A' ' 110' ' ' LEU . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 51' ' ' VAL . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HG2' HG21 ' A' ' 55' ' ' VAL . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 HD12 ' HG2' ' A' ' 17' ' ' ARG . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.904 ' CD2' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG23 HD21 ' A' ' 15' ' ' LEU . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' HB1' ' A' ' 90' ' ' ALA . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 59' ' ' GLU . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 58' ' ' ILE . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.735 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.638 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 12' ' ' PHE . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.661 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 50' ' ' LEU . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.735 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 104' ' ' PHE . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 119' ' ' ALA . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.7 HD11 HG12 ' A' ' 65' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.483 ' HB2' HD11 ' A' ' 92' ' ' LEU . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.973 ' O ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.884 0.373 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.569 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.414 ' CG2' HD13 ' A' ' 95' ' ' LEU . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 130' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.539 ' N ' HG22 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 69' ' ' LEU . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 115' ' ' ALA . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 HG11 ' A' ' 126' ' ' VAL . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.77 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.569 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.77 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' PHE . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.49 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 119' ' ' ALA . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 85' ' ' LEU . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.594 HD11 HG12 ' A' ' 65' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.976 ' O ' HD12 ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.976 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.774 0.321 . . . . 1.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.541 ' HA ' HD22 ' A' ' 110' ' ' LEU . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.669 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.758 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD3' ' H ' ' A' ' 24' ' ' ASN . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.758 HG13 ' CD1' ' A' ' 15' ' ' LEU . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.643 HG21 HD23 ' A' ' 95' ' ' LEU . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 51' ' ' VAL . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.049 HG23 ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.049 ' H ' HG23 ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.799 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 130' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.729 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG22 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.825 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.592 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 123' ' ' VAL . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 123' ' ' VAL . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.736 ' CD2' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 92' ' ' LEU . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.799 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 88' ' ' GLY . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 119' ' ' ALA . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 HG12 ' A' ' 65' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.568 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.969 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.757 0.313 . . . . 1.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' HD21 ' A' ' 95' ' ' LEU . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 15' ' ' LEU . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 ' OG1' HD23 ' A' ' 95' ' ' LEU . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.826 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.681 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.588 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 126' ' ' VAL . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.564 ' O ' HG13 ' A' ' 89' ' ' VAL . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.748 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' PHE . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.464 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.717 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 119' ' ' ALA . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 85' ' ' LEU . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.681 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.785 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 1.0 110.48 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 10' ' ' THR . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLY . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.677 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.592 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.76 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.2 m-80 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' CG ' HG11 ' A' ' 33' ' ' VAL . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 95' ' ' LEU . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.762 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.459 ' CG2' HG23 ' A' ' 130' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.649 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD11 ' H ' ' A' ' 74' ' ' ILE . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.468 ' C ' HD13 ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.656 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 77' ' ' LEU . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.754 ' N ' HD13 ' A' ' 85' ' ' LEU . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.762 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 53' ' ' THR . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.851 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 104' ' ' PHE . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.048 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.596 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.774 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 110' ' ' LEU . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 6' ' ' GLY . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CG ' ' OD1' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 15' ' ' LEU . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.569 HG21 HD23 ' A' ' 95' ' ' LEU . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.725 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.814 ' CG2' HG11 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 65' ' ' ILE . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.518 ' C ' HD23 ' A' ' 69' ' ' LEU . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' HD21 ' A' ' 69' ' ' LEU . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 123' ' ' VAL . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.469 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.814 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' CE1' ' A' ' 134' ' ' TYR . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 107' ' ' ILE . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 105' ' ' ILE . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.997 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.604 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 HG12 ' A' ' 65' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.998 ' O ' HD12 ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CE1' HG21 ' A' ' 93' ' ' ILE . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.756 0.312 . . . . 1.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.722 ' HA ' HD22 ' A' ' 110' ' ' LEU . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' GLY . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 27' ' ' GLU . 10.2 t30 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.825 ' H ' HD22 ' A' ' 24' ' ' ASN . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 10' ' ' THR . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.532 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.2 m-80 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.593 HG21 ' HG ' ' A' ' 95' ' ' LEU . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.01 ' H ' HG23 ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.561 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 69' ' ' LEU . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' N ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.636 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.494 ' C ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 85' ' ' LEU . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 107' ' ' ILE . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.897 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 107' ' ' ILE . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 53' ' ' THR . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.745 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.636 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 65' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 92' ' ' LEU . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.531 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.853 0.359 . . . . 1.0 110.411 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 10' ' ' THR . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HA ' HD22 ' A' ' 110' ' ' LEU . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' GLY . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.686 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 51' ' ' VAL . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 38' ' ' ILE . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 15' ' ' LEU . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.65 HG21 ' HG ' ' A' ' 95' ' ' LEU . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.467 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.782 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.563 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 69' ' ' LEU . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.537 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.782 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.957 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.957 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.65 ' HG ' HG21 ' A' ' 53' ' ' THR . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 107' ' ' ILE . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.601 ' HA ' HD23 ' A' ' 110' ' ' LEU . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 119' ' ' ALA . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 65' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 135' ' ' ILE . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.523 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.7 p90 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.828 0.347 . . . . 1.0 110.663 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.61 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.753 HD13 HG22 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.1 m-80 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.753 HG22 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' HD23 ' A' ' 95' ' ' LEU . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.779 ' CG2' HG11 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.466 ' CG2' HG23 ' A' ' 130' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.575 HD12 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.528 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.779 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.755 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.632 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.771 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.771 0.32 . . . . 1.0 110.492 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.463 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.727 ' CD1' HG13 ' A' ' 51' ' ' VAL . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB3' HD22 ' A' ' 40' ' ' ASN . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.647 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 15' ' ' LEU . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 95' ' ' LEU . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 59' ' ' GLU . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' ILE . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.57 HG22 HG12 ' A' ' 130' ' ' ILE . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.631 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.69 ' CG ' ' HB1' ' A' ' 119' ' ' ALA . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.607 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 53' ' ' THR . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 105' ' ' ILE . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.925 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 121' ' ' LYS . 2.7 p30 -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 104' ' ' PHE . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.631 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 65' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.756 0.313 . . . . 1.0 110.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 110' ' ' LEU . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 17' ' ' ARG . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 21.2 m120 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.6 m-80 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' NZ ' HD11 ' A' ' 95' ' ' LEU . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.715 HG22 ' HB1' ' A' ' 90' ' ' ALA . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.784 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.624 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 69' ' ' LEU . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.518 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.784 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB1' HG22 ' A' ' 53' ' ' THR . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.796 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.722 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 104' ' ' PHE . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.447 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.613 ' HB1' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.428 HG23 ' OE2' ' A' ' 81' ' ' GLU . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 65' ' ' ILE . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.598 HD11 HG12 ' A' ' 65' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' THR . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' HD13 ' A' ' 110' ' ' LEU . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' GLY . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.571 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.942 ' O ' HG12 ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 48' ' ' LYS . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.44 ' CG2' HD13 ' A' ' 95' ' ' LEU . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 130' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.76 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 69' ' ' LEU . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.499 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.598 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 95' ' ' LEU . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 104' ' ' PHE . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 119' ' ' ALA . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.604 HG13 HD21 ' A' ' 85' ' ' LEU . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.598 HD11 ' HA3' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.672 HD11 HG12 ' A' ' 65' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HB2' HD11 ' A' ' 92' ' ' LEU . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.737 0.303 . . . . 1.0 110.468 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 110' ' ' LEU . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.65 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.408 ' CE2' HD11 ' A' ' 58' ' ' ILE . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.747 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' O ' HG12 ' A' ' 51' ' ' VAL . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.653 HG21 ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' HD23 ' A' ' 95' ' ' LEU . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.033 ' H ' HG23 ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.832 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.432 ' CG2' HG23 ' A' ' 130' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 69' ' ' LEU . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 12' ' ' PHE . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' OE1' HG21 ' A' ' 123' ' ' VAL . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.626 ' C ' HD11 ' A' ' 127' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.832 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.812 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.884 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 107' ' ' ILE . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.771 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 119' ' ' ALA . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 65' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 51' ' ' VAL . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.566 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.463 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.538 ' H ' ' ND2' ' A' ' 24' ' ' ASN . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 36' ' ' LYS . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB2' HG21 ' A' ' 38' ' ' ILE . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 55' ' ' VAL . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.631 HG22 ' HB1' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' VAL . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG23 ' A' ' 130' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.797 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 77' ' ' LEU . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.566 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.76 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.76 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.555 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 104' ' ' PHE . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 119' ' ' ALA . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.463 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.797 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.953 ' O ' HD12 ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.953 HD12 ' O ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -76.23 74.78 3.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.373 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 26.3 p90 -58.2 -36.01 72.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.678 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 14.0 ptm180 -56.81 -32.85 66.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -58.22 -40.68 82.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.443 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.55 -42.79 46.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.88 66.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.802 0.334 . . . . 1.0 110.848 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG2' HD11 ' A' ' 107' ' ' ILE . 35.8 ttm180 -74.63 -44.17 51.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.353 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD2' HD13 ' A' ' 110' ' ' LEU . 1.8 t70 -60.71 -43.09 98.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.921 0.391 . . . . 1.0 110.972 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -61.66 -20.1 63.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.759 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.13 66.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.089 0.471 . . . . 1.0 111.232 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.35 -47.77 82.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.53 -178.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.49 -37.35 65.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.132 -178.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.51 -46.94 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 119.97 -0.692 . . . . 1.0 109.32 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -64.26 -33.06 74.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.983 -1.008 . . . . 1.0 109.327 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 21.8 t80 -63.61 -36.01 82.42 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.507 -0.477 . . . . 1.0 109.931 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -32.38 73.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.656 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 5.9 t-105 -62.42 -32.2 73.0 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.31 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.512 ' OD2' ' ND2' ' A' ' 83' ' ' ASN . 3.4 m-20 -66.23 -33.73 76.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.0 mp -91.77 -45.54 8.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.356 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.09 -47.07 5.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.308 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.32 44.57 93.32 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ASN . 98.6 mt-10 -132.78 172.56 12.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.764 0.316 . . . . 1.0 110.968 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLU . 20.2 t-20 -32.7 97.48 0.11 Allowed Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.375 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.65 -17.07 6.4 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.533 2.155 . . . . 1.0 112.332 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.2 -48.04 55.17 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.216 -0.754 . . . . 1.0 111.216 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.77 -44.78 72.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.299 0.571 . . . . 1.0 110.327 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mt -55.94 -41.13 74.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.212 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.93 -40.6 73.36 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 78.5 tttt -57.08 -33.04 66.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.453 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.75 -42.95 85.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.66 -45.31 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -35.78 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 -178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.9 mt-10 -58.88 -49.11 78.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.804 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -44.27 52.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.028 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 38' ' ' ILE . 25.2 mttt -84.9 117.64 24.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 1.0 110.422 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -64.92 48.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.204 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' LYS . 45.7 mm -43.62 -38.98 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.089 0.471 . . . . 1.0 110.32 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 41' ' ' LYS . 8.3 mmtp 58.18 -84.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' ASN . 1.6 m120 -43.54 89.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 1.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 39' ' ' LYS . 48.3 tttp -52.47 -34.58 49.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.339 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.45 -41.28 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.794 0.807 . . . . 1.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.35 -47.8 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.131 -1.395 . . . . 1.0 111.448 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.26 -42.45 91.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.856 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -69.31 -47.2 65.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.74 -37.77 74.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.384 -0.825 . . . . 1.0 109.831 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.94 95.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.789 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 tmtt? -58.22 -52.16 66.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -57.69 -37.8 74.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.503 -0.771 . . . . 1.0 110.451 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.22 -44.91 92.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.983 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 48' ' ' LYS . 8.2 p -68.49 -32.86 57.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.071 -0.652 . . . . 1.0 110.701 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -27.94 68.89 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.66 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.493 HG22 ' HB1' ' A' ' 90' ' ' ALA . 86.7 m -58.42 -31.53 67.82 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -78.01 -38.68 44.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.889 -1.505 . . . . 1.0 111.293 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -77.15 -14.57 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.815 -177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -49.77 -14.53 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -178.43 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.065 0.46 . . . . 1.0 110.259 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG23 ' H ' ' A' ' 59' ' ' GLU . 6.4 tt -27.9 -56.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.542 0.941 . . . . 1.0 113.542 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG23 ' A' ' 58' ' ' ILE . 27.4 mt-10 -58.64 -48.98 79.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.504 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -57.21 -37.17 71.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.931 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.781 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.5 mt -59.52 -46.26 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.936 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 4.1 m-20 -56.23 -45.13 80.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 t -58.28 -44.24 88.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.667 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.0 mt -59.58 -37.73 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.573 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.06 -39.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.091 0.472 . . . . 1.0 110.292 177.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 65' ' ' ILE . 10.2 tt0 -62.25 -37.8 86.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.517 -0.765 . . . . 1.0 112.686 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -57.05 -27.76 61.95 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.293 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.574 ' C ' ' H ' ' A' ' 70' ' ' LYS . 15.3 t-80 -102.54 -19.31 14.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.804 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 69' ' ' LEU . 16.5 mt -56.02 0.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.424 -0.51 . . . . 1.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 68' ' ' HIS . 86.0 mttt 54.7 17.81 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.715 0.293 . . . . 1.0 110.534 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.63 -32.52 5.49 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 14.1 m0 -52.56 178.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 1.0 110.675 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -119.25 134.22 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.073 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.17 -25.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.947 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 76' ' ' ARG . 4.4 p30 -62.23 -23.75 66.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.651 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 75' ' ' ASP . 18.0 ttm-85 30.0 -98.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.992 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -140.48 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.46 134.18 51.23 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.566 -1.014 . . . . 1.0 110.566 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -50.89 17.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 1.0 111.405 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.47 -49.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 1.0 110.835 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.8 mm-40 -48.06 -50.06 29.37 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.25 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -51.01 -50.54 58.32 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.891 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -71.5 -45.15 63.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.0 110.118 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -37.71 68.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.039 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.713 HD21 HG11 ' A' ' 126' ' ' VAL . 3.6 mp -54.71 -45.86 74.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.73 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -59.78 -43.23 94.47 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.0 111.327 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.12 -34.42 77.56 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.521 -0.472 . . . . 1.0 111.825 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.37 -47.24 64.41 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.287 -0.959 . . . . 1.0 111.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.781 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.26 -30.21 49.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 1.0 110.734 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.713 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.51 -41.18 6.19 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.297 -0.561 . . . . 1.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 92' ' ' LEU . 16.3 mp0 -68.07 -59.68 3.06 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.31 -0.956 . . . . 1.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.36 -84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.634 -0.712 . . . . 1.0 112.122 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.3 mp -119.83 -30.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.993 0.425 . . . . 1.0 111.369 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.713 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 3.4 m-85 -52.5 -37.37 57.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.544 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.9 tp -101.96 6.79 41.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.569 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' O ' ' OG ' ' A' ' 97' ' ' SER . 3.4 ttmp? 99.47 -57.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.033 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' A' ' 96' ' ' LYS . 16.2 m 143.65 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.643 0.59 . . . . 1.0 110.795 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 tppt? 81.23 98.16 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.381 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 43.72 71.06 1.58 Allowed Pre-proline 0 C--N 1.333 -0.14 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.112 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 15.7 Cg_exo -65.03 -43.83 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.046 2.498 . . . . 1.0 113.065 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.82 -48.77 83.62 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.995 -0.621 . . . . 1.0 111.623 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -71.57 -34.81 70.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.863 0.363 . . . . 1.0 110.732 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.32 -45.99 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.888 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.1 m-85 -66.7 -48.2 69.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.967 -0.693 . . . . 1.0 110.726 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.05 -53.2 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.766 -177.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.99 -49.26 74.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.881 -0.785 . . . . 1.0 108.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.497 HD11 ' HG2' ' A' ' 8' ' ' ARG . 3.8 mm -59.41 -43.15 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.303 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 104' ' ' PHE . 33.2 t -68.5 -36.77 76.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ILE . 22.3 t0 -59.62 -35.83 75.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -59.87 -35.09 74.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.896 -1.047 . . . . 1.0 109.601 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -66.3 -40.32 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.15 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -53.55 -37.98 63.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.262 0.553 . . . . 1.0 110.457 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.93 -45.08 64.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.712 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -84.98 -66.9 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.048 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -90.11 165.5 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.222 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -47.75 140.65 6.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.301 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.42 -35.83 80.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.026 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.64 -34.12 72.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.0 110.468 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.892 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.09 -33.72 76.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.109 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.32 -36.65 77.16 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 45.9 mtpt -61.87 -46.25 90.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.135 0.493 . . . . 1.0 109.738 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE1' ' NE ' ' A' ' 76' ' ' ARG . 67.9 t80 -70.51 -37.7 74.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.87 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 119' ' ' ALA . 46.2 t -60.05 -46.37 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.293 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 6.0 p30 -67.47 -49.77 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.811 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -56.83 -50.48 63.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.299 -0.72 . . . . 1.0 111.299 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.713 HG11 HD21 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -62.75 -29.75 47.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.626 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -61.51 -47.17 86.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.112 0.482 . . . . 1.0 109.705 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -60.14 -28.45 67.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.167 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.85 -38.59 70.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.568 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 65' ' ' ILE . 10.8 mt -67.84 -39.37 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.54 -0.464 . . . . 1.0 109.959 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.47 -51.98 63.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.946 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -60.8 -42.87 98.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.514 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -63.04 -34.07 76.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -60.86 -52.37 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.903 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.02 -32.25 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.351 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 9.0 p -82.4 -33.43 28.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 1.0 110.232 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 138' ' ' SER . 32.7 t -80.97 -3.01 50.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.68 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 137' ' ' SER . 6.8 t -33.52 -97.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.068 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 138' ' ' SER . 18.5 tptm -174.59 149.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.612 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -117.66 -22.3 8.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.263 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 51.02 87.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -74.67 154.14 87.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.06 146.38 90.86 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.534 2.156 . . . . 1.0 111.912 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.5 t -45.76 -53.86 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 147' ' ' SER . 0.7 OUTLIER -173.86 -19.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.309 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER 47.93 -94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.493 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 145' ' ' LEU . 27.3 t 54.76 9.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.803 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 146' ' ' LYS . 55.8 mt-10 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.046 -0.978 . . . . 1.0 110.497 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -146.54 -73.03 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.626 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 8.6 p90 -63.51 -47.14 82.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.506 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.619 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 17.8 ptp180 -57.19 -32.55 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.408 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -56.15 -43.24 78.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' THR . . . -69.59 -41.89 74.13 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -67.83 -36.51 80.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 1.0 110.324 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -74.89 -45.19 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.226 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.29 -47.25 83.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 1.0 110.793 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 6' ' ' GLY . 62.6 p -61.37 -19.44 61.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.72 -39.36 61.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 1.0 111.412 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.74 -48.55 79.3 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.065 -0.654 . . . . 1.0 111.315 -178.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.664 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.36 -38.94 69.47 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.4 p -70.14 -38.51 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.648 -0.821 . . . . 1.0 109.738 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -58.44 -34.56 70.94 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -60.64 -43.25 97.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.312 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 28' ' ' LEU . 10.2 mpt_? -63.13 -31.96 73.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.776 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.408 ' NE1' HD13 ' A' ' 58' ' ' ILE . 12.1 t-105 -62.09 -33.82 75.15 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.103 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' OD2' ' NH1' ' A' ' 82' ' ' ARG . 9.4 t70 -66.86 -34.6 78.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.883 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -91.75 -45.71 8.28 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.467 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.653 ' HG3' HD11 ' A' ' 28' ' ' LEU . 3.5 mmp_? -96.74 -47.11 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.17 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 26.44 29.01 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.545 -0.622 . . . . 1.0 111.545 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.03 130.51 39.51 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.975 0.417 . . . . 1.0 111.012 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' CB ' ' OE2' ' A' ' 27' ' ' GLU . 14.1 m120 38.88 83.61 0.2 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.216 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -53.84 -35.13 78.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.545 2.163 . . . . 1.0 112.047 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.74 99.75 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE2' ' CB ' ' A' ' 24' ' ' ASN . 35.0 mt-10 -62.81 -51.2 68.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.103 0.477 . . . . 1.0 110.156 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.653 HD11 ' HG3' ' A' ' 21' ' ' ARG . 3.6 mm? -57.31 -37.16 72.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -64.69 -38.06 89.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.857 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 13.4 tptp -56.72 -32.93 66.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.82 -42.73 81.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.74 -43.56 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.352 0.501 . . . . 1.0 112.352 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.78 -35.69 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.2 mt-10 -62.36 -46.29 89.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.852 -1.067 . . . . 1.0 110.323 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -45.14 45.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.382 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.3 mptt -89.53 138.06 31.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.851 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -80.65 52.41 1.67 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 38' ' ' ILE . 41.0 mm -47.46 102.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.333 . . . . 1.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -68.27 155.21 40.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 1.0 109.855 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.4 m-80 57.78 104.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.744 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -51.27 -34.14 31.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.31 -42.08 69.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.827 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -61.07 -43.26 99.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.16 -1.382 . . . . 1.0 111.532 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -62.93 -44.23 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.926 -0.309 . . . . 1.0 110.885 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.68 -45.72 70.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -55.98 -37.43 69.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.874 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -63.68 -41.5 98.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.032 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 19.6 ttpt -60.03 -51.17 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.12 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.23 -32.39 66.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.315 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.318 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -65.17 -33.98 67.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.612 -0.835 . . . . 1.0 110.174 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' ARG . 3.5 m-20 -57.08 -35.58 69.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.838 -0.745 . . . . 1.0 110.624 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.424 ' OG1' HD23 ' A' ' 95' ' ' LEU . 67.1 m -59.63 -32.19 70.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.397 -0.964 . . . . 1.0 108.397 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.13 -40.6 52.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.963 -1.471 . . . . 1.0 110.172 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.73 -14.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.874 -1.057 . . . . 1.0 111.275 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -49.24 -21.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.539 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -176.8 35.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 HH21 ' A' ' 86' ' ' ARG . 3.2 tt -31.09 -49.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.271 -0.877 . . . . 1.0 112.651 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.02 -48.89 79.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.912 -0.715 . . . . 1.0 110.091 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' HIS . 24.5 tt0 -57.39 -37.23 72.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.636 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.803 ' CG2' HG11 ' A' ' 89' ' ' VAL . 11.5 mt -59.68 -46.68 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 120.204 -0.599 . . . . 1.0 109.526 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -46.12 79.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.5 t -58.89 -43.54 91.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.149 -0.932 . . . . 1.0 109.979 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.11 -36.9 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.326 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.586 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -68.92 -40.0 80.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.18 178.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 65' ' ' ILE . 88.7 mt-10 -61.9 -35.33 78.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.352 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -54.48 -25.86 27.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.678 -0.409 . . . . 1.0 110.862 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.6 t-80 -102.78 -40.42 6.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.586 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 49.1 mt -37.82 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.792 0.33 . . . . 1.0 111.02 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' HIS . 13.4 tttp 79.65 -26.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 161.34 -3.78 0.08 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -82.23 -167.1 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 1.0 110.621 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -125.86 141.21 52.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.387 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.93 -24.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 1.0 109.921 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 76' ' ' ARG . 39.0 t70 -67.11 -24.77 65.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.058 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 75' ' ' ASP . 10.3 tpt180 16.15 -100.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.492 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 128.31 33.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.157 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 129.23 6.61 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.769 -0.933 . . . . 1.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.81 -52.11 14.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.723 0.297 . . . . 1.0 110.782 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.9 t -51.7 -46.75 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.099 0.476 . . . . 1.0 110.142 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.667 ' CG ' HG22 ' A' ' 123' ' ' VAL . 1.5 tm-20 -46.53 -50.96 16.43 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.001 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' NH1' ' OD2' ' A' ' 19' ' ' ASP . 11.1 ttp85 -52.07 -51.28 58.61 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.936 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -42.1 66.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.708 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.51 83.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.215 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 89' ' ' VAL . 2.0 tt -55.94 -44.66 78.58 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.294 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.553 HH21 HD11 ' A' ' 58' ' ' ILE . 2.9 mpp_? -60.21 -43.38 96.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.984 -0.686 . . . . 1.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.26 -35.06 79.59 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.095 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.88 -47.54 74.12 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.484 -0.865 . . . . 1.0 110.975 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.803 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.8 p -67.33 -32.56 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.8 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.22 -40.69 11.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -69.65 -59.89 2.67 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.465 -0.894 . . . . 1.0 111.174 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.0 mm? -5.91 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.791 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.29 -29.79 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 1.0 111.467 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 13.5 m-85 -53.42 -33.93 55.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.489 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.47 -19.98 15.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.276 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt 59.83 81.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.3 t -104.7 168.41 9.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.499 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -95.29 -12.44 26.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 100' ' ' PRO . 19.4 mm-40 -140.39 63.78 23.07 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.672 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 39.9 Cg_exo -53.35 -33.28 65.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.54 2.16 . . . . 1.0 112.464 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.98 -50.32 58.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.407 -0.677 . . . . 1.0 111.407 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -73.95 -37.87 64.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.683 0.278 . . . . 1.0 111.069 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.98 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.827 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.604 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -69.46 -46.38 66.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.977 0.418 . . . . 1.0 110.691 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -48.51 -53.07 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.08 -0.648 . . . . 1.0 111.339 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' OD2' ' CD ' ' A' ' 102' ' ' ARG . 94.7 m-20 -56.28 -43.12 78.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.338 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 87' ' ' LEU . 3.6 mm -56.98 -47.07 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.943 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.93 -36.3 78.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.21 -33.31 74.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.756 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -64.57 -38.58 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.206 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -52.58 -37.66 58.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 1.0 110.196 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -45.31 89.62 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.877 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -87.99 -69.04 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.994 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -78.16 148.35 34.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.934 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -42.25 147.24 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.317 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.26 -31.76 72.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.678 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -59.36 -42.62 92.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.017 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.978 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.0 -37.77 86.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.058 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.48 -36.82 71.95 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.549 -1.02 . . . . 1.0 110.549 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -61.89 -45.86 91.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.54 -39.99 67.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.444 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 119' ' ' ALA . 23.0 t -59.88 -40.5 82.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.199 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.28 -51.89 39.94 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.734 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.73 -52.8 49.89 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 65' ' ' ILE . 3.2 p -59.17 -29.35 41.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.048 -0.261 . . . . 1.0 110.936 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -46.71 86.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.419 . . . . 1.0 110.006 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.2 t -60.1 -29.58 68.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.298 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -56.02 -40.06 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.848 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 65' ' ' ILE . 5.9 mt -67.75 -38.82 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.812 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.12 -46.18 75.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.803 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -65.57 -39.26 91.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.6 -33.82 76.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.66 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -59.9 -52.49 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.832 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -53.08 128.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.539 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.51 ' N ' HD12 ' A' ' 135' ' ' ILE . 19.2 p -104.1 -39.59 6.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.182 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 138' ' ' SER . 97.6 p -111.67 -20.47 12.11 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.192 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.601 ' CA ' HD13 ' A' ' 135' ' ' ILE . 0.5 OUTLIER 83.37 -157.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.62 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -132.2 128.7 38.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.434 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -140.7 -147.38 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 141' ' ' GLU . 24.8 mp0 -133.69 -42.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.427 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -85.52 147.9 47.88 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.166 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 145.55 80.96 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.4 2.067 . . . . 1.0 111.887 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.4 p -86.91 87.03 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.4 tp -156.73 86.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.627 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' CD ' ' N ' ' A' ' 146' ' ' LYS . 12.0 mptt -88.27 99.86 12.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.407 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p 60.63 165.71 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.386 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.524 -179.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' C ' ' H ' ' A' ' 3' ' ' TYR . 24.6 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ttp85 52.42 9.49 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 1' ' ' MET . 29.8 p90 -60.0 -35.6 75.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.602 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 13.7 ptp180 -57.07 -38.98 74.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 32.9 tttm -56.82 -37.64 71.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.314 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.04 -42.83 58.46 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.66 -34.23 67.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.0 110.373 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.2 ttm-85 -74.51 -43.98 53.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.63 -43.37 97.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.498 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 p -61.93 -19.72 63.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.114 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.46 -46.03 66.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.345 0.593 . . . . 1.0 110.836 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.77 -46.6 84.34 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.269 -178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.658 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.92 -42.21 65.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 -178.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.577 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -64.67 -45.32 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 118.968 -1.093 . . . . 1.0 109.289 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 51' ' ' VAL . 48.3 mt -64.99 -31.92 73.39 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.021 -0.991 . . . . 1.0 109.62 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.94 -37.05 83.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.855 -0.612 . . . . 1.0 109.909 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -65.48 -32.29 73.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.021 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.5 t90 -62.29 -31.57 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.173 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' CG ' HH21 ' A' ' 82' ' ' ARG . 4.1 m-20 -66.57 -34.68 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.757 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.37 -45.58 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.317 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.69 -46.64 6.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.508 -0.314 . . . . 1.0 110.913 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 58.78 29.08 63.98 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.5 tp10 -132.86 123.89 26.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.719 0.295 . . . . 1.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' GLU . 27.4 m-20 39.52 98.4 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.06 -23.45 9.13 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.246 1.964 . . . . 1.0 112.275 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.1 -47.72 29.42 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.87 -47.21 87.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.2 0.524 . . . . 1.0 110.351 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -56.28 -37.63 70.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.801 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.68 -45.75 91.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 40.0 mtpt -57.64 -32.59 67.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -71.81 -38.5 70.21 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.8 p -73.16 -43.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.389 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.79 -35.66 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -68.69 -48.95 62.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.692 -1.14 . . . . 1.0 110.61 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -43.88 64.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.883 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -157.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.23 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -138.87 46.83 1.95 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.712 0.292 . . . . 1.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.61 88.12 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' LYS . 72.3 tttt -60.92 -75.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.775 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -46.14 93.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.759 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LYS . 19.6 ttpt -51.34 -33.17 28.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.184 0.516 . . . . 1.0 109.846 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.41 -43.86 68.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.403 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.55 84.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.267 -1.333 . . . . 1.0 111.133 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.4 t80 -60.18 -42.26 94.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.704 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -68.75 -47.1 67.14 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -57.15 -37.65 72.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.694 -0.685 . . . . 1.0 109.466 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.22 94.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.529 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 79.1 tttt -59.56 -51.52 69.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.448 -0.796 . . . . 1.0 109.924 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -57.13 -35.05 69.01 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.96 -48.49 79.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.687 -179.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 HD21 ' A' ' 15' ' ' LEU . 2.2 p -68.97 -32.91 56.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.976 -0.689 . . . . 1.0 109.925 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.78 -33.21 68.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 120.047 -0.661 . . . . 1.0 111.121 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.518 HG22 ' HB1' ' A' ' 90' ' ' ALA . 89.2 m -60.99 -33.47 73.28 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.092 0.949 . . . . 1.0 108.48 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.0 -37.13 58.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.806 -1.543 . . . . 1.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' VAL . 36.4 t -78.69 -16.0 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.21 -0.905 . . . . 1.0 111.538 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -51.36 -14.32 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.123 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.53 -55.9 0.57 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.602 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 36.1 mt 80.1 -94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 40.6 mt-10 -59.6 -45.83 90.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.432 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 57' ' ' HIS . 23.9 tt0 -51.62 -37.34 49.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.051 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 89' ' ' VAL . 22.8 mt -62.1 -49.34 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.633 -0.827 . . . . 1.0 109.577 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -55.78 -45.45 78.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.3 t -58.25 -45.71 87.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.213 -0.903 . . . . 1.0 109.053 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.2 mt -59.12 -37.81 70.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.854 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.73 -42.4 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.198 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 76.6 mt-10 -64.29 -36.44 84.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.772 -0.649 . . . . 1.0 112.505 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -55.46 -26.03 39.94 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.825 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -102.17 -35.23 8.96 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.498 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 27.5 mt -39.65 -24.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.763 0.316 . . . . 1.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' HIS . 5.8 tttp 80.49 -38.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.407 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' TRP . . . 167.67 65.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 6.5 m0 -154.08 -172.82 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 1.0 110.554 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 p -104.74 159.76 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -56.52 -38.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.215 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 76' ' ' ARG . 16.9 m-20 -63.56 -34.58 78.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.99 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 27.83 43.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 1.0 110.731 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.7 tp 70.59 101.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.329 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.98 113.79 2.72 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.84 -51.53 16.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.263 . . . . 1.0 110.8 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 115' ' ' ALA . 19.0 t -51.51 -46.31 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.471 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.699 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 20.2 mt-10 -47.49 -50.68 22.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.586 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 HH21 ' CG ' ' A' ' 19' ' ' ASP . 20.5 ttp180 -55.86 -48.77 74.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.101 -0.64 . . . . 1.0 109.855 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' OD1' ' OD2' ' A' ' 19' ' ' ASP . 28.7 m120 -63.63 -47.35 81.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.18 -50.59 73.0 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.097 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -58.19 -34.27 70.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.89 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 1.9 tpt180 -56.48 -46.98 80.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.601 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -65.21 -36.93 85.71 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.139 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.15 -48.0 85.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.264 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.679 HG21 HG23 ' A' ' 61' ' ' ILE . 2.5 p -65.33 -39.38 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.124 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.25 -41.97 13.72 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' C ' ' A' ' 92' ' ' LEU . 13.8 mt-10 -72.44 -56.91 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.844 -0.742 . . . . 1.0 111.255 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -7.71 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.661 -0.699 . . . . 1.0 112.608 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.05 -32.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.572 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.35 -32.4 38.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.006 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HG ' HG21 ' A' ' 53' ' ' THR . 65.4 mt -100.81 -20.69 15.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 1.0 110.435 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.5 tttp 62.35 53.44 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 1.0 110.22 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 44.1 t -77.19 -167.27 0.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.818 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' N ' ' OG ' ' A' ' 97' ' ' SER . 90.6 mttt -139.41 4.4 2.19 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -143.81 70.56 16.99 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.359 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 11.3 Cg_exo -67.08 -38.45 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.932 2.422 . . . . 1.0 112.915 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.82 -49.23 72.25 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.194 -0.527 . . . . 1.0 112.082 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -71.92 -36.2 69.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 1.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -58.56 -49.18 83.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.22 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.505 ' CE1' HD12 ' A' ' 127' ' ' LEU . 10.6 m-85 -54.25 -47.01 72.73 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.576 -0.45 . . . . 1.0 110.561 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.66 -51.32 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.055 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.38 -48.84 71.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.87 -46.36 87.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.09 -36.55 77.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.657 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 105' ' ' ILE . 3.0 m-20 -58.47 -38.05 76.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.38 -32.94 70.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.284 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 115' ' ' ALA . 1.1 t -66.91 -40.87 86.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.072 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -53.58 -37.89 63.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.23 0.538 . . . . 1.0 110.538 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -64.54 -45.11 88.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.317 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -102.22 -74.47 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.42 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.5 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.59 171.94 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.968 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.78 161.18 27.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.341 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.15 -31.9 72.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -59.2 -39.42 82.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.397 . . . . 1.0 110.275 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -66.63 -38.66 87.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.907 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.9 -37.63 91.26 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -62.58 -46.53 87.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.983 0.421 . . . . 1.0 110.082 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -62.31 -37.87 87.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.716 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -59.71 -42.16 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.635 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -66.6 -50.41 63.12 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.804 -0.358 . . . . 1.0 110.493 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.39 -45.89 92.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -68.31 -29.26 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.414 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.505 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -61.72 -47.8 83.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.936 0.398 . . . . 1.0 110.276 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 -31.54 72.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.145 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.59 -38.86 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.246 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -68.26 -38.78 80.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.076 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' CE1' HD11 ' A' ' 135' ' ' ILE . 23.1 t80 -54.82 -53.32 56.81 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.193 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -36.97 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.331 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.43 75.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.372 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.2 t80 -66.38 -45.54 79.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.576 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -84.21 121.15 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.1 p -101.43 -24.58 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 139' ' ' LYS . 24.9 p -73.54 -7.22 50.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.591 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.3 p -65.63 4.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 137' ' ' SER . 7.3 mtpm? -124.23 166.46 15.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 140' ' ' GLU . 17.7 mp0 -86.89 -5.32 59.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.472 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -74.03 138.21 43.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.601 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -80.8 146.64 60.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.279 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.84 150.92 85.49 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.419 2.08 . . . . 1.0 112.049 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 m -155.51 85.35 1.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.405 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -86.46 2.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.647 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -73.7 83.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.5 t -54.31 167.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.972 -1.014 . . . . 1.0 110.523 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.6 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -88.92 41.23 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.2 p90 -64.7 -44.49 90.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.891 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 5.4 ptm180 -57.17 -34.58 68.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.728 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -56.55 -43.27 79.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.345 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.67 -42.38 87.68 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.25 -37.06 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 1.0 110.733 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 107' ' ' ILE . 22.8 ttm-85 -74.33 -45.44 47.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.875 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.571 ' HA ' HD22 ' A' ' 110' ' ' LEU . 61.4 m-20 -67.22 -38.99 86.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 1.0 110.288 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.9 m -62.23 -20.76 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.61 -40.2 93.99 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.46 -49.61 75.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 1.0 112.211 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.683 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -55.9 -36.56 67.81 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.018 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -66.39 -42.67 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.8 mm? -59.86 -34.58 73.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.663 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -61.97 -40.56 95.99 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -62.6 -31.73 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -62.02 -34.79 76.85 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.55 ' CG ' HD22 ' A' ' 83' ' ' ASN . 4.4 m-20 -66.8 -32.81 74.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.691 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.0 mp -90.71 -45.7 8.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.48 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.29 -46.76 5.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.026 -0.27 . . . . 1.0 111.101 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.86 40.81 97.27 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 24' ' ' ASN . 20.6 tt0 -132.79 165.29 24.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.374 -0.232 . . . . 1.0 110.374 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLU . 6.8 t-20 -18.2 86.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.637 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' GLU . 47.1 Cg_exo -53.38 -23.3 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.588 2.192 . . . . 1.0 112.202 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.95 71.23 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -60.71 -49.78 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.197 0.523 . . . . 1.0 109.942 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.09 -37.09 71.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.39 -39.17 72.54 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.897 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 73.9 tttt -57.35 -32.95 67.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.745 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.04 -40.63 75.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -73.6 -42.75 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.52 -35.56 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.7 mt-10 -65.96 -49.01 69.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.172 . . . . 1.0 111.104 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.36 -44.03 53.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.681 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -80.81 -6.89 59.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' LYS . 53.2 m-80 39.56 48.58 1.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.944 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' ASN . 38.2 mm -37.94 93.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.643 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 37' ' ' ASN . 41.8 tttp -63.37 62.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.025 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' ILE . 1.8 m120 161.0 91.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.782 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -57.22 -35.31 69.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.714 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -53.11 -40.7 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.864 0.84 . . . . 1.0 109.199 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.28 -46.35 61.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.128 -1.397 . . . . 1.0 111.513 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.1 t80 -56.36 -42.59 78.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.939 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -68.97 -47.28 66.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -59.48 -36.85 76.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.31 -0.859 . . . . 1.0 109.819 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.37 93.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.283 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -58.57 -52.32 66.15 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.804 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -58.67 -35.59 72.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.183 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.19 -43.65 92.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.611 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 15' ' ' LEU . 44.7 t -64.91 -35.13 74.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.544 -0.462 . . . . 1.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 56' ' ' ARG . 37.2 t70 -60.48 -30.58 69.78 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.938 -0.705 . . . . 1.0 110.879 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.678 HG21 ' HG ' ' A' ' 95' ' ' LEU . 90.6 m -58.81 -31.2 68.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.65 -42.94 40.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.943 -1.481 . . . . 1.0 110.107 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.26 -15.57 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.407 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 52' ' ' ASP . 22.5 ttt85 -50.12 -14.68 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.381 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CD2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -135.05 -37.0 0.81 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.663 0.268 . . . . 1.0 110.496 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.43 -110.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.389 0.515 . . . . 1.0 112.389 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -59.54 -43.33 93.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 74.8 tt0 -51.31 -37.35 47.11 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.807 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.8 mt -60.23 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 119.707 -0.797 . . . . 1.0 109.325 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 65' ' ' ILE . 76.9 m-20 -55.86 -44.75 78.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -59.86 -42.57 93.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.608 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.88 -36.43 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -65.56 -44.9 93.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.0 110.808 177.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' N ' HG22 ' A' ' 65' ' ' ILE . 71.4 mt-10 -60.99 -35.24 76.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.615 -0.72 . . . . 1.0 112.704 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -54.24 -26.17 27.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.112 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.614 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 2.9 t60 -102.36 -42.05 6.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.236 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' HIS . 25.9 mt -34.55 -48.28 0.36 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.764 0.316 . . . . 1.0 110.874 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 72.61 59.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.703 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.35 -48.21 1.08 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 3.8 m0 -60.19 170.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 1.0 110.885 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 t -123.11 143.81 49.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.141 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -56.06 -23.82 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 77' ' ' LEU . 20.7 m-20 -59.68 -23.31 62.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.007 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 75' ' ' ASP . 8.1 ttt180 -20.94 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.747 -0.661 . . . . 1.0 111.992 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER 42.89 -172.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.864 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 77' ' ' LEU . . . 52.38 111.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.319 -0.712 . . . . 1.0 111.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.01 -51.75 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 80' ' ' VAL . 3.3 t -51.75 -48.77 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.004 0.43 . . . . 1.0 110.147 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 22.3 mt-10 -47.32 -48.96 25.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.656 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -51.94 40.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.846 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.55 HD22 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -72.21 -44.41 62.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.113 0.482 . . . . 1.0 110.545 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.92 75.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.452 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -55.61 -45.87 77.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.224 -0.59 . . . . 1.0 110.423 -178.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -59.59 -44.86 93.23 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.76 -0.776 . . . . 1.0 110.159 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.59 -35.45 81.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.011 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -65.02 -47.87 77.44 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.379 -0.915 . . . . 1.0 111.389 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.807 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.58 -35.27 74.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.868 0.366 . . . . 1.0 110.241 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.946 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.21 -43.39 7.17 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.382 0.611 . . . . 1.0 110.057 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.2 -57.97 3.57 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.111 -1.036 . . . . 1.0 111.681 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.3 mp -13.18 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 -31.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.958 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.946 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 19.3 m-85 -53.78 -32.26 51.83 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.749 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.678 ' HG ' HG21 ' A' ' 53' ' ' THR . 12.9 mt -90.23 -20.3 23.16 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.399 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' CD ' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 62.45 50.74 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 1.0 109.962 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 t -77.91 158.12 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.848 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -83.0 -21.84 33.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.98 70.49 28.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.828 -0.624 . . . . 1.0 109.917 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -62.59 -26.28 75.78 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.97 2.447 . . . . 1.0 112.728 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.66 -50.06 59.0 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.952 -0.642 . . . . 1.0 111.927 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.8 -41.43 62.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.675 0.274 . . . . 1.0 111.653 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.16 -49.0 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.779 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.47 -46.42 73.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.387 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -50.39 -52.37 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.5 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -55.96 -41.02 74.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.593 -0.731 . . . . 1.0 110.595 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 8' ' ' ARG . 2.8 mm -56.67 -47.29 82.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.73 -36.65 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.402 -0.519 . . . . 1.0 109.953 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.86 -35.87 73.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.918 -1.142 . . . . 1.0 107.918 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.83 -34.34 74.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.831 -1.077 . . . . 1.0 109.902 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.53 -38.92 83.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.247 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -52.31 -37.54 56.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 1.0 110.255 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -69.24 -44.86 71.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 1.0 111.012 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.46 -66.39 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.105 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -86.28 147.5 26.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.888 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 1.4 p30 -39.7 151.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.943 -0.572 . . . . 1.0 111.136 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -62.39 -32.64 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -59.76 -36.49 76.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.398 . . . . 1.0 110.272 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -68.01 -36.12 79.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.252 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.92 -36.97 83.07 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -62.13 -46.82 87.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.035 0.445 . . . . 1.0 109.849 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.492 ' O ' HG12 ' A' ' 126' ' ' VAL . 84.3 t80 -67.86 -42.71 80.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.243 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 119' ' ' ALA . 49.6 t -60.49 -42.56 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.084 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.84 -51.88 43.36 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.529 -0.469 . . . . 1.0 111.031 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.18 66.97 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.661 -0.576 . . . . 1.0 111.661 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 8.4 p -64.36 -28.86 45.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.989 -0.284 . . . . 1.0 111.13 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.5 OUTLIER -60.22 -46.76 88.66 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.502 -0.479 . . . . 1.0 109.878 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.1 m -59.55 -29.17 67.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.483 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -55.42 -41.35 72.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.894 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.524 HD11 HG12 ' A' ' 65' ' ' ILE . 5.4 mt -68.42 -38.07 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.065 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -54.41 -52.59 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.028 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.88 -37.61 71.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.79 78.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.0 110.307 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' HD13 ' A' ' 135' ' ' ILE . 9.0 t80 -58.39 -43.96 88.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.576 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -85.39 79.75 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 1.0 110.161 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.64 -27.13 12.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.569 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.9 t -75.33 -20.7 58.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.86 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.7 p -45.09 -86.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.73 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -44.65 -70.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.795 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.48 110.2 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.86 -60.5 2.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.651 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.46 159.45 55.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.78 139.01 55.75 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.757 2.305 . . . . 1.0 111.994 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.4 t -93.51 -147.79 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.25 107.96 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.437 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -93.86 138.97 31.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.492 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 p -80.45 160.53 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.602 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.45 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -157.54 -21.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.524 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 6.9 p90 -65.8 -39.33 90.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.342 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.547 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.0 ptm180 -58.17 -40.51 81.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.545 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 4' ' ' ARG . 31.8 ttmt -56.96 -36.32 70.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.331 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.46 -36.43 59.14 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.62 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.0 110.33 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 42.9 mtt180 -74.34 -38.05 63.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 110' ' ' LEU . 12.0 t70 -61.15 -48.07 83.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 1.0 110.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -62.11 -20.48 64.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.025 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.54 -46.58 73.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.921 0.391 . . . . 1.0 110.996 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.48 -42.71 88.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.154 0.502 . . . . 1.0 110.035 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 15.6 tp -51.9 -46.38 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.484 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -63.11 -45.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.508 -0.477 . . . . 1.0 109.722 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.02 -33.7 75.99 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.609 -0.723 . . . . 1.0 109.175 179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -63.99 -37.23 86.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.983 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -66.45 -31.6 72.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.807 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.441 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -62.89 -31.13 72.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.409 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.92 -33.85 76.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.646 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.47 -46.0 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.261 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.57 -46.79 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.04 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.5 9.29 61.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' ASN . 95.8 mt-10 -89.56 173.44 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 1.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.851 HD22 ' H ' ' A' ' 27' ' ' GLU . 13.7 t30 -38.5 124.61 1.13 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.441 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.13 -27.19 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.243 1.962 . . . . 1.0 112.264 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.09 -47.05 91.73 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.851 ' H ' HD22 ' A' ' 24' ' ' ASN . 38.6 mt-10 -64.87 -49.22 71.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.064 0.459 . . . . 1.0 110.376 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.82 -37.39 71.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.67 -41.75 77.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.1 mtmt -56.92 -32.8 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.329 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.01 -41.87 81.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.703 0.631 . . . . 1.0 112.703 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 32' ' ' VAL . 2.3 p -73.82 -44.2 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.99 -36.12 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 -178.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.4 mt-10 -61.27 -49.46 76.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.961 -1.018 . . . . 1.0 110.486 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.39 -43.81 54.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ILE . 4.2 ttmm -102.37 111.86 24.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -64.69 49.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.288 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' LYS . 23.1 mm -26.88 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.887 0.375 . . . . 1.0 111.029 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.3 mptm? -45.12 152.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 1.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.65 97.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -51.05 -33.05 23.82 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.4 m-20 -54.03 -42.84 69.61 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.193 -0.912 . . . . 1.0 109.713 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.05 -47.61 85.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.379 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 38' ' ' ILE . 2.7 t80 -59.03 -47.57 84.74 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.729 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.69 -48.56 59.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.18 -37.19 79.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.667 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.19 -42.32 94.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.781 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 51' ' ' VAL . 34.6 ttpt -59.09 -51.82 68.39 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.04 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -57.29 -36.82 71.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.115 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.22 -45.43 91.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.797 -179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -65.5 -33.43 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.219 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' ARG . 32.6 m-20 -58.48 -29.78 66.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.627 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HG ' ' A' ' 95' ' ' LEU . 88.2 m -58.8 -31.58 68.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.126 -1.064 . . . . 1.0 108.126 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.69 -41.66 44.52 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.347 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 57' ' ' HIS . 12.9 t -78.7 -16.91 13.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.067 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 56.0 ttt180 -51.07 -15.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.286 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' N ' ' C ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -178.56 35.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.727 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 tt -33.69 -49.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 1.0 112.597 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.28 -48.56 81.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.954 -0.699 . . . . 1.0 110.201 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.56 -37.34 67.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.793 -0.64 . . . . 1.0 109.783 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 13.1 mt -60.16 -47.5 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 120.133 -0.627 . . . . 1.0 109.824 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -55.89 -45.68 78.54 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 t -57.93 -45.26 86.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.188 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 130' ' ' ILE . 23.7 mt -59.37 -39.18 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.079 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -72.75 -38.11 57.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.332 177.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 65' ' ' ILE . 24.7 tt0 -63.93 -37.61 88.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.439 -0.801 . . . . 1.0 112.722 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -56.57 -26.51 55.36 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.044 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 6.4 t-80 -102.63 -29.38 11.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.744 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.7 mt -38.15 -33.01 0.08 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.846 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.7 tttt 71.67 61.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.604 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 36.91 93.67 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.416 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -129.88 167.3 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 m -112.03 128.75 56.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.305 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.11 -24.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.071 0.463 . . . . 1.0 109.912 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -67.7 -22.1 65.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.9 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -33.95 -87.52 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.966 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ARG . 2.2 mm? -49.6 -173.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 1.0 111.69 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.75 168.22 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.874 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -51.92 14.0 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.587 -0.306 . . . . 1.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.3 t -51.39 -45.6 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.933 0.397 . . . . 1.0 110.662 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 123' ' ' VAL . 4.5 mm-40 -47.32 -50.9 20.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.013 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 75' ' ' ASP . 1.2 ttt180 -51.64 -50.78 59.65 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.23 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -69.16 -48.17 63.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.301 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -56.93 -44.33 82.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.284 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -55.92 -44.91 78.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.899 ' N ' HD13 ' A' ' 85' ' ' LEU . 3.7 mtt180 -61.74 -43.68 98.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.651 -0.419 . . . . 1.0 110.837 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.75 -34.0 77.29 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.056 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.29 -47.49 71.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.359 -0.925 . . . . 1.0 111.482 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.3 p -62.29 -33.85 61.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.742 0.306 . . . . 1.0 110.717 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.858 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -45.21 10.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.432 -0.507 . . . . 1.0 110.181 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.627 ' OE2' HD11 ' A' ' 107' ' ' ILE . 2.9 mt-10 -73.83 -55.14 6.57 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.481 -0.887 . . . . 1.0 111.7 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 127' ' ' LEU . 4.5 mp -11.51 -73.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.718 0.636 . . . . 1.0 112.718 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.81 -32.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.254 0.464 . . . . 1.0 112.254 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 5.1 m-85 -53.1 -31.99 44.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.299 -177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 53' ' ' THR . 60.3 mt -98.71 -20.29 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.842 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttm 58.89 32.43 22.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.363 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 t -46.79 157.19 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.817 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -25.25 61.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -139.91 69.83 36.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.035 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.99 -17.75 46.36 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.92 2.413 . . . . 1.0 112.749 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.56 -49.95 22.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.364 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -37.28 65.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.723 0.297 . . . . 1.0 111.187 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.97 -49.54 82.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.672 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.89 -46.89 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.484 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.505 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.24 -53.23 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 119.786 -0.766 . . . . 1.0 111.144 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -56.65 -42.23 78.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.338 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.8 mt -56.33 -47.85 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.4 t -67.52 -36.77 77.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.417 -0.513 . . . . 1.0 110.073 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.37 -35.47 79.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -61.98 -32.22 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.818 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.433 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.92 -39.21 84.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.405 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -52.24 -37.89 56.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.197 0.523 . . . . 1.0 110.619 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.59 -44.97 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.382 -0.827 . . . . 1.0 110.96 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.78 -63.88 1.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.011 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.31 156.19 17.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.2 OUTLIER -40.11 143.69 0.26 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.285 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -36.79 83.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -59.29 -30.28 68.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.018 0.437 . . . . 1.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.891 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.91 -36.82 70.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.913 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.49 -37.07 80.37 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -46.93 86.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.143 0.497 . . . . 1.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -66.02 -39.27 90.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.6 t -59.7 -46.36 93.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.536 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.412 ' HB2' HG11 ' A' ' 108' ' ' VAL . 33.2 t-20 -66.92 -50.55 62.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.362 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.74 -48.23 73.16 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.73 -30.81 43.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.406 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 92' ' ' LEU . 9.6 tt -65.51 -46.09 81.0 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 1.0 110.117 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.2 p -58.45 -28.88 65.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.409 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.676 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.27 -40.41 77.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 65' ' ' ILE . 14.4 mt -58.77 -39.73 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.675 -0.41 . . . . 1.0 109.915 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -52.31 62.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.986 ' O ' HD12 ' A' ' 135' ' ' ILE . 16.8 ttpt -59.38 -36.48 75.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.824 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.89 70.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.916 0.388 . . . . 1.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 136' ' ' THR . 83.3 t80 -63.56 -47.24 82.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.404 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.83 -6.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.011 ' N ' HD13 ' A' ' 135' ' ' ILE . 17.0 p -68.06 -32.18 72.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.789 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -83.27 -36.47 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.5 m -76.23 5.39 7.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.536 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -132.22 -176.44 4.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.382 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -159.71 -23.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' CG ' ' H ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER 47.49 -141.79 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.487 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.547 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -72.44 148.16 90.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.326 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.4 151.9 83.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.377 2.052 . . . . 1.0 112.013 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -138.93 106.59 5.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mt -105.7 -169.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.43 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -55.92 -168.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.6 p -144.61 114.2 7.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.529 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.608 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -168.94 23.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.695 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.5 p90 -65.69 -35.72 81.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.415 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.9 ptp85 -59.54 -38.65 81.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -56.66 -38.65 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.532 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -71.34 -31.38 66.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.48 -35.4 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.014 -0.275 . . . . 1.0 110.968 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -74.96 -45.26 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.854 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 1.1 p-10 -66.99 -36.98 83.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.009 0.433 . . . . 1.0 110.533 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 m -62.1 -20.94 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.73 83.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 1.0 112.132 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.76 -38.5 69.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.628 . . . . 1.0 110.93 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.52 -42.93 94.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.427 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.5 mm? -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.21 -38.09 89.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -64.1 -32.53 74.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.128 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.99 -33.74 76.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.211 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.957 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.8 mm? -89.5 -45.71 9.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.756 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -106.28 -47.23 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.589 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.96 34.57 65.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 24' ' ' ASN . 48.5 tt0 -133.13 131.33 40.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.871 0.367 . . . . 1.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 23' ' ' GLU . 42.3 t-20 33.5 80.52 0.25 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.608 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -55.11 -24.93 43.04 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.649 2.232 . . . . 1.0 112.197 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.39 -44.24 65.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.166 -0.774 . . . . 1.0 111.166 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.93 -49.84 76.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 1.0 110.085 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 17' ' ' ARG . 9.0 mp -56.67 -40.09 74.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.202 -0.908 . . . . 1.0 110.909 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.638 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -61.53 -43.2 99.3 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.053 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 14.2 mtpp -57.94 -33.1 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.583 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.2 -38.78 68.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.9 p -73.14 -44.01 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.616 0.245 . . . . 1.0 111.624 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.0 -35.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 -179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.9 mt-10 -66.54 -49.03 67.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.856 -1.066 . . . . 1.0 111.164 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -74.42 -44.06 53.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.912 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 37' ' ' ASN . 66.8 tttt -84.19 -4.19 58.65 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.116 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' LYS . 20.8 m120 37.71 47.2 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.06 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -33.44 -31.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.132 -0.485 . . . . 1.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' LYS . 7.4 tmtm? 66.1 -76.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 29.9 m120 -54.84 83.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.25 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 39' ' ' LYS . 79.6 tttt -51.32 -35.25 37.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -53.39 -41.13 65.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.857 0.837 . . . . 1.0 108.766 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -71.86 -48.33 46.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.124 -1.398 . . . . 1.0 111.503 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 44' ' ' TYR . 1.5 t80 -59.27 -44.27 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.63 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.5 -47.16 67.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -60.54 -37.12 80.18 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.389 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -65.47 -38.22 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.308 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.734 ' O ' HG12 ' A' ' 51' ' ' VAL . 9.8 ttpp -58.76 -51.48 69.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.0 109.591 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -58.07 -37.02 73.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.658 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.63 -42.6 93.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.215 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.3 p -65.11 -34.33 69.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.22 -0.592 . . . . 1.0 111.558 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.4 m-20 -61.97 -28.49 69.59 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.964 -0.694 . . . . 1.0 110.974 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.557 HG22 ' HB1' ' A' ' 90' ' ' ALA . 92.2 m -57.57 -32.86 67.56 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.55 -41.62 38.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.818 -1.537 . . . . 1.0 110.541 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 57' ' ' HIS . 15.4 t -78.71 -13.94 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.988 -1.006 . . . . 1.0 111.776 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.0 ttt85 -48.66 -13.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.185 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.16 -52.4 0.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.936 -0.306 . . . . 1.0 110.665 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 32.3 mt 79.09 -97.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.662 0.615 . . . . 1.0 112.662 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -59.41 -45.96 90.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.385 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 20.6 tt0 -52.27 -37.27 55.02 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.312 -0.555 . . . . 1.0 109.952 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.744 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.0 mt -60.6 -49.56 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 119.997 -0.681 . . . . 1.0 109.631 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.85 -45.7 82.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -59.58 -41.59 90.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.369 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.6 mt -59.89 -37.59 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.29 -38.62 74.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.201 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 65' ' ' ILE . 32.5 mt-10 -60.12 -35.56 75.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 1.0 112.207 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.72 -25.74 29.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.635 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.968 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 44.9 t-80 -99.27 -40.16 8.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.723 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 71' ' ' GLY . 66.9 mt -45.18 -15.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 68' ' ' HIS . 27.7 ttmt 70.62 -40.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . -177.24 -10.15 0.02 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -77.37 -176.52 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 1.0 110.645 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -120.52 144.53 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.04 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.68 -24.31 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.083 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.644 ' O ' ' N ' ' A' ' 77' ' ' LEU . 51.1 p30 -60.75 -24.55 65.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.281 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.546 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 36.14 -83.82 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.984 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -154.41 -61.95 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.62 138.96 45.02 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.98 -50.29 20.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.649 0.262 . . . . 1.0 111.592 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 3.5 t -51.34 -48.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 1.0 110.99 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.664 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 3.4 mm-40 -47.69 -47.55 29.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.161 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -50.84 -51.25 53.02 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.1 p30 -72.41 -44.94 61.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.209 -0.597 . . . . 1.0 110.007 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.92 -38.82 76.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.042 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -55.22 -47.64 75.04 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.597 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -61.02 -42.04 97.71 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.557 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.97 -37.42 84.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.641 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -67.14 -46.5 71.65 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.529 -0.843 . . . . 1.0 111.8 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -65.62 -31.03 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.12 -42.1 8.56 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.6 mp0 -69.15 -58.81 3.57 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.412 -0.915 . . . . 1.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -4.01 -83.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.792 -0.64 . . . . 1.0 112.03 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -119.99 -31.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.017 0.437 . . . . 1.0 111.434 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 4.1 m-85 -53.07 -37.2 61.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.795 -0.638 . . . . 1.0 111.301 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 95' ' ' LEU . 11.2 tp -101.49 -19.91 15.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 96' ' ' LYS . 2.8 ttmp? 61.14 63.44 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.37 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 p -75.02 163.15 27.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -86.41 -27.82 23.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.307 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.56 70.06 31.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -52.59 -41.49 68.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.006 2.471 . . . . 1.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.89 64.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -72.26 -36.07 68.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.588 0.232 . . . . 1.0 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -58.66 -43.13 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.077 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.41 -48.91 73.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.764 -0.774 . . . . 1.0 109.905 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.43 -52.32 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.029 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.08 -48.16 76.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -58.61 -43.62 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 104' ' ' PHE . 90.8 t -69.38 -36.86 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 105' ' ' ILE . 11.0 t70 -57.0 -34.26 67.96 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.22 -35.77 78.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.683 179.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.15 -39.52 84.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.341 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -53.25 -38.23 62.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 1.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -65.91 -45.06 83.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.174 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -94.35 -70.77 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.436 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -78.3 179.47 6.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.005 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -78.28 152.82 32.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.193 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -62.43 -32.16 72.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -59.84 -38.84 83.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 1.0 110.396 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.23 -36.92 84.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.129 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.01 -36.33 80.61 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -61.77 -46.86 87.78 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.93 -39.87 83.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.286 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 119' ' ' ALA . 57.2 t -59.66 -48.28 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.849 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.61 -50.04 68.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.499 -0.318 . . . . 1.0 111.001 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.23 -44.41 93.29 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -70.15 -28.8 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.376 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -62.1 -47.84 82.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.037 0.446 . . . . 1.0 110.237 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.8 t -63.69 -29.66 70.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.68 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.968 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.33 -34.34 68.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.852 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.688 HD11 HG12 ' A' ' 65' ' ' ILE . 12.2 mt -67.44 -39.89 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.034 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -55.05 -52.24 63.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.702 0.287 . . . . 1.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -57.69 -40.72 80.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.552 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 136' ' ' THR . . . -68.3 -33.49 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.732 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -61.21 -52.19 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.181 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.918 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.8 -25.16 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.92 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 133' ' ' ALA . 0.6 OUTLIER -62.82 -30.12 71.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.339 . . . . 1.0 110.515 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.5 p -106.63 -36.52 6.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.292 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 p 41.81 -98.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -124.0 165.44 17.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' OE1' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm-20 -47.78 -37.63 13.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 16.5 tp10 66.53 158.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.655 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -69.03 146.75 97.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.172 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.75 154.94 71.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.374 2.05 . . . . 1.0 112.032 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t 58.37 17.88 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.618 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.405 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 4.2 tp 50.47 -139.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 145' ' ' LEU . 35.3 mttp -69.54 152.77 44.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.642 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.0 t 56.66 177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.625 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 148' ' ' GLU . 33.4 mp0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.567 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -164.52 6.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.582 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.548 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 6.3 p90 -59.25 -42.02 90.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.325 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 18.1 ptt85 -61.64 -36.01 79.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.459 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -57.47 -41.29 80.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.489 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.73 52.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.44 -40.74 79.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.32 . . . . 1.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.71 -44.34 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.556 ' OD1' HD13 ' A' ' 110' ' ' LEU . 62.5 t0 -61.15 -46.12 91.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.027 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -62.29 -21.01 64.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.426 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.35 -45.76 69.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 1.0 110.93 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.69 -42.84 84.5 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.408 -0.517 . . . . 1.0 110.97 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.33 -43.91 71.61 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -67.22 -39.92 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 119.369 -0.932 . . . . 1.0 109.325 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.656 HD21 HG23 ' A' ' 51' ' ' VAL . 85.1 mt -64.2 -33.93 76.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 9.2 t80 -62.79 -37.96 88.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.353 -0.84 . . . . 1.0 109.804 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -65.86 -32.66 74.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.221 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -31.31 72.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.231 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -66.83 -34.52 78.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.1 mp -92.1 -46.22 7.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.618 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -96.94 -47.3 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.151 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.25 50.22 52.24 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASN . 1.6 mt-10 -130.53 173.07 11.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -32.13 96.97 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.927 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HG2' HG21 ' A' ' 55' ' ' VAL . 51.5 Cg_exo -50.54 -29.81 25.96 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.489 2.126 . . . . 1.0 112.355 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' CA ' ' NZ ' ' A' ' 48' ' ' LYS . . . -65.88 -47.8 71.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -60.86 -50.08 74.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.247 0.546 . . . . 1.0 110.348 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 HD12 ' HG2' ' A' ' 17' ' ' ARG . 4.4 mm? -56.26 -39.22 72.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.904 ' CD2' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -56.14 -42.33 76.79 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 3.6 tptt -57.23 -33.07 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.438 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.16 -41.75 85.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.632 0.604 . . . . 1.0 112.632 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.1 p -73.8 -45.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.2 0.444 . . . . 1.0 112.2 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.16 -36.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 -178.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 1.5 mt-10 -58.8 -49.27 78.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.796 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.74 -44.42 49.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 38' ' ' ILE . 8.1 mttp -84.39 117.67 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.424 . . . . 1.0 110.702 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.13 50.46 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 36' ' ' LYS . 40.6 mm -46.16 -36.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.387 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' LYS . 38.7 mtmt 57.43 -90.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 39' ' ' LYS . 10.0 m-20 -37.84 89.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.93 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 39' ' ' LYS . 56.6 tttt -53.32 -33.88 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.211 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.19 -40.18 64.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.815 0.817 . . . . 1.0 109.151 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.42 -47.65 54.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.161 -1.382 . . . . 1.0 111.415 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.87 -42.62 84.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.982 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -69.13 -47.74 64.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.063 -0.718 . . . . 1.0 109.063 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.63 -37.14 70.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -65.26 -42.82 92.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 51' ' ' VAL . 13.4 ttmm -58.95 -52.0 67.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.895 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.19 70.66 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.697 . . . . 1.0 110.197 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.41 -47.69 83.09 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.966 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG23 HD21 ' A' ' 15' ' ' LEU . 3.1 p -69.25 -31.81 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.3 -29.9 71.13 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.245 -0.982 . . . . 1.0 110.49 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' HB1' ' A' ' 90' ' ' ALA . 59.6 m -60.85 -33.87 73.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.39 -36.58 58.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.873 -1.512 . . . . 1.0 110.635 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.9 t -78.98 -16.85 13.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.405 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -55.37 -14.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.813 0.34 . . . . 1.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -124.92 -42.07 2.06 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.515 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 59' ' ' GLU . 4.5 mt 69.21 -117.56 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.22 -0.445 . . . . 1.0 112.188 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 58' ' ' ILE . 56.6 mt-10 -59.8 -39.6 85.52 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.514 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 64' ' ' ILE . 43.4 tt0 -50.22 -36.72 32.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.709 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.735 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.1 mt -58.9 -50.41 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.757 -0.777 . . . . 1.0 110.164 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -56.28 -46.01 79.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.214 -1.032 . . . . 1.0 108.214 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -43.18 91.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.367 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.478 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.2 mt -59.38 -38.08 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.5 -39.15 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.634 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 65' ' ' ILE . 75.2 mt-10 -59.82 -35.71 75.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -54.54 -24.92 22.84 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.668 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -100.6 -38.99 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.841 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 62.7 mt -45.51 -22.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.684 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt 54.83 36.91 27.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.553 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 127.67 -65.8 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -42.89 167.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.056 0.455 . . . . 1.0 110.852 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.0 p -117.42 147.22 42.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.938 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.638 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -55.81 -23.85 15.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -58.78 -23.67 60.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.303 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -45.79 162.57 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.546 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 122' ' ' PHE . 11.2 mt 57.47 -179.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -41.52 162.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -39.22 63.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 1.0 110.65 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 12' ' ' PHE . 40.0 t -51.53 -46.66 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.429 . . . . 1.0 110.493 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -47.69 -49.3 28.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.925 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -51.58 -49.79 61.4 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.879 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.52 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 16.6 m-80 -69.09 -45.09 71.13 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.46 78.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.661 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -56.24 -41.69 76.15 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.432 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -56.44 -44.92 80.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.067 -178.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 50' ' ' LEU . 25.0 mt -60.53 -41.84 95.27 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.948 -0.701 . . . . 1.0 111.761 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.58 -48.55 80.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.921 -1.133 . . . . 1.0 111.08 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.735 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.1 p -67.85 -36.8 77.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 1.0 110.19 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -47.75 -40.92 21.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' C ' ' A' ' 92' ' ' LEU . 3.5 mt-10 -72.95 -57.33 4.13 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.686 -0.806 . . . . 1.0 110.478 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.618 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -5.1 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.73 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.55 -33.0 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.888 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -53.9 -39.48 65.82 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.123 -177.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 11.6 tp -101.6 -18.43 15.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.981 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 18.3 tttp 83.23 -46.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.318 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 t 47.69 -174.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.055 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -130.77 -30.8 1.8 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.11 72.5 76.15 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.006 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 46.2 Cg_exo -50.8 -42.84 49.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.067 2.511 . . . . 1.0 113.07 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.77 -49.2 81.27 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.216 -0.753 . . . . 1.0 111.216 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -72.46 -35.53 68.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 1.0 110.657 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.2 t -58.56 -46.19 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.57 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -53.95 -47.54 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.252 -0.579 . . . . 1.0 110.048 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.97 -50.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.982 -178.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.23 -48.88 70.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.87 -46.0 87.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 104' ' ' PHE . 25.6 t -67.6 -35.87 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.035 -0.984 . . . . 1.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' ILE . 28.6 t70 -56.52 -37.41 70.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.73 -33.73 73.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.653 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.94 -39.96 86.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.234 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -57.08 -38.41 73.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.207 0.527 . . . . 1.0 110.867 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -61.3 -45.3 95.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.398 -0.819 . . . . 1.0 111.157 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.91 -73.87 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.517 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -68.41 -178.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.202 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -82.22 146.43 29.51 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.448 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.66 -32.04 73.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.503 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.45 -41.9 90.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 1.0 110.412 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -65.96 -32.87 74.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.284 0.564 . . . . 1.0 110.041 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.26 76.79 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.891 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -62.14 -46.63 88.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 24.9 t80 -64.47 -33.46 75.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.457 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 119' ' ' ALA . 76.7 t -61.1 -47.78 92.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.224 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -67.23 -50.8 59.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.475 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.3 -52.9 46.73 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.61 -0.596 . . . . 1.0 111.61 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 6.8 p -62.99 -29.24 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.936 -0.305 . . . . 1.0 110.67 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -63.35 -45.76 89.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.972 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.8 m -57.5 -28.73 63.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.409 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.25 -35.29 69.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.121 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.7 HD11 HG12 ' A' ' 65' ' ' ILE . 12.1 mt -67.67 -40.21 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.483 ' HB2' HD11 ' A' ' 92' ' ' LEU . 10.3 t80 -62.98 -43.94 97.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.865 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.973 ' O ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER -57.5 -37.24 72.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.703 -0.399 . . . . 1.0 109.978 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.54 -33.32 69.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.642 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' O ' ' N ' ' A' ' 136' ' ' THR . 55.0 t80 -63.53 -46.26 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.55 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.018 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.89 -5.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.067 0.395 . . . . 1.0 112.067 -178.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.018 ' N ' HD13 ' A' ' 135' ' ' ILE . 34.1 p -76.02 -38.65 57.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 1.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -17.4 43.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.65 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -44.94 -27.58 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.583 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 140' ' ' GLU . 14.2 ttmt -106.44 -157.74 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.402 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.18 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.35 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 49.84 42.21 23.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.763 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 142' ' ' LYS . 2.2 mtmp? -69.79 151.42 96.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 1.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 144' ' ' SER . 17.9 Cg_endo -60.83 148.58 91.7 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.298 1.999 . . . . 1.0 111.922 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 143' ' ' PRO . 15.4 m -43.87 170.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.68 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.829 ' N ' HD22 ' A' ' 145' ' ' LEU . 2.2 mm? -89.08 -58.81 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -54.28 149.08 10.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.556 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 148' ' ' GLU . 92.9 p -167.81 -84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.583 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' ' OG ' ' A' ' 147' ' ' SER . 44.9 mm-40 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 1.0 109.429 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -163.76 -26.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.668 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 20.4 p90 -54.88 -39.4 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 51.5 ttp180 -57.4 -32.96 67.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -56.57 -37.48 70.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.161 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.6 -48.97 20.64 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.344 -1.102 . . . . 1.0 110.344 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.47 66.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.924 0.392 . . . . 1.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.569 HH21 ' CG ' ' A' ' 106' ' ' ASP . 27.9 ttp180 -74.3 -44.98 50.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.124 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -65.9 -42.77 89.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.055 0.455 . . . . 1.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.4 p -61.93 -19.42 62.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.2 -44.78 64.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.326 0.584 . . . . 1.0 111.004 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.637 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.12 -49.11 76.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.127 -0.629 . . . . 1.0 111.383 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -55.09 -41.46 71.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.509 -0.476 . . . . 1.0 111.442 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.3 p -70.24 -38.48 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.736 -0.786 . . . . 1.0 109.427 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -63.22 -33.32 75.24 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CD2' ' OD1' ' A' ' 83' ' ' ASN . 13.4 t80 -62.2 -37.5 85.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.298 -0.864 . . . . 1.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -33.68 76.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.36 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 10.1 t-105 -63.09 -32.86 74.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 25.6 t70 -66.63 -33.3 75.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp -91.37 -45.38 8.61 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.313 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -46.73 5.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.976 -0.289 . . . . 1.0 110.891 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 60.93 19.06 55.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -132.6 125.25 30.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.731 0.3 . . . . 1.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.75 87.76 0.11 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.887 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.78 -17.74 12.17 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.274 1.982 . . . . 1.0 111.839 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.6 -46.95 29.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.94 -48.73 79.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.538 . . . . 1.0 109.935 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 -36.14 70.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.315 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.43 -40.61 71.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.269 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 9.2 mtpp -57.91 -33.21 68.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.332 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -67.92 -40.7 83.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 2.0 p -73.42 -44.03 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.86 -36.09 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -62.39 -49.23 76.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.959 -1.019 . . . . 1.0 111.273 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.6 -44.18 51.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.293 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' ASN . 44.1 tttt -81.24 -5.4 57.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.833 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LYS . 26.4 m120 36.95 47.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.089 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' LYS . 39.2 mm -41.68 99.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.564 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 41' ' ' LYS . 20.6 mmtp -45.38 -98.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.57 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -41.17 95.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.498 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 54.5 tttp -51.16 -32.87 24.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.193 0.521 . . . . 1.0 109.717 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -53.7 -44.16 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.776 0.798 . . . . 1.0 109.388 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.02 91.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.212 -1.358 . . . . 1.0 111.379 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 2.0 t80 -58.5 -43.94 89.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.337 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -68.57 -45.71 71.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -57.91 -37.42 73.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.554 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.69 91.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.488 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 77.2 tttt -59.46 -52.33 66.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.734 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -58.09 -32.89 68.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.986 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.81 -46.57 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.62 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -66.19 -34.61 71.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 119.411 -0.916 . . . . 1.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -57.65 -32.38 67.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.733 -0.787 . . . . 1.0 110.469 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.414 ' CG2' HD13 ' A' ' 95' ' ' LEU . 86.2 m -60.0 -32.66 71.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -76.9 -38.58 53.25 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.864 -1.516 . . . . 1.0 110.713 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.6 -16.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.236 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.8 -14.71 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' ND1' ' CZ ' ' A' ' 94' ' ' PHE . 3.4 m80 -126.2 -43.91 1.77 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt 69.4 -114.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.122 -0.49 . . . . 1.0 112.085 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -59.71 -41.0 89.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.317 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -50.59 -37.33 39.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.52 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 7.6 mt -59.05 -50.14 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.784 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 16.6 m-20 -55.75 -46.17 77.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -58.77 -44.89 90.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.166 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 130' ' ' ILE . 18.2 mt -58.9 -38.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.28 -41.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.012 177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.539 ' N ' HG22 ' A' ' 65' ' ' ILE . 4.7 tt0 -64.05 -36.76 85.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.375 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -56.2 -26.11 49.62 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.882 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 37.7 t-80 -101.84 -36.51 8.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.425 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 69' ' ' LEU . 27.4 mt -40.86 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.938 0.399 . . . . 1.0 110.501 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 68' ' ' HIS . 64.7 tttt 68.18 24.89 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.728 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 122.24 -48.23 0.97 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 5.2 m0 -45.72 176.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.799 0.333 . . . . 1.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 m -120.32 141.64 49.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.597 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.22 -24.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.075 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 76' ' ' ARG . 26.3 t0 -60.36 -23.3 64.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.86 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 75' ' ' ASP . 30.8 mmt-85 -34.35 142.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.598 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLY . 4.1 mm? 57.98 -174.03 0.08 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.811 -0.631 . . . . 1.0 111.271 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -36.06 157.32 0.01 OUTLIER Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.737 -0.665 . . . . 1.0 112.067 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CE1' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -74.47 -34.54 63.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.805 0.336 . . . . 1.0 110.962 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 115' ' ' ALA . 22.7 t -50.49 -49.5 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.363 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -48.56 -49.81 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.973 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -50.95 -49.7 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' OD1' ' CD2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -68.86 -48.22 63.99 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 1.0 109.653 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -58.0 -39.55 78.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 HG11 ' A' ' 126' ' ' VAL . 1.6 mp -56.06 -45.96 79.11 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 120.377 -0.529 . . . . 1.0 109.811 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.524 ' NH1' ' OD1' ' A' ' 62' ' ' ASP . 11.6 mtp85 -61.52 -41.33 97.16 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.261 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.77 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -63.22 -35.83 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.974 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.34 67.62 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.65 -0.786 . . . . 1.0 111.771 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.52 -32.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.523 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.21 -43.81 10.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 92' ' ' LEU . 2.2 mp0 -71.98 -58.24 3.61 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.36 -0.936 . . . . 1.0 111.111 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 91' ' ' GLU . 18.4 mt -8.96 -78.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.634 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.17 -31.54 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.55 0.574 . . . . 1.0 112.55 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' CZ ' ' ND1' ' A' ' 57' ' ' HIS . 1.4 m-30 -55.87 -38.94 70.79 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.14 -0.624 . . . . 1.0 111.24 -177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.1 tp -101.71 -13.96 17.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.192 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 23.7 ttmt 83.75 -47.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.551 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 14.7 t 50.72 176.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 97' ' ' SER . 29.9 mtpt -121.26 -34.95 3.37 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.557 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.47 ' OE2' ' CZ ' ' A' ' 102' ' ' ARG . 6.0 pt-20 -127.97 79.05 74.4 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.416 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.584 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 41.5 Cg_exo -53.77 -43.68 55.78 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.769 2.313 . . . . 1.0 112.793 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -48.27 85.56 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' CZ ' ' OE2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -71.38 -34.7 70.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.82 0.343 . . . . 1.0 110.588 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -57.26 -49.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.383 -179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -57.34 -48.96 77.65 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.563 -0.855 . . . . 1.0 110.413 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.81 -53.35 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.839 -177.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.569 ' CG ' HH21 ' A' ' 8' ' ' ARG . 14.0 t70 -56.02 -47.96 76.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.77 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.88 -44.06 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.465 -0.789 . . . . 1.0 108.939 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' PHE . 97.4 t -68.92 -36.43 74.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.8 t70 -58.7 -35.04 72.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.85 -36.22 78.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.714 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.49 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -62.09 -39.51 84.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.305 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -52.82 -37.87 60.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.145 0.498 . . . . 1.0 110.699 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -69.93 -45.04 68.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.0 111.331 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.13 -70.67 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.493 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -82.31 171.65 13.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.269 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.3 150.34 48.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.42 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 7.8 pm0 -62.8 -36.09 82.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.398 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.71 -36.45 76.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.95 0.405 . . . . 1.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -64.38 -36.38 83.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.342 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.95 -37.04 83.53 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.229 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -61.94 -46.3 89.9 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -65.57 -34.53 78.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.21 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 119' ' ' ALA . 87.9 t -67.25 -41.58 86.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.08 -51.89 41.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 1.0 110.915 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.9 -53.34 46.13 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 HD21 ' A' ' 85' ' ' LEU . 3.8 p -58.76 -29.15 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.016 -0.273 . . . . 1.0 110.84 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -60.67 -46.22 91.18 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.3 m -60.8 -29.31 69.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.593 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.664 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.22 -37.67 70.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.801 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.594 HD11 HG12 ' A' ' 65' ' ' ILE . 8.5 mt -67.27 -39.92 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.169 -0.612 . . . . 1.0 109.605 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -59.26 -50.41 74.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.641 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.976 ' O ' HD12 ' A' ' 135' ' ' ILE . 45.9 tttp -60.05 -37.0 78.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.393 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.38 -33.16 69.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 1.0 110.552 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 136' ' ' THR . 81.9 t80 -62.06 -46.03 90.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.357 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.013 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -47.23 -6.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -178.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.013 ' N ' HD13 ' A' ' 135' ' ' ILE . 16.0 p -64.58 -21.34 66.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.901 0.381 . . . . 1.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 138' ' ' SER . 25.9 m -73.15 -15.13 61.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 137' ' ' SER . 11.5 p 59.22 120.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.431 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -159.44 -27.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.317 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.55 -54.69 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.326 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -50.71 154.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.455 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -74.69 146.78 83.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.101 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.51 154.92 71.56 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.347 2.031 . . . . 1.0 112.296 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.7 m -56.28 112.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.62 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 147' ' ' SER . 13.2 mt -122.29 104.09 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.411 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.4 mttt 63.36 -72.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 145' ' ' LEU . 16.1 m -66.64 -173.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.607 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 148' ' ' GLU . 1.2 pm0 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.494 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -101.58 174.7 5.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.639 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -66.37 -43.59 85.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.94 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -57.21 -36.48 70.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.667 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.7 -38.93 86.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.433 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.75 -42.39 46.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.84 66.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.735 0.302 . . . . 1.0 110.476 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mtm105 -74.34 -44.34 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.962 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.541 ' HA ' HD22 ' A' ' 110' ' ' LEU . 81.9 m-20 -62.28 -47.08 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 1.0 110.967 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.1 p -61.78 -20.44 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.283 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.79 -45.74 70.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.993 0.425 . . . . 1.0 111.503 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.579 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.73 -48.11 80.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.377 -178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.669 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.06 -39.79 66.56 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.115 -178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -62.22 -46.44 96.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.558 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.758 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.2 mp -65.1 -32.76 74.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.227 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -63.18 -36.67 84.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.816 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -32.21 73.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.014 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 37.4 t90 -60.45 -36.56 78.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.0 109.958 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.25 -34.11 75.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.386 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.1 mp -92.22 -46.06 7.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -84.18 -47.35 10.93 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.307 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TRP . . . 132.5 -88.88 0.27 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.0 tt0 -132.99 174.74 10.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.718 0.294 . . . . 1.0 111.448 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.9 m120 92.83 69.71 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.739 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HD3' ' H ' ' A' ' 24' ' ' ASN . 16.0 Cg_exo -65.61 -42.47 12.3 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.074 2.516 . . . . 1.0 112.785 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -46.78 93.73 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 7.0 mp0 -70.63 -45.51 65.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.599 . . . . 1.0 110.285 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.93 -41.23 74.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.282 -0.872 . . . . 1.0 111.013 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.594 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.85 -39.14 93.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -57.66 -32.59 67.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.642 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.12 -39.89 71.78 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.45 -43.33 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.862 0.319 . . . . 1.0 111.862 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.95 -35.8 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.1 mt-10 -66.57 -49.01 67.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.685 -1.143 . . . . 1.0 110.986 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -73.86 -43.91 57.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 1.0 111.288 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -151.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.384 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -146.47 46.83 1.21 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.76 0.314 . . . . 1.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 mm -73.4 84.48 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.996 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -78.1 4.29 12.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.006 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 63.5 m-80 -115.36 87.42 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.22 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -51.15 -36.12 39.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.0 110.102 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.87 -39.91 66.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.832 0.825 . . . . 1.0 108.916 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -71.21 -47.96 54.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.048 -1.433 . . . . 1.0 111.403 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -58.68 -43.06 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.742 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -69.53 -47.94 62.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.6 -38.0 71.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.464 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.71 -43.86 95.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.21 -0.904 . . . . 1.0 110.669 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -58.88 -52.03 67.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.268 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -57.28 -37.56 72.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.483 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.85 -47.42 84.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.387 0.613 . . . . 1.0 109.46 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.758 HG13 ' CD1' ' A' ' 15' ' ' LEU . 8.2 t -65.28 -34.59 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.276 -0.874 . . . . 1.0 110.634 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 56' ' ' ARG . 9.9 t70 -61.17 -33.7 73.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.67 -0.812 . . . . 1.0 110.99 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.643 HG21 HD23 ' A' ' 95' ' ' LEU . 59.1 m -60.08 -31.05 69.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.17 -41.52 49.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.015 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 51' ' ' VAL . 11.4 t -78.32 -22.57 13.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.236 -0.893 . . . . 1.0 111.337 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.7 ttt180 -51.77 -14.29 0.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.395 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -156.74 20.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.195 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.049 HG23 ' H ' ' A' ' 59' ' ' GLU . 5.9 tt -10.8 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.354 0.872 . . . . 1.0 113.354 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.049 ' H ' HG23 ' A' ' 58' ' ' ILE . 36.5 mt-10 -59.75 -46.11 90.15 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.932 0.396 . . . . 1.0 111.514 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' CD ' ' CD2' ' A' ' 57' ' ' HIS . 26.8 tt0 -52.04 -36.89 51.76 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.433 -0.507 . . . . 1.0 110.359 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.799 ' CG2' HG11 ' A' ' 89' ' ' VAL . 54.8 mt -60.3 -49.44 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 119.834 -0.746 . . . . 1.0 109.974 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 63' ' ' SER . 1.0 OUTLIER -56.21 -44.09 79.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 4.1 t -58.47 -43.96 89.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.569 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 130' ' ' ILE . 22.1 mt -60.07 -37.76 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.083 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.729 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.07 -37.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.315 177.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' N ' HG22 ' A' ' 65' ' ' ILE . 60.9 mt-10 -59.5 -35.63 74.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 1.0 112.386 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -54.85 -25.58 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.991 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.825 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -101.59 -36.17 8.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.065 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 31.9 mt -41.85 -46.71 4.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 1.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 20.2 ttmt 80.64 52.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.579 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.92 43.58 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.072 -0.811 . . . . 1.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 171.02 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 1.0 110.394 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.1 p -124.0 137.38 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.363 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.592 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -55.64 -24.2 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' LEU . 11.3 t70 -77.05 -22.34 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 tpt180 -62.61 55.85 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.091 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER 175.17 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.252 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.41 157.85 0.42 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.05 -51.62 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.124 -0.23 . . . . 1.0 110.987 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -50.85 -48.27 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.024 0.44 . . . . 1.0 110.304 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 123' ' ' VAL . 6.7 mm-40 -47.09 -50.85 19.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -50.22 65.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.42 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -66.4 -47.8 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.27 -45.3 76.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.427 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 123' ' ' VAL . 2.0 mt -56.21 -44.13 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.458 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.1 mtp85 -58.43 -43.63 88.82 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.65 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.736 ' CD2' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -63.64 -38.89 92.81 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.099 -1.041 . . . . 1.0 111.12 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 92' ' ' LEU . . . -62.13 -48.9 79.88 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.227 -0.987 . . . . 1.0 111.291 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.799 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -65.29 -40.13 87.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.93 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.808 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.14 -43.49 9.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.662 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 92' ' ' LEU . 27.6 mm-40 -75.24 -57.06 4.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.62 -0.832 . . . . 1.0 111.762 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 88' ' ' GLY . 5.9 mp -13.14 -72.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.177 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.01 -32.5 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.717 0.636 . . . . 1.0 112.717 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.808 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -53.47 -32.1 48.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.525 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.51 -20.19 17.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.219 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt 58.06 75.69 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.688 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 2.0 t -102.65 -179.57 4.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.422 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.7 mttt -102.27 -22.97 14.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.845 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.8 pm0 -144.56 67.08 14.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.795 0.331 . . . . 1.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -67.19 -15.95 47.48 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.718 2.279 . . . . 1.0 112.033 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.21 -48.96 61.63 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.167 -0.539 . . . . 1.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -42.21 64.66 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.039 -0.264 . . . . 1.0 111.321 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.39 -49.69 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.442 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -65.81 -47.06 76.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.919 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -51.79 -51.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.203 -0.599 . . . . 1.0 110.983 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -55.62 -40.86 72.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.694 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.09 -49.21 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.68 -36.67 77.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.169 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.16 -37.25 79.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -62.29 -32.32 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.784 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -65.68 -39.21 84.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.187 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -53.05 -38.03 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.0 110.697 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -70.96 -45.24 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -83.31 -64.83 1.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.322 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -89.65 171.86 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.953 0.406 . . . . 1.0 111.119 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -53.62 134.22 41.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.521 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.71 -34.92 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.009 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.84 -41.62 91.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.351 . . . . 1.0 110.266 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.74 -32.78 73.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 1.0 110.028 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.42 -36.35 69.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.669 -0.972 . . . . 1.0 110.669 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 19.9 ttmt -62.3 -46.66 87.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.792 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 24.5 t80 -66.83 -36.66 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.494 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 119' ' ' ALA . 94.7 t -60.21 -46.23 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.923 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 125' ' ' GLY . 3.7 p30 -67.42 -50.51 59.15 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.574 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 124' ' ' ASN . . . -55.36 -49.61 63.45 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.361 -0.696 . . . . 1.0 111.361 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 2.4 p -70.63 -29.57 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 104' ' ' PHE . 9.2 tt -64.94 -46.12 82.91 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.455 -0.498 . . . . 1.0 110.123 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 p -58.02 -28.29 64.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.777 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -37.3 70.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.573 -0.74 . . . . 1.0 111.025 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 HG12 ' A' ' 65' ' ' ILE . 14.0 mt -62.76 -40.66 89.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.388 -0.525 . . . . 1.0 109.984 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.85 -52.74 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.087 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -60.55 -36.99 79.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.65 ' O ' HG22 ' A' ' 136' ' ' THR . . . -65.99 -33.32 75.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.903 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -65.52 -52.55 51.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.523 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.969 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -53.87 -21.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.963 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -62.6 -20.22 64.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 1.0 110.837 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 138' ' ' SER . 69.2 m -73.1 -36.28 66.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.674 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 137' ' ' SER . 17.2 p 59.64 143.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.43 -58.26 2.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.304 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.45 -80.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.666 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -42.89 115.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -83.06 146.42 51.64 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.427 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.94 136.08 43.59 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.422 2.082 . . . . 1.0 111.969 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.1 m -62.2 88.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.565 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 147' ' ' SER . 7.0 tp -47.09 157.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.447 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.51 14.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.76 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 145' ' ' LEU . 51.1 m -56.72 -32.73 65.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 1.0 110.494 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.655 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -160.41 -19.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.433 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 17.6 p90 -65.53 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.5 ptp85 -57.0 -33.91 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.95 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -60.07 -39.2 85.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.432 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.49 -43.67 44.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.73 -37.69 71.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.694 0.283 . . . . 1.0 110.653 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 33.8 mtm-85 -74.87 -45.09 45.27 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.5 -45.49 90.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.58 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -61.7 -20.66 63.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.548 . . . . 1.0 111.07 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.57 -41.56 77.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.212 0.449 . . . . 1.0 112.212 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.3 -49.57 75.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -55.32 -37.23 67.13 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.012 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -61.76 -46.71 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -64.84 -32.93 74.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -62.26 -35.97 80.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.962 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.14 74.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.621 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 18' ' ' TRP . 8.8 t-105 -62.48 -33.02 74.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.3 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -66.25 -34.36 77.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.456 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp -92.26 -45.86 8.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.412 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.75 -46.85 6.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.09 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 18' ' ' TRP . . . 69.89 4.75 49.4 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.3 tt0 -89.94 167.81 12.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.657 0.265 . . . . 1.0 110.368 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' GLU . 53.5 t30 -37.36 123.07 0.9 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.689 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.35 -30.83 6.29 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.164 1.909 . . . . 1.0 112.386 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 -40.78 94.76 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.59 -50.81 41.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 1.0 110.143 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -57.12 -35.56 69.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.626 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.81 -43.2 72.71 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.083 -0.508 . . . . 1.0 109.8 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmtm? -57.32 -32.62 66.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.61 -38.63 67.75 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 29' ' ' PHE . 1.7 p -73.79 -44.31 52.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.45 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.871 -0.788 . . . . 1.0 108.871 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -60.82 -48.48 81.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.917 -1.038 . . . . 1.0 110.856 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.82 -44.49 55.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.947 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 38' ' ' ILE . 35.2 mttt -94.17 115.78 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 1.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -65.67 47.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.895 -0.593 . . . . 1.0 111.074 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' LYS . 22.6 mm -34.32 95.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.262 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' ASN . 75.0 mttt -52.1 154.64 2.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.59 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 55.77 96.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.555 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -50.89 -32.69 21.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.29 -41.93 69.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.154 -0.93 . . . . 1.0 110.011 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -60.77 -47.51 86.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.27 -1.332 . . . . 1.0 111.558 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -56.44 -45.19 80.93 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.485 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -69.37 -47.6 63.8 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.968 -0.753 . . . . 1.0 108.968 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -58.83 -37.04 75.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.654 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.38 -42.79 96.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.695 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -58.45 -52.44 65.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.883 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' HD21 ' A' ' 95' ' ' LEU . 12.2 tmtt? -57.78 -37.9 74.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -58.99 -46.05 89.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 15' ' ' LEU . 41.3 t -65.57 -34.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.062 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' ARG . 8.3 t70 -60.64 -30.49 69.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.237 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 ' OG1' HD23 ' A' ' 95' ' ' LEU . 59.0 m -59.53 -31.79 69.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.36 -40.46 51.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.831 -1.531 . . . . 1.0 110.524 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.0 -16.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.294 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 52' ' ' ASP . 62.7 ttt180 -53.58 -14.47 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.252 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 -46.56 1.33 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.658 0.266 . . . . 1.0 110.696 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mt 70.87 -110.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.26 -0.427 . . . . 1.0 112.146 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.495 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 35.3 mt-10 -59.79 -43.37 94.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.364 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.82 -36.96 40.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.923 -0.581 . . . . 1.0 110.321 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.826 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.3 mt -59.25 -50.38 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.74 -0.784 . . . . 1.0 110.01 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -56.25 -45.43 80.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.558 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.8 t -58.29 -44.44 88.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.17 -39.33 78.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.89 -39.01 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.325 0.584 . . . . 1.0 109.934 177.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 65' ' ' ILE . 29.3 tt0 -62.94 -36.98 85.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.375 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -56.6 -28.7 60.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.58 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.681 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.0 t-160 -102.36 -28.78 12.04 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.649 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 69' ' ' LEU . 14.8 mt -40.37 -23.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.565 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 68' ' ' HIS . 29.5 ttpt 62.21 50.01 4.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.484 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.24 -54.73 0.8 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 7.0 m0 -45.71 170.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 1.0 110.762 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -125.06 136.12 53.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.588 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.3 tt -55.24 -24.07 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -73.58 -22.2 60.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.006 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 20.6 ttt85 -65.27 55.5 0.03 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.181 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -177.49 176.74 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.867 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -42.69 169.81 0.01 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.341 -0.704 . . . . 1.0 111.341 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.01 -53.92 8.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.991 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -53.29 -51.24 42.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.035 0.445 . . . . 1.0 110.947 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.97 -45.12 41.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.685 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' NH1' HH11 ' A' ' 86' ' ' ARG . 1.7 tmm_? -51.56 -52.33 48.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.47 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -72.94 -40.46 65.37 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.455 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.99 69.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.927 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 126' ' ' VAL . 3.4 mp -56.58 -46.56 80.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.089 -0.644 . . . . 1.0 110.109 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.564 ' O ' HG13 ' A' ' 89' ' ' VAL . 48.6 mtp180 -60.6 -40.0 90.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.577 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -67.82 -34.01 75.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.097 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.89 -40.64 89.21 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.517 -0.849 . . . . 1.0 111.818 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.826 HG11 ' CG2' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -65.23 -31.23 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.776 -0.369 . . . . 1.0 111.038 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.6 -41.69 6.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' C ' ' A' ' 92' ' ' LEU . 5.0 mp0 -71.06 -59.25 2.88 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.249 -0.98 . . . . 1.0 110.262 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -4.21 -83.49 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.728 -0.669 . . . . 1.0 111.409 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.57 -31.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 1.0 111.338 -179.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.748 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.1 m-30 -53.87 -39.72 65.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.283 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.9 -20.44 15.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.635 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 24.6 ttmt 81.93 -48.88 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.496 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 98' ' ' LYS . 6.7 t 48.26 177.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.929 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 97' ' ' SER . 6.6 mtpm? -111.42 -40.42 4.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.401 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -125.01 79.3 65.44 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.948 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 51.6 Cg_exo -50.54 -43.29 45.82 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.934 2.422 . . . . 1.0 113.089 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.89 -48.55 79.92 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -35.98 70.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.35 . . . . 1.0 110.61 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.54 -43.2 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.535 -179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.621 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 6.9 m-85 -64.24 -48.44 75.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.325 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.71 -52.08 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.617 -178.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.96 -49.12 72.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 87' ' ' LEU . 4.0 mm -59.01 -43.68 89.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.246 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' PHE . 89.7 t -68.47 -36.4 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.255 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 105' ' ' ILE . 14.1 t0 -57.8 -35.35 70.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.93 -36.26 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.962 179.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -63.58 -39.94 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.512 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -52.83 -37.79 60.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.237 0.541 . . . . 1.0 110.58 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -70.11 -45.12 67.56 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.294 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -92.0 -70.2 0.7 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.504 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -85.85 174.29 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 1.0 111.372 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 117' ' ' GLU . 56.8 t0 -60.54 135.92 57.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.253 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 pm0 -62.62 -32.22 73.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.854 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.95 -44.01 94.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.332 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.717 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.72 -36.62 83.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.04 82.43 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -61.93 -46.67 88.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 16.6 t80 -66.94 -34.59 78.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.675 -0.693 . . . . 1.0 110.09 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 119' ' ' ALA . 82.2 t -61.73 -41.9 92.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.202 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -68.01 -51.14 50.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.994 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.48 -53.47 44.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 85' ' ' LEU . 5.1 p -59.24 -29.28 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.113 -0.235 . . . . 1.0 110.699 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -60.33 -45.85 91.98 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.148 0.499 . . . . 1.0 109.671 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 m -58.23 -27.92 64.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.939 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.681 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -57.06 -40.35 76.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.542 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 11.9 mt -58.91 -38.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.256 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.4 t80 -52.69 -44.63 66.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.817 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -57.31 -38.64 74.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 1.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.95 73.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -69.76 -52.25 26.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.677 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.785 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -63.98 -36.03 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.308 -178.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 3.6 t -82.24 -20.09 38.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.766 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -72.9 -5.58 39.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.557 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m 63.22 -139.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.701 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 3.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.394 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -162.36 167.67 23.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 142' ' ' LYS . 5.5 tt0 -107.24 172.8 6.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.396 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 141' ' ' GLU . 13.0 ptpt -68.92 149.58 97.83 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.84 131.31 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.381 2.054 . . . . 1.0 111.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.2 t -97.15 105.51 17.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.27 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.579 ' N ' HD22 ' A' ' 145' ' ' LEU . 3.7 mm? -56.27 136.23 53.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.252 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 148' ' ' GLU . 61.9 mttp -46.08 117.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.414 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 t -76.95 17.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.658 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -168.27 -1.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.472 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 22.8 p90 -61.5 -35.8 78.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.1 ptt180 -57.15 -35.84 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.456 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.287 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 10' ' ' THR . . . -72.92 -42.31 45.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.696 -0.961 . . . . 1.0 110.696 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -56.71 -38.72 72.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.359 . . . . 1.0 110.354 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -74.76 -40.6 61.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.975 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' OD2' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.34 -40.93 96.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.904 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLY . 32.1 p -61.65 -20.32 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.235 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -54.45 -44.63 72.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.885 0.374 . . . . 1.0 111.665 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.52 79.69 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.508 -0.477 . . . . 1.0 111.822 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.677 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.11 -38.17 67.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.148 -178.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -66.87 -42.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.226 -0.59 . . . . 1.0 109.518 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.4 mm? -60.72 -33.69 73.26 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 1.0 108.778 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -61.04 -41.29 96.31 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.961 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 28' ' ' LEU . 37.9 mtt180 -65.53 -31.48 72.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.206 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.645 ' CE3' ' NH2' ' A' ' 86' ' ' ARG . 33.5 t90 -61.87 -31.89 72.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.267 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -66.71 -35.31 79.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.872 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp -91.67 -45.28 8.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.2 -46.84 6.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.552 -0.295 . . . . 1.0 110.799 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 54.03 18.79 9.56 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.219 -0.752 . . . . 1.0 111.219 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -132.9 135.26 45.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 1.0 110.83 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.4 m120 41.74 87.26 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.853 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.88 -24.56 5.85 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.474 2.116 . . . . 1.0 112.216 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.19 -47.96 41.73 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.67 -47.2 86.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.304 0.573 . . . . 1.0 109.992 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 4.4 mt -55.78 -37.13 68.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.156 -0.929 . . . . 1.0 110.412 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.59 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -57.11 -42.25 80.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 56.3 tttm -57.11 -32.73 66.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.225 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.99 -41.75 81.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.4 -45.32 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.96 -35.88 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.8 mt-10 -61.89 -48.57 79.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.058 -0.974 . . . . 1.0 110.589 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -71.64 -43.95 65.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 33' ' ' VAL . 15.3 ttmt -89.16 125.72 35.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.555 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.592 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -71.15 53.47 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.193 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.8 mm -48.14 -40.01 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.948 0.404 . . . . 1.0 110.193 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.3 mttp 63.3 -85.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.76 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.2 m-80 -45.92 88.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.743 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' LYS . 49.6 tttm -51.79 -33.54 35.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.192 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.14 -44.05 67.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.784 0.802 . . . . 1.0 109.042 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.41 77.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.159 -1.382 . . . . 1.0 111.035 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' CG ' HG11 ' A' ' 33' ' ' VAL . 3.5 t80 -59.3 -42.16 90.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.822 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.88 -46.78 67.51 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -58.04 -37.83 75.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . . . -64.03 -39.74 94.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.294 -0.866 . . . . 1.0 110.846 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 51' ' ' VAL . 38.9 tttt -58.13 -51.61 68.99 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.604 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.84 -38.79 76.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.789 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.77 -42.41 93.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.978 -0.556 . . . . 1.0 111.332 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 48' ' ' LYS . 1.8 p -65.22 -34.29 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.552 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' ARG . 51.5 t0 -64.11 -28.66 69.93 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.955 -0.698 . . . . 1.0 111.023 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 95' ' ' LEU . 97.5 m -57.27 -31.52 65.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.693 -1.225 . . . . 1.0 107.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.31 -43.84 31.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.813 -1.54 . . . . 1.0 110.379 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 t -79.01 -15.8 13.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.768 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -50.11 -15.91 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.088 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -132.2 -38.61 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.233 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 59' ' ' GLU . 3.8 mt 70.25 -111.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.002 -0.545 . . . . 1.0 112.323 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 58' ' ' ILE . 24.3 mt-10 -59.49 -41.86 90.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.684 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.2 tt0 -50.79 -37.71 44.01 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.435 -0.506 . . . . 1.0 110.604 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.762 ' CG2' HG11 ' A' ' 89' ' ' VAL . 3.9 mt -61.25 -49.47 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 119.375 -0.93 . . . . 1.0 109.2 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -45.84 80.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -59.35 -42.6 91.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.582 -0.736 . . . . 1.0 109.15 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.459 ' CG2' HG23 ' A' ' 130' ' ' ILE . 8.0 mt -59.17 -38.79 76.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.649 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.87 -38.82 66.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.626 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.8 tt0 -61.6 -38.42 87.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.709 -0.678 . . . . 1.0 112.172 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -58.36 -35.53 72.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.076 0.399 . . . . 1.0 112.076 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 11.7 t-80 -102.2 -9.4 20.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD11 ' H ' ' A' ' 74' ' ' ILE . 11.2 mt -42.82 -19.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.37 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 68' ' ' HIS . 20.3 tttp 79.83 12.77 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.523 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.09 15.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.468 ' C ' HD13 ' A' ' 69' ' ' LEU . 7.4 m0 -105.66 -174.21 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 1.0 110.506 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -125.61 117.33 23.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.415 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.656 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -56.01 -23.87 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.04 -22.48 52.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.94 -1.027 . . . . 1.0 109.061 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.9 mmm180 -82.7 67.82 8.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 77' ' ' LEU . 1.3 pp -179.92 175.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.568 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . -40.13 160.83 0.01 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.88 -53.72 8.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.287 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.2 t -51.87 -50.5 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.012 0.434 . . . . 1.0 110.723 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -48.34 -49.64 33.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.322 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -51.93 -51.0 60.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.092 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -71.8 -45.99 59.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.29 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HA ' HD23 ' A' ' 87' ' ' LEU . . . -57.73 -39.5 77.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.205 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.88 -46.55 78.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.434 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.754 ' N ' HD13 ' A' ' 85' ' ' LEU . 11.4 mtp180 -60.63 -42.51 97.07 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.556 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD21 HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -62.2 -36.12 80.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.14 -47.6 63.75 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.29 -0.957 . . . . 1.0 111.657 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.762 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.25 -32.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.897 0.379 . . . . 1.0 110.32 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.844 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.63 -44.79 13.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.576 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.7 mp0 -68.55 -58.16 4.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' C ' ' O ' ' A' ' 91' ' ' GLU . 12.4 tp -5.21 -84.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.231 -0.895 . . . . 1.0 112.599 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.3 -29.57 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.049 0.452 . . . . 1.0 110.91 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -52.94 -40.66 63.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.69 -0.687 . . . . 1.0 110.399 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 53' ' ' THR . 9.8 tp -101.95 -20.36 14.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.3 tttt 67.13 91.39 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.7 p -103.53 -170.11 1.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -129.2 -10.06 4.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.767 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 1.6 pm0 -138.29 70.4 47.27 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.126 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.0 Cg_exo -52.44 -43.85 51.32 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.938 2.425 . . . . 1.0 112.807 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.79 -48.17 83.18 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' NH1' ' OD1' ' A' ' 106' ' ' ASP . 1.7 tmt_? -71.6 -35.37 70.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.71 0.29 . . . . 1.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -57.94 -49.5 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.251 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.3 m-85 -55.81 -48.57 75.17 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.916 -0.714 . . . . 1.0 109.908 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -49.49 -51.41 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.82 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 22.5 m-20 -51.57 -49.56 61.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.851 HG23 HD21 ' A' ' 87' ' ' LEU . 1.6 mp -59.86 -49.79 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.752 0.787 . . . . 1.0 109.336 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 104' ' ' PHE . 21.6 t -61.13 -33.6 56.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.133 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' ILE . 21.6 t0 -54.41 -47.73 72.43 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.461 -0.495 . . . . 1.0 111.487 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.048 HD13 ' H ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -68.93 -27.52 65.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 118.725 -1.19 . . . . 1.0 111.142 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.596 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -60.26 -37.64 74.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -38.76 64.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.201 0.524 . . . . 1.0 110.466 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -45.52 79.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.443 -0.798 . . . . 1.0 110.879 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.02 -69.03 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.909 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -79.37 173.98 12.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.821 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.63 152.03 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.26 -36.67 82.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.978 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -42.21 93.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 1.0 110.25 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -68.57 -37.26 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.175 0.512 . . . . 1.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.44 -36.63 85.15 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.227 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -61.91 -45.68 92.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 15.6 t80 -60.56 -36.19 77.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.51 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.9 -45.31 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.401 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -50.02 63.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.966 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.64 -53.34 44.43 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.378 -0.689 . . . . 1.0 111.378 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -61.59 -28.75 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.249 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -57.19 -46.13 83.13 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.122 0.486 . . . . 1.0 109.895 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -61.9 -29.88 70.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.363 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 68' ' ' HIS . . . -57.22 -36.41 70.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.811 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 65' ' ' ILE . 17.1 mt -67.47 -39.35 82.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.711 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.71 -52.37 62.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.958 -0.564 . . . . 1.0 111.501 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -41.79 83.19 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.622 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -68.55 -33.03 73.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.11 -52.25 65.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.774 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -48.68 -34.7 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.749 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 21.4 p -79.33 -27.45 42.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.426 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.0 p -91.48 -7.02 51.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 139' ' ' LYS . 42.4 m -78.58 155.94 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.699 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 138' ' ' SER . 6.7 tptm 58.2 153.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.566 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 20.2 mp0 -125.14 -178.78 4.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLU . 21.2 mt-10 59.56 123.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.602 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -76.31 146.8 78.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.744 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.29 155.31 70.55 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.375 2.05 . . . . 1.0 111.417 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m 56.25 90.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.613 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.65 -41.02 4.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -82.32 82.95 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.562 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 76.7 p -116.23 -58.25 2.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.483 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.631 179.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -161.16 -16.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 5.5 p90 -63.8 -38.04 89.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 1.0 110.248 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -61.69 -39.36 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.407 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -56.63 -42.89 79.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.28 -43.77 97.97 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.13 67.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.0 110.09 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 87.4 mtt-85 -74.5 -44.44 51.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 110' ' ' LEU . 3.8 m-20 -61.27 -50.47 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.458 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 6' ' ' GLY . 59.4 p -62.07 -20.76 64.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.688 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -55.28 -46.4 76.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.118 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.62 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -58.52 -43.13 89.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.076 0.465 . . . . 1.0 110.168 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 10.9 tp -53.02 -45.34 67.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.848 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -69.16 -38.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.989 0.423 . . . . 1.0 110.167 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.5 mm? -60.83 -33.87 73.69 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 83' ' ' ASN . 13.3 t80 -61.49 -40.7 95.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.336 -0.847 . . . . 1.0 110.488 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -61.62 -32.41 72.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.425 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 22.6 t-105 -61.95 -35.31 78.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.741 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CG ' ' OD1' ' A' ' 83' ' ' ASN . 1.1 m-20 -66.4 -32.99 74.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.986 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.2 mp -90.49 -45.61 8.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.277 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -46.4 5.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.879 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.37 20.16 35.94 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' ASN . 44.1 tt0 -132.73 124.81 28.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 1.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLU . 35.1 t-20 40.67 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.27 -18.78 8.33 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.488 2.125 . . . . 1.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 -45.22 38.55 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -58.48 -49.96 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 1.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.54 -37.29 70.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.441 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.619 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.2 -41.92 76.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.866 -0.607 . . . . 1.0 110.142 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 7.0 mmtt -57.11 -32.96 66.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.456 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -70.57 -40.79 73.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.595 0.591 . . . . 1.0 112.595 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.6 p -73.63 -43.18 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -35.88 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 1.9 mt-10 -64.52 -49.58 70.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.795 -1.093 . . . . 1.0 111.22 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -75.49 -44.13 45.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 1.0 112.05 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -84.35 -7.11 59.42 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 1.0 111.613 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 38' ' ' ILE . 83.3 m-20 39.9 46.4 1.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.647 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.2 mm -26.79 107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 38' ' ' ILE . 25.7 ttmt -30.89 -84.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.448 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 14.1 m-80 -77.46 113.4 15.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.972 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -55.52 -35.28 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.3 -43.33 71.02 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.845 0.831 . . . . 1.0 109.447 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -61.26 -45.49 94.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.293 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -55.47 -45.86 76.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 1.0 110.573 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.37 -47.6 63.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -59.0 -36.76 75.45 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.508 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -60.24 -42.31 94.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.102 -0.954 . . . . 1.0 111.211 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -58.75 -51.93 67.86 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.8 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 10.6 tmtt? -58.12 -36.31 72.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.617 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 1.0 109.818 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 15' ' ' LEU . 41.4 t -64.25 -34.77 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.203 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.83 -31.27 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.953 -0.699 . . . . 1.0 111.417 -177.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.569 HG21 HD23 ' A' ' 95' ' ' LEU . 60.8 m -59.62 -32.74 70.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.725 ' O ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -40.25 54.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.936 -1.483 . . . . 1.0 110.071 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.22 -16.25 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 1.0 111.287 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' ASP . 52.9 ttt-85 -61.02 -14.29 22.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.148 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -124.26 -58.1 1.55 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.633 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt 73.51 -107.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.912 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -59.56 -43.56 93.53 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.84 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ILE . 67.5 tt0 -51.13 -37.27 45.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.369 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.814 ' CG2' HG11 ' A' ' 89' ' ' VAL . 17.7 mt -59.37 -50.53 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.761 -0.776 . . . . 1.0 109.522 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 66' ' ' GLU . 3.6 t70 -56.69 -45.85 81.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 t -60.27 -41.77 93.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.396 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' HG23 ' A' ' 130' ' ' ILE . 10.5 mt -59.55 -37.12 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -70.15 -41.09 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.201 177.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 65' ' ' ILE . 38.9 mt-10 -59.39 -34.7 72.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.662 -0.699 . . . . 1.0 112.412 -177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -53.93 -34.32 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 3.4 t60 -102.14 -39.87 7.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.066 0.46 . . . . 1.0 109.929 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 65' ' ' ILE . 3.5 tp -36.38 -64.54 0.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.209 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.609 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 31.7 ttmt 103.81 70.65 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.858 0.724 . . . . 1.0 111.025 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 67.51 -37.65 0.22 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.951 -0.46 . . . . 1.0 111.951 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.518 ' C ' HD23 ' A' ' 69' ' ' LEU . 18.6 m0 -49.01 -171.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.97 0.415 . . . . 1.0 111.281 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' HD21 ' A' ' 69' ' ' LEU . 13.9 m -125.93 134.97 51.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.316 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.61 -24.79 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' O ' ' C ' ' A' ' 76' ' ' ARG . 8.9 t70 -60.42 -23.12 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.789 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.514 ' C ' ' O ' ' A' ' 75' ' ' ASP . 54.7 ttt180 -20.66 86.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.686 -0.688 . . . . 1.0 112.088 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.9 tp 55.36 156.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.192 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.53 109.65 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.303 -0.719 . . . . 1.0 111.303 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.03 -52.43 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.0 t -52.33 -42.67 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.187 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 123' ' ' VAL . 3.1 tm-20 -46.67 -52.44 13.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.846 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 26.8 ttp180 -52.27 -51.15 60.13 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.487 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -69.54 -46.39 66.57 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.572 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.64 84.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.913 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 89' ' ' VAL . 5.1 tp -57.37 -41.45 80.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.358 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' VAL . 30.2 mtp85 -61.05 -43.87 98.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.59 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.12 -34.15 77.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.488 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.469 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.02 -46.8 69.56 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.666 -0.778 . . . . 1.0 111.564 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.814 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -63.38 -33.11 59.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.97 -44.85 10.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 92' ' ' LEU . 14.5 mm-40 -72.79 -57.55 4.0 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.773 -0.771 . . . . 1.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.1 mm? -9.1 -76.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.581 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.519 HG21 ' CE1' ' A' ' 134' ' ' TYR . 1.3 mp -120.08 -32.85 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.862 0.69 . . . . 1.0 112.862 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.1 m-30 -53.79 -34.01 57.74 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.171 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -101.09 -20.58 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.109 179.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' SER . 11.9 tttp 76.69 -46.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.633 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 47.54 174.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.458 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' N ' ' OG ' ' A' ' 97' ' ' SER . 77.1 mttt -102.3 -28.63 12.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.882 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.5 pm0 -139.33 64.66 32.5 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.019 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.56 -34.93 44.55 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.915 2.41 . . . . 1.0 112.729 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.06 69.14 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.764 -0.732 . . . . 1.0 111.377 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -74.09 -39.86 63.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 107' ' ' ILE . 11.7 t -59.24 -49.44 83.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.869 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.609 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.01 -46.66 73.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.26 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.497 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.76 -53.35 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.919 -0.712 . . . . 1.0 111.158 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 105' ' ' ILE . 42.3 t0 -56.91 -41.28 77.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.615 -0.721 . . . . 1.0 110.438 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -56.64 -47.36 82.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 124' ' ' ASN . 99.2 t -66.64 -37.36 79.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.596 -0.442 . . . . 1.0 109.911 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.02 -35.5 80.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.28 -32.51 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.659 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -67.75 -38.64 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.503 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -52.44 -38.11 58.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.098 0.475 . . . . 1.0 110.714 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -67.25 -44.64 78.92 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -81.46 -64.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.067 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.42 -178.81 7.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.041 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.13 145.89 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.139 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -62.26 -33.1 73.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.788 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.93 -38.43 82.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 1.0 110.177 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.997 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.22 -34.78 78.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.294 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.08 -37.08 70.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -62.31 -46.26 89.57 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -72.2 -38.34 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.676 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.2 t -60.02 -48.75 86.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.73 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -67.8 -51.26 50.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.368 -179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.33 -46.01 87.58 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.832 -0.507 . . . . 1.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.604 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.2 p -70.6 -29.72 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.191 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -64.09 -44.43 92.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.274 -0.57 . . . . 1.0 110.063 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.8 p -58.2 -29.27 65.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -57.47 -34.63 69.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.856 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 HG12 ' A' ' 65' ' ' ILE . 8.3 mt -66.83 -39.52 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.08 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -57.0 -35.98 69.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.841 0.353 . . . . 1.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.998 ' O ' HD12 ' A' ' 135' ' ' ILE . 15.4 tptm -65.19 -35.46 81.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 136' ' ' THR . . . -70.16 -33.32 71.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.506 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 136' ' ' THR . 48.9 t80 -58.61 -45.73 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.991 -0.55 . . . . 1.0 112.05 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.043 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.38 -7.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 1.0 111.837 -178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.043 ' N ' HD13 ' A' ' 135' ' ' ILE . 12.5 t -69.16 -25.95 64.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 1.0 110.343 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 14.6 t -81.62 -31.98 32.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 139' ' ' LYS . 87.3 p -54.91 -107.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.405 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.532 ' N ' ' OG ' ' A' ' 138' ' ' SER . 52.6 pttt -84.39 168.37 15.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -168.94 150.83 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.45 -155.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -85.76 152.22 56.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.54 142.67 85.3 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.458 2.105 . . . . 1.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 145' ' ' LEU . 46.7 t -142.44 -171.95 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.652 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 146' ' ' LYS . 0.5 OUTLIER -163.58 153.59 15.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.307 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 145' ' ' LEU . 29.5 ttmt 60.37 101.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.583 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -156.13 140.07 16.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.507 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.448 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -164.28 11.56 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.548 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 12.4 p90 -60.29 -36.13 77.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.509 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 13.0 ptm180 -69.13 -32.72 72.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.766 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -56.38 -43.67 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.24 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' HG23 ' A' ' 10' ' ' THR . . . -63.08 -43.98 97.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.484 -1.046 . . . . 1.0 110.484 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.43 -33.52 65.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -72.42 -44.31 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.722 ' HA ' HD22 ' A' ' 110' ' ' LEU . 10.4 m-20 -64.72 -44.01 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 1.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 6' ' ' GLY . 71.0 p -61.85 -19.33 62.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -52.4 -45.95 66.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.136 0.493 . . . . 1.0 110.997 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.84 -47.88 81.38 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.472 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' A' ' 12' ' ' PHE . 1.2 tt -54.28 -42.93 70.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.536 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' ALA . 1.2 p -68.86 -38.29 78.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.934 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.69 -33.81 75.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.824 -0.806 . . . . 1.0 108.824 179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -62.4 -36.23 81.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.914 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -32.05 72.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 1.0 111.016 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.609 ' CZ2' ' CD1' ' A' ' 58' ' ' ILE . 11.9 t-105 -62.17 -33.06 73.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.444 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.1 -33.73 76.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.5 mp -91.63 -45.38 8.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.496 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.51 -46.64 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.356 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.81 10.71 51.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.729 -0.948 . . . . 1.0 110.729 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 24' ' ' ASN . 97.8 mt-10 -96.95 173.66 7.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 1.0 110.656 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 27' ' ' GLU . 10.2 t30 -32.89 115.44 0.41 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.07 -16.26 14.21 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.226 1.95 . . . . 1.0 112.383 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.11 -47.8 29.0 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.825 ' H ' HD22 ' A' ' 24' ' ' ASN . 63.9 mt-10 -69.17 -45.98 68.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 1.0 110.071 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.834 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.598 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.73 -38.13 71.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 39.6 tttm -58.38 -32.55 68.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.648 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.51 -38.67 71.11 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.0 p -73.03 -43.27 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.98 -0.288 . . . . 1.0 111.406 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.44 -35.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.2 mt-10 -69.59 -49.14 56.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.618 -1.173 . . . . 1.0 111.032 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.55 -44.38 71.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.747 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 63.8 tttt -84.43 -136.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.524 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 36' ' ' LYS . 75.2 m-20 -163.06 46.07 0.13 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 10' ' ' THR . 26.8 mm -38.99 -35.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.688 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' ASN . 14.6 tptm 68.69 -111.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.2 m-80 -36.12 105.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 1.0 111.024 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -55.94 -34.99 66.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.219 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.38 -45.01 69.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.921 0.867 . . . . 1.0 109.033 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.02 -41.29 97.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.046 -1.434 . . . . 1.0 111.152 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -59.49 -44.77 92.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.958 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.26 -46.6 66.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -58.0 -37.59 74.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.719 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.27 93.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.629 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 34.4 tttt -59.67 -51.89 67.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.872 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -57.42 -33.65 68.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.314 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.49 -47.18 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.397 -178.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.2 p -65.8 -33.79 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.591 -0.844 . . . . 1.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.2 m-20 -58.49 -34.68 71.19 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.663 -0.815 . . . . 1.0 110.672 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.593 HG21 ' HG ' ' A' ' 95' ' ' LEU . 85.4 m -59.47 -31.29 69.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.61 -42.32 42.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.83 -1.532 . . . . 1.0 110.316 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 57' ' ' HIS . 20.3 t -79.18 -20.56 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.686 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' ASP . 53.3 ttt85 -51.45 -14.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.701 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' O ' ' C ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -154.5 19.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.17 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 59' ' ' GLU . 7.1 tt -10.9 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 113.383 0.882 . . . . 1.0 113.383 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.01 ' H ' HG23 ' A' ' 58' ' ' ILE . 35.2 mt-10 -59.54 -46.61 88.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.811 0.339 . . . . 1.0 111.279 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 26.4 tt0 -52.85 -37.26 60.02 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -63.54 -47.79 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 119.92 -0.712 . . . . 1.0 109.383 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.15 -44.56 79.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.721 -1.214 . . . . 1.0 107.721 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -58.47 -44.36 89.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.484 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 130' ' ' ILE . 18.5 mt -59.21 -37.58 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.836 -0.802 . . . . 1.0 108.836 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -71.46 -39.92 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.696 177.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 65' ' ' ILE . 84.4 mt-10 -62.46 -36.93 84.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.9 -0.591 . . . . 1.0 112.23 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.48 -25.34 36.36 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.866 -0.333 . . . . 1.0 110.702 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.561 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -100.06 -32.29 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.122 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 69' ' ' LEU . 24.8 mt -47.54 -15.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.764 -0.374 . . . . 1.0 110.519 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' N ' ' C ' ' A' ' 68' ' ' HIS . 11.8 mtpt 55.3 29.69 13.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.397 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 119.99 -49.97 0.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.464 ' CG ' ' NH2' ' A' ' 76' ' ' ARG . 7.5 m0 -45.4 173.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.384 . . . . 1.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -120.68 132.52 55.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.189 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' HG21 ' A' ' 65' ' ' ILE . 1.7 tt -54.98 -23.85 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 76' ' ' ARG . 6.1 m-20 -59.43 -22.74 61.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.789 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 75' ' ' ASP . 13.0 tpp180 -26.75 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.516 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.0 tp 35.9 -157.05 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.094 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 45.53 101.26 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.022 -0.831 . . . . 1.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -72.22 -53.79 11.52 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.726 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.6 t -52.78 -49.29 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.268 0.556 . . . . 1.0 109.937 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.636 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 7.8 mm-40 -47.46 -49.59 25.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.568 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -51.72 51.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' C ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -72.37 -45.2 60.87 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.845 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.35 -38.77 74.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.881 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.846 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.8 tm? -54.71 -48.94 71.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.689 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 85' ' ' LEU . 7.2 mtp180 -60.64 -43.64 97.33 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.841 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -58.66 -41.33 85.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.766 -179.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 107' ' ' ILE . . . -67.31 -47.7 62.28 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.074 -1.06 . . . . 1.0 112.27 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 61' ' ' ILE . 2.0 p -63.29 -32.85 57.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.742 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.897 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -46.42 -45.07 17.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.927 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 107' ' ' ILE . 3.9 mt-10 -74.04 -53.6 9.65 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.626 -0.83 . . . . 1.0 111.736 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.2 mm? -10.7 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.09 -0.505 . . . . 1.0 112.311 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.78 -31.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 1.0 111.948 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.1 m-85 -52.96 -32.29 45.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.213 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 53' ' ' THR . 30.9 mt -93.61 -13.54 27.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 53.62 58.3 5.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.516 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.2 t -86.74 156.65 19.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.19 -57.47 11.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -128.38 76.14 78.54 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.65 -16.19 3.51 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.762 2.308 . . . . 1.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.36 -48.14 65.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.709 -0.556 . . . . 1.0 111.709 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -45.47 63.98 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.18 -40.11 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -67.57 -47.22 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.142 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.01 -51.09 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.119 0.485 . . . . 1.0 111.223 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -55.39 -40.36 71.29 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.148 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.745 HD11 ' OE2' ' A' ' 91' ' ' GLU . 3.1 mt -56.69 -48.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 104' ' ' PHE . 37.8 t -63.45 -37.86 80.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.29 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -63.85 -37.9 89.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.89 -31.91 73.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.825 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.96 -37.76 80.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.455 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -51.43 -36.87 45.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.195 0.522 . . . . 1.0 110.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -57.2 -45.44 83.76 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.455 -0.793 . . . . 1.0 111.011 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -95.19 -72.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.998 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.57 149.73 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.835 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.5 159.8 17.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.16 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.04 -31.7 72.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 118' ' ' LYS . 4.0 mptp? -59.5 -45.0 92.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.124 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.636 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.7 -39.97 69.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.669 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.13 -35.85 85.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.352 -1.099 . . . . 1.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -61.3 -46.04 91.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -60.65 -48.94 79.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.506 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -37.99 81.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.508 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -68.53 -52.71 29.02 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.388 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.69 -48.45 81.51 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -66.9 -30.08 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.567 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 7.8 tt -64.5 -42.88 95.57 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.858 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -58.12 -29.49 65.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -58.02 -35.99 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.295 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 65' ' ' ILE . 15.8 mt -65.26 -39.2 84.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 92' ' ' LEU . 1.1 t80 -53.83 -52.69 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.865 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -61.29 -37.04 81.78 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.495 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.531 ' HB2' ' ND1' ' A' ' 68' ' ' HIS . . . -62.74 -33.68 75.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -61.91 -50.16 73.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -60.87 -32.52 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.788 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 25.9 p -72.43 -23.79 61.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 1.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.8 m -75.53 -18.25 59.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 t -83.84 107.48 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.49 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -41.27 -69.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.68 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 142' ' ' LYS . 5.6 pt-20 -172.24 72.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.816 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.88 -81.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 140' ' ' GLU . 2.0 mmmm -87.25 157.49 53.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.496 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.28 153.68 32.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.215 1.943 . . . . 1.0 112.059 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.1 m -156.82 92.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.458 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.8 mt 47.95 96.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 148' ' ' GLU . 21.5 tptt -149.04 52.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.9 p 75.13 -35.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.757 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 146' ' ' LYS . 11.4 pt-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.717 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -151.33 4.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.529 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 31.6 p90 -52.65 -35.87 55.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -57.59 -33.36 68.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.515 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -56.64 -42.52 79.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 10' ' ' THR . . . -68.72 -44.35 70.89 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.82 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.752 0.311 . . . . 1.0 110.429 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' NH2' ' OH ' ' A' ' 46' ' ' TYR . 60.2 mtt85 -74.66 -44.83 48.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HA ' HD22 ' A' ' 110' ' ' LEU . 2.0 m-20 -61.57 -47.96 83.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.0 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' GLY . 74.7 p -61.86 -20.68 63.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.352 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.12 67.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.439 . . . . 1.0 111.647 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.95 -48.53 79.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.917 -177.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.686 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.7 -37.49 68.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.972 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -67.46 -41.16 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 51' ' ' VAL . 1.7 mm? -60.89 -34.66 74.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.3 -38.83 92.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.596 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -60.85 -32.71 72.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.714 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -62.56 -36.6 83.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.047 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.44 -32.64 74.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.777 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 20' ' ' LEU . 11.1 mp -91.07 -45.48 8.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.431 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -100.21 -47.03 5.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.05 36.02 92.88 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 24' ' ' ASN . 34.4 mt-10 -130.11 172.98 11.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.669 0.271 . . . . 1.0 110.598 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -28.2 92.81 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 23' ' ' GLU . 31.8 Cg_exo -55.57 -33.26 86.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.51 2.14 . . . . 1.0 112.244 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.95 -39.86 92.41 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.58 -52.79 49.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.999 0.428 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.37 -38.41 77.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.631 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.623 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.87 -40.26 72.69 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.685 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.7 ttpm? -56.96 -33.07 66.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.679 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -69.19 -41.36 77.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -73.8 -43.26 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.65 -36.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 -178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.7 mt-10 -63.67 -49.07 74.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.703 -1.135 . . . . 1.0 110.848 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.74 -43.98 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.861 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -84.46 -9.01 58.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.827 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER 42.78 44.83 3.98 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.829 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' C ' ' O ' ' A' ' 37' ' ' ASN . 25.7 mm -30.91 127.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.617 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -77.97 147.89 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.75 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.98 102.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.324 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -51.1 -33.59 26.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.2 m-20 -53.68 -44.48 69.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.775 0.798 . . . . 1.0 109.259 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.61 84.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.277 -1.329 . . . . 1.0 111.403 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 38' ' ' ILE . 3.1 t80 -59.84 -44.7 93.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.398 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -69.05 -46.26 68.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' NH2' ' A' ' 8' ' ' ARG . 29.1 t80 -56.19 -37.45 69.62 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.604 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.07 99.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -58.84 -51.01 71.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -57.53 -37.35 72.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.752 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.62 -45.66 88.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.163 0.506 . . . . 1.0 109.655 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG13 HD22 ' A' ' 15' ' ' LEU . 52.9 t -65.77 -34.98 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.818 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ARG . 60.6 m-20 -62.14 -30.62 71.16 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.866 -0.734 . . . . 1.0 110.521 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.65 HG21 ' HG ' ' A' ' 95' ' ' LEU . 74.4 m -60.0 -31.22 69.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.3 -40.57 51.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.832 -1.531 . . . . 1.0 110.099 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 18.4 t -78.4 -15.2 13.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.87 -1.059 . . . . 1.0 111.355 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 52' ' ' ASP . 55.9 ttt180 -50.17 -14.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.859 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.467 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -143.14 -52.21 0.36 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.859 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.5 mt 76.11 -98.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.194 0.442 . . . . 1.0 112.194 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.57 -45.98 90.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.142 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 32.7 tt0 -52.73 -37.13 58.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.105 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.782 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.0 mt -61.11 -48.55 88.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 119.816 -0.754 . . . . 1.0 109.277 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.1 -45.41 79.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 t -60.4 -41.55 94.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.586 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.5 mt -59.29 -36.77 65.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.563 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.28 -40.76 78.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.51 177.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 65' ' ' ILE . 94.1 mt-10 -62.24 -36.56 82.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.422 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.8 -26.21 45.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.693 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' LYS . 7.4 t-80 -102.25 -33.93 9.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 69' ' ' LEU . 29.1 mt -43.08 -18.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.638 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.5 tttt 73.63 -4.1 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.555 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.68 -40.98 0.95 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -50.97 -176.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 1.0 110.788 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -125.25 143.44 50.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.009 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.537 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.15 -23.52 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 77' ' ' LEU . 13.0 t70 -66.68 -23.24 66.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.562 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' LEU . 10.6 ttt-85 -29.84 85.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.705 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.6 tp 49.44 171.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.093 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.98 105.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -53.03 10.5 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.851 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.6 t -53.12 -44.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.313 0.578 . . . . 1.0 110.176 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.8 mt-10 -47.2 -48.82 23.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.271 -0.877 . . . . 1.0 111.343 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.62 -52.12 32.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.363 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -72.35 -46.61 54.68 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.39 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -57.3 -39.79 76.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.969 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.3 tm? -55.71 -48.07 75.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.544 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -62.69 -41.46 99.13 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.307 -0.557 . . . . 1.0 110.765 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.11 -37.61 85.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.497 -0.481 . . . . 1.0 111.332 -179.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.2 -47.89 68.8 Favored Glycine 0 N--CA 1.455 -0.097 0 C-N-CA 120.256 -0.974 . . . . 1.0 111.82 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.782 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.05 -34.42 66.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.673 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.957 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.75 -44.9 9.62 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.231 0.538 . . . . 1.0 109.934 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 92' ' ' LEU . 24.0 mp0 -73.09 -57.42 4.04 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.335 -0.946 . . . . 1.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 91' ' ' GLU . 5.9 mp -11.93 -75.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.948 0.722 . . . . 1.0 112.948 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.49 -31.32 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.574 -0.451 . . . . 1.0 111.92 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.957 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 11.3 m-85 -53.07 -32.06 45.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.292 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.65 ' HG ' HG21 ' A' ' 53' ' ' THR . 13.3 mt -90.14 -15.94 30.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.349 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 60.94 34.3 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.457 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -64.59 146.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.663 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.35 -26.16 63.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.62 70.15 25.6 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.56 -20.54 53.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.909 2.406 . . . . 1.0 112.392 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.72 -48.9 63.72 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.202 -0.523 . . . . 1.0 111.905 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -72.31 -40.65 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.077 -0.249 . . . . 1.0 111.111 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 107' ' ' ILE . 2.3 t -59.72 -49.6 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.386 . . . . 1.0 110.129 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -57.02 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.24 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -52.25 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.397 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.77 -41.13 73.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.527 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.601 ' HA ' HD23 ' A' ' 110' ' ' LEU . 1.1 mp -57.1 -48.17 82.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.17 -37.53 80.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.02 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.54 -37.89 87.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -62.03 -31.79 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.934 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -66.9 -38.24 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.477 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -52.21 -37.83 56.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.154 0.502 . . . . 1.0 110.54 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -60.13 -44.98 94.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.177 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -90.56 -69.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.225 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 172.58 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.24 157.3 37.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.202 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.34 -42.94 99.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -59.66 -37.91 80.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 1.0 110.067 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -66.4 -38.76 88.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.13 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.29 88.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.81 86.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -64.11 -40.77 96.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.031 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 119' ' ' ALA . 98.2 t -61.17 -39.35 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.519 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -67.86 -52.42 36.84 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.201 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.65 94.46 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -29.55 39.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.013 -0.275 . . . . 1.0 111.068 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' VAL . 0.3 OUTLIER -62.71 -47.22 84.53 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.973 0.416 . . . . 1.0 110.16 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -60.49 -29.87 69.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.462 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.45 -39.36 73.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.006 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 65' ' ' ILE . 7.6 mt -67.96 -38.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.396 -0.521 . . . . 1.0 110.204 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -54.24 -53.39 54.26 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.308 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.13 -36.95 78.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.31 -39.74 73.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.621 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 135' ' ' ILE . 7.5 t80 -62.62 -40.48 97.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.557 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.523 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -88.83 26.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.339 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 133' ' ' ALA . 11.8 t -81.11 -21.78 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.6 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.1 p -74.85 -3.78 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.64 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 p -55.98 109.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -84.25 158.06 21.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.505 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.51 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.652 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -114.92 -172.77 2.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.657 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -69.56 149.68 96.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.449 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.66 153.03 79.95 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.474 2.116 . . . . 1.0 111.771 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.7 m -156.27 -15.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 mt 42.87 91.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.666 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -76.3 66.0 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.47 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -144.77 -19.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.556 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.03 20.39 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.7 p90 -54.26 -42.65 70.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.663 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.61 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -65.02 -37.46 87.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.737 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -42.11 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.504 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.19 -40.3 50.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . . . -57.17 -39.19 74.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.077 -0.249 . . . . 1.0 110.588 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 11.1 mtp180 -74.69 -44.38 50.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.68 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -60.96 -50.23 74.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 1.0 110.518 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.5 p -62.29 -20.51 64.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.068 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -53.3 -45.95 69.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.236 0.541 . . . . 1.0 111.004 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -58.51 -45.66 88.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.513 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -53.93 -38.8 65.27 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.32 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.69 -46.79 95.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 119.809 -0.757 . . . . 1.0 109.153 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.753 HD13 HG22 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.3 -34.11 76.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.038 178.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -61.0 -38.07 84.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.839 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -34.12 77.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.014 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -62.66 -31.95 72.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' OD2' ' CD2' ' A' ' 79' ' ' TYR . 58.0 t0 -66.87 -34.01 76.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.89 -45.54 8.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.498 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -97.76 -46.96 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.346 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.44 41.57 66.58 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.631 -0.988 . . . . 1.0 110.631 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 24' ' ' ASN . 26.0 tt0 -131.77 163.35 28.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.629 0.252 . . . . 1.0 110.514 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -24.13 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.223 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' GLU . 49.6 Cg_exo -51.59 -22.6 13.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.385 2.057 . . . . 1.0 112.178 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.13 -40.83 55.5 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.241 -0.504 . . . . 1.0 111.844 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -50.02 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.948 0.404 . . . . 1.0 110.543 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.72 -37.08 82.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.944 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -56.14 -41.14 74.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 37.5 tttt -57.11 -32.71 66.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.76 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -69.75 -41.5 75.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.97 -42.99 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.76 -36.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.6 mt-10 -63.01 -45.92 90.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.729 -1.123 . . . . 1.0 110.174 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' VAL . 1.5 tm-20 -74.47 -43.75 54.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.757 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 33' ' ' VAL . 45.3 mttt -87.24 124.75 33.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.555 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.1 m-80 -69.69 48.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.225 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 mm -40.44 -39.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 1.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 tttp 73.66 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.0 111.241 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -62.33 98.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.326 . . . . 1.0 110.59 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -55.81 -33.7 64.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.149 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.0 -45.55 67.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.865 0.841 . . . . 1.0 109.073 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 3' ' ' TYR . . . -61.86 -47.4 85.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.113 -1.403 . . . . 1.0 110.896 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.725 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.04 -47.52 65.15 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -56.47 -36.26 68.87 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.212 -0.904 . . . . 1.0 109.744 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -59.87 -46.22 89.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.65 -51.19 70.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.181 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.37 -35.51 70.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.083 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.56 -46.92 85.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.753 HG22 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -69.77 -32.9 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.146 179.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -53.74 -29.64 40.61 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.163 -0.615 . . . . 1.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' HD23 ' A' ' 95' ' ' LEU . 65.7 m -59.85 -32.21 70.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.38 -38.94 55.02 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.023 -1.444 . . . . 1.0 110.196 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.67 -16.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.998 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -54.48 -14.56 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.86 -61.12 0.63 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.522 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 43.8 mt 81.4 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.535 0.568 . . . . 1.0 112.535 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.54 -46.14 89.75 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.713 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -52.52 -37.27 57.2 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.298 -0.561 . . . . 1.0 110.181 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.779 ' CG2' HG11 ' A' ' 89' ' ' VAL . 47.8 mt -60.9 -48.91 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.837 -0.745 . . . . 1.0 109.313 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -55.84 -45.44 78.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 t -58.65 -43.16 89.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.692 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.466 ' CG2' HG23 ' A' ' 130' ' ' ILE . 9.6 mt -59.6 -37.53 71.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -70.78 -39.28 75.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.485 177.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 65' ' ' ILE . 42.1 mt-10 -62.12 -35.71 79.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 1.0 112.469 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -54.72 -25.96 30.9 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.774 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -102.51 -35.2 8.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.674 -0.411 . . . . 1.0 111.295 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -41.93 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 68' ' ' HIS . 23.2 ttmt 73.69 0.01 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.64 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 143.03 -39.5 1.32 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 71' ' ' GLY . 9.9 m0 -51.13 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 1.0 110.803 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.3 p -125.48 141.72 51.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.126 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.575 HD12 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.57 -23.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 77' ' ' LEU . 2.1 m-20 -74.67 -22.62 58.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.025 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 63.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.154 -0.476 . . . . 1.0 111.153 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.1 mt 166.05 -174.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.093 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -47.07 165.74 0.11 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CD2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -74.27 -53.01 10.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.582 0.23 . . . . 1.0 111.303 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -51.05 -50.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 1.0 110.81 -178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 54.3 mp0 -46.38 -50.86 15.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.237 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.528 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -54.75 -52.23 63.19 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.373 -0.531 . . . . 1.0 110.551 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.81 -39.2 66.83 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.416 -0.514 . . . . 1.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' VAL . . . -55.73 -50.42 70.42 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.125 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.15 -37.0 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.584 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.477 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 67.0 mtp180 -60.21 -44.26 95.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.261 -0.575 . . . . 1.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -67.04 -32.56 73.84 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.225 -0.59 . . . . 1.0 110.577 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.47 -44.83 82.45 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.784 -0.722 . . . . 1.0 111.515 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.779 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -63.74 -32.15 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.067 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.01 -43.48 9.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.163 0.506 . . . . 1.0 109.85 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.2 mm-40 -67.53 -59.76 3.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.593 -0.843 . . . . 1.0 111.572 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' C ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm? -5.93 -83.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.072 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.09 -30.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.394 . . . . 1.0 111.842 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.755 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.2 m-85 -52.92 -32.54 46.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.56 -177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -96.42 -20.22 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.369 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.2 tttm 62.78 71.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.571 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -101.35 150.69 22.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.445 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.2 -22.42 59.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.516 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' N ' ' A' ' 99' ' ' GLU . 1.4 pm0 -142.3 67.25 20.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.388 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 99' ' ' GLU . 15.0 Cg_exo -65.72 -16.26 52.57 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.728 2.285 . . . . 1.0 112.199 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.64 -50.01 68.15 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.982 -0.627 . . . . 1.0 112.009 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -73.14 -38.51 66.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.704 0.288 . . . . 1.0 111.307 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.47 -49.48 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.665 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -56.85 -46.41 81.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.984 0.421 . . . . 1.0 110.235 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -49.65 -51.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.427 -179.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -55.24 -41.95 72.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.898 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.3 -48.72 79.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.0 -36.67 78.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.273 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.47 -36.52 80.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.77 -32.74 72.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 1.0 109.981 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -67.49 -38.68 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.234 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -52.39 -37.71 57.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.22 0.534 . . . . 1.0 110.643 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -67.41 -45.2 76.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.013 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -86.51 -67.73 0.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.229 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 111' ' ' VAL . . . -82.54 149.9 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.057 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 2.7 p-10 -42.0 144.25 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 111.349 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.52 -31.96 72.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.63 -37.56 78.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 1.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -69.69 -36.66 76.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.65 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.48 -36.4 77.09 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -62.21 -46.58 88.28 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.492 ' CG ' ' CD1' ' A' ' 77' ' ' LEU . 20.5 t80 -68.38 -40.93 81.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.354 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 119' ' ' ALA . 39.7 t -59.69 -40.33 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.488 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -66.93 -50.69 61.58 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.527 -0.469 . . . . 1.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.78 -42.01 94.27 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -70.51 -30.62 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.751 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -63.91 -46.84 83.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.964 0.411 . . . . 1.0 110.076 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -60.25 -30.2 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.769 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.632 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.3 -40.96 78.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.665 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -63.22 -38.91 83.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.8 -47.2 74.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.624 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -36.97 80.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.22 74.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.814 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.65 -52.28 65.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.305 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.771 ' C ' HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -47.21 -33.35 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.398 -178.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.02 -21.19 18.14 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.939 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.9 t -73.42 -23.09 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.66 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.1 m -76.25 57.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -152.74 -165.2 2.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.442 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -42.18 130.48 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.94 -84.22 0.64 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -85.36 130.24 52.34 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.314 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.7 145.75 76.57 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.115 1.877 . . . . 1.0 111.685 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.405 ' HG ' ' HZ2' ' A' ' 146' ' ' LYS . 33.1 t -171.8 88.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.672 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 145' ' ' LEU . 9.3 mp -94.01 100.59 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HZ2' ' HG ' ' A' ' 144' ' ' SER . 23.6 pttm -166.98 163.72 16.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.651 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m 53.04 33.33 14.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.654 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.553 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -76.68 -56.91 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.52 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 11.5 p90 -63.98 -36.76 85.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.492 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 20.7 ttm180 -63.07 -32.83 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.44 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 78.9 tttt -56.5 -41.4 76.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.344 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.7 -43.01 52.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.723 -0.951 . . . . 1.0 110.723 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.56 75.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 1.0 110.631 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -74.5 -44.88 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.043 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 5' ' ' LYS . 3.8 m-20 -62.73 -47.0 85.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.0 110.684 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 37.7 p -61.94 -20.51 63.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.256 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.44 -42.8 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 1.0 111.834 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -58.06 -48.91 78.69 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.504 -0.479 . . . . 1.0 111.983 -178.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -55.2 -36.8 66.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.995 -178.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -63.35 -45.79 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.244 0.545 . . . . 1.0 109.57 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.727 ' CD1' HG13 ' A' ' 51' ' ' VAL . 1.1 mp -62.67 -33.22 74.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.264 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -62.41 -37.0 84.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.258 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -63.24 -32.67 74.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.14 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 65.4 t90 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -66.53 -33.15 75.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.857 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 20' ' ' LEU . 10.6 mp -90.7 -45.69 8.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.351 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -47.89 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 1.0 110.785 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 61.78 28.7 70.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 24' ' ' ASN . 49.5 mt-10 -132.62 123.74 26.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.637 0.256 . . . . 1.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' O ' ' O ' ' A' ' 23' ' ' GLU . 9.1 t-20 33.4 100.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.44 -17.09 11.63 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.256 1.971 . . . . 1.0 112.162 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -47.68 29.45 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -63.75 -46.29 86.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.505 . . . . 1.0 109.979 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.04 -36.89 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.372 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.86 -41.67 78.38 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 59.1 mttp -57.0 -32.91 66.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.489 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -69.91 -40.62 75.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.2 p -73.85 -44.7 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.601 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.02 -35.99 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 3.4 mt-10 -61.58 -48.76 79.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.0 110.56 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -73.38 -43.87 59.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.81 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 38' ' ' ILE . 3.4 tptp -87.84 116.16 25.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.128 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -65.06 50.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.588 . . . . 1.0 111.265 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 36' ' ' LYS . 39.1 mm -42.52 -43.98 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 1.0 110.127 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB3' HD22 ' A' ' 40' ' ' ASN . 15.4 tptt 69.21 -76.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.647 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -55.72 95.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.643 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -57.04 -36.09 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.993 0.425 . . . . 1.0 110.128 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.948 0.88 . . . . 1.0 109.064 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -66.72 -47.57 71.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 113.968 -1.469 . . . . 1.0 111.566 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -59.27 -43.78 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.994 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.92 -47.27 66.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.43 -37.59 70.44 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.724 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.21 99.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.306 -0.861 . . . . 1.0 111.152 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.54 -51.06 71.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.914 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.88 -37.9 74.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.773 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.192 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 15' ' ' LEU . 40.8 t -65.03 -35.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' ARG . 27.0 t0 -62.06 -28.66 69.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.833 -0.747 . . . . 1.0 110.763 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 95' ' ' LEU . 90.2 m -57.66 -30.91 65.8 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.303 -1.369 . . . . 1.0 107.303 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.18 -42.82 36.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.515 -1.675 . . . . 1.0 110.719 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.77 -15.75 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.157 -0.929 . . . . 1.0 111.835 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.9 mtp180 -50.29 -14.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.012 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -133.15 -31.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.707 0.289 . . . . 1.0 110.595 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' N ' ' A' ' 59' ' ' GLU . 9.1 mt 68.25 -118.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.107 0.479 . . . . 1.0 112.213 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' ILE . 23.0 mt-10 -59.81 -38.95 83.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.762 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CD ' ' CE1' ' A' ' 57' ' ' HIS . 40.6 tt0 -50.56 -37.52 39.99 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.862 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.3 mt -60.44 -48.67 87.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 119.352 -0.939 . . . . 1.0 109.592 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -55.44 -43.9 75.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -58.91 -44.63 91.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.137 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.57 HG22 HG12 ' A' ' 130' ' ' ILE . 15.9 mt -58.65 -37.85 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -70.78 -42.78 77.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 176.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 65' ' ' ILE . 16.1 tt0 -65.32 -36.41 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.026 -0.988 . . . . 1.0 112.36 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -55.47 -27.77 50.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.443 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.631 ' HD1' ' C ' ' A' ' 129' ' ' ALA . 4.4 t-160 -102.08 -24.9 13.9 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.84 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 12.6 mt -42.16 -42.55 3.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 1.0 110.374 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 28.1 tttp 85.1 45.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.24 -26.15 16.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 72' ' ' TRP . 6.7 m0 -67.34 168.98 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 1.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.5 m -111.6 131.54 55.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.167 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -55.89 -23.9 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 76' ' ' ARG . 33.2 t70 -60.0 -23.08 63.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.808 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' C ' ' O ' ' A' ' 75' ' ' ASP . 17.3 tpt180 -20.55 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.536 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 78' ' ' GLY . 16.4 mt 42.92 -169.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.744 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' LEU . . . 41.94 98.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -52.19 38.44 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.137 -0.225 . . . . 1.0 111.286 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 80' ' ' VAL . 2.8 t -51.68 -48.45 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.002 0.43 . . . . 1.0 110.286 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.69 ' CG ' ' HB1' ' A' ' 119' ' ' ALA . 0.6 OUTLIER -47.18 -49.14 23.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.058 -179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -51.69 -50.97 59.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.045 -0.662 . . . . 1.0 110.553 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -71.52 -43.72 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.009 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -55.91 -40.82 73.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.607 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -56.55 -46.29 80.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.038 -0.528 . . . . 1.0 109.794 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 89' ' ' VAL . 52.7 mtp180 -60.07 -42.39 94.45 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.351 -0.54 . . . . 1.0 110.626 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.58 -35.02 79.61 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.401 -0.52 . . . . 1.0 110.735 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 91' ' ' GLU . . . -65.59 -46.11 86.18 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.657 -0.783 . . . . 1.0 111.583 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.4 p -64.94 -33.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.76 0.314 . . . . 1.0 110.495 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.888 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.02 -41.74 7.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.425 0.631 . . . . 1.0 109.528 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' C ' ' A' ' 92' ' ' LEU . 25.6 mp0 -72.85 -58.93 2.97 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.261 -0.976 . . . . 1.0 110.894 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.608 ' C ' ' O ' ' A' ' 91' ' ' GLU . 3.2 mm? -8.07 -80.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.702 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.46 -30.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 1.0 111.743 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.888 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 42.2 m-85 -53.74 -33.52 55.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.59 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 53' ' ' THR . 8.5 tp -101.43 -12.72 18.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.936 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mttm 50.39 65.74 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.426 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 t -80.25 165.56 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -78.5 -26.99 46.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.241 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -139.86 66.93 34.49 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.005 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.92 -22.07 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.941 2.427 . . . . 1.0 112.756 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.05 -50.23 18.7 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.619 -0.8 . . . . 1.0 111.244 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -37.52 64.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.671 0.272 . . . . 1.0 111.178 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -59.17 -49.64 82.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.722 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -67.93 -46.94 70.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.283 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.502 ' N ' ' CG ' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -49.45 -53.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.016 -178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 105' ' ' ILE . 67.0 t0 -56.76 -42.7 79.84 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.051 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.94 -47.16 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.1 t -67.98 -36.51 75.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.798 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -61.33 -35.52 77.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.279 -1.008 . . . . 1.0 108.279 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.97 -32.18 72.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.702 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -65.97 -39.16 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.19 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -52.73 -37.76 59.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.245 0.545 . . . . 1.0 110.549 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -64.92 -45.73 84.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.943 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -82.5 -65.82 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.66 -0.7 . . . . 1.0 111.064 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' CB ' ' OE2' ' A' ' 81' ' ' GLU . . . -88.22 147.85 24.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.887 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 7.3 p-10 -36.14 145.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.42 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.29 -33.28 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.139 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.61 -29.98 68.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 1.0 110.296 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.925 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -71.45 -37.19 71.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.142 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.97 79.16 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 10.4 mtpt -62.61 -45.79 91.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 1.0 109.889 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.16 -34.42 74.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.971 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 119' ' ' ALA . 24.9 t -66.2 -48.67 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.368 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 121' ' ' LYS . 2.7 p30 -66.92 -50.96 60.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.29 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 124' ' ' ASN . . . -55.48 -50.23 61.09 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.207 -0.757 . . . . 1.0 111.207 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 1.3 p -70.73 -29.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.602 HD22 ' CE1' ' A' ' 104' ' ' PHE . 7.6 tt -64.68 -43.83 92.29 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.182 0.515 . . . . 1.0 109.718 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 t -58.11 -27.82 64.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.474 -0.784 . . . . 1.0 109.478 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.631 ' C ' ' HD1' ' A' ' 68' ' ' HIS . . . -56.58 -38.6 72.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.362 -0.835 . . . . 1.0 111.047 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 65' ' ' ILE . 6.3 mt -59.88 -40.24 82.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.338 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -54.7 -42.67 71.73 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.632 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.45 -41.55 88.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.0 110.356 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 136' ' ' THR . . . -67.21 -33.34 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.287 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.18 -52.34 66.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -50.24 -32.95 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.52 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 133' ' ' ALA . 2.5 p -83.49 -30.05 27.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.755 0.312 . . . . 1.0 110.394 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -77.05 -22.91 52.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.656 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -71.34 -43.57 66.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -76.94 149.51 36.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.664 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 140' ' ' GLU . 17.0 mp0 -79.59 126.74 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.401 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -91.86 -10.56 39.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.581 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' N ' ' OE1' ' A' ' 141' ' ' GLU . 1.3 pttp -84.59 152.53 60.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.88 155.11 71.05 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.657 2.238 . . . . 1.0 112.257 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 146' ' ' LYS . 54.1 p -127.15 112.95 15.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.321 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.5 mt 55.93 5.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 144' ' ' SER . 83.8 mttt -92.55 -45.83 7.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.44 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.1 p -172.87 174.65 3.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.56 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.068 -0.968 . . . . 1.0 110.497 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.358 -0.608 . . . . 1.0 109.358 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 55.53 50.04 15.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.511 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 27.0 p90 -64.65 -35.18 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.633 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -56.92 -32.74 66.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -56.54 -43.17 79.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.2 -43.46 63.55 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.4 -33.62 65.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 1.0 110.483 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -71.16 -44.08 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 110' ' ' LEU . 14.6 m-20 -60.78 -48.54 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.015 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 p -61.9 -19.76 63.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -52.82 -44.24 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.204 0.526 . . . . 1.0 111.403 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.07 -48.13 79.32 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.593 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -54.55 -41.33 69.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.856 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 11' ' ' ALA . 1.5 p -69.32 -39.09 78.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.795 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -62.99 -33.67 75.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.63 -38.03 88.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.332 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -63.98 -32.56 74.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.015 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' O ' ' CA ' ' A' ' 22' ' ' GLY . 52.7 t90 -62.51 -34.38 76.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.277 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -66.8 -33.25 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.806 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.9 mp -91.24 -45.59 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.276 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.56 -46.59 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.972 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 18' ' ' TRP . . . 57.56 22.02 44.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -132.89 126.96 33.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.799 0.333 . . . . 1.0 110.559 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 40.59 92.03 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.737 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.0 -22.41 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.428 2.085 . . . . 1.0 112.002 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.12 -46.48 35.26 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -59.83 -48.5 81.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.259 0.552 . . . . 1.0 110.334 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 17' ' ' ARG . 13.3 mt -56.4 -37.56 70.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.331 -0.849 . . . . 1.0 110.689 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.73 -38.34 69.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.824 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 30.9 ttmt -56.91 -32.96 66.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.566 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.52 -43.36 85.43 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 p -73.39 -42.71 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -46.6 -35.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 1.3 mt-10 -64.29 -48.03 77.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.63 -1.168 . . . . 1.0 110.718 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.33 -44.17 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -82.86 -6.21 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.896 -0.321 . . . . 1.0 110.959 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 39' ' ' LYS . 21.2 m120 40.45 48.33 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.992 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' LYS . 42.6 mm -44.01 96.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.425 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' LYS . 93.4 mttt -44.04 -94.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.778 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 40' ' ' ASN . 1.6 m-80 -42.54 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.79 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' LYS . 20.0 tptp -51.5 -33.58 32.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 1.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.74 -44.12 69.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.715 0.769 . . . . 1.0 109.471 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.63 -47.54 84.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.226 -1.352 . . . . 1.0 111.208 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.42 -41.45 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -69.22 -47.01 65.98 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -59.49 -37.56 78.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.415 -0.811 . . . . 1.0 109.699 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.77 92.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 72.7 tttt -60.23 -51.55 69.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.649 -0.705 . . . . 1.0 109.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' NZ ' HD11 ' A' ' 95' ' ' LEU . 47.9 tttm -57.92 -31.58 66.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -57.73 -46.82 83.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.181 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -67.17 -34.17 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.156 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -58.16 -30.82 66.68 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.715 -0.794 . . . . 1.0 110.676 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.715 HG22 ' HB1' ' A' ' 90' ' ' ALA . 54.9 m -59.1 -32.69 70.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.75 -39.52 44.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.627 -1.624 . . . . 1.0 110.986 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' C ' ' N ' ' A' ' 57' ' ' HIS . 21.7 t -78.03 -16.14 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.813 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -51.47 -13.87 0.26 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -139.06 -57.0 0.61 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.667 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 41.1 mt 80.18 -98.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.58 -45.67 91.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.198 -0.455 . . . . 1.0 111.37 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 41.5 tt0 -51.73 -37.1 49.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.293 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.784 ' CG2' HG11 ' A' ' 89' ' ' VAL . 5.2 mt -61.3 -49.67 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 119.741 -0.784 . . . . 1.0 109.785 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD2' ' NH1' ' A' ' 86' ' ' ARG . 6.4 m-20 -56.37 -45.16 80.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.976 -1.12 . . . . 1.0 107.976 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.2 t -59.27 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.601 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CG2' HG23 ' A' ' 130' ' ' ILE . 13.3 mt -59.23 -36.65 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -67.0 -42.56 88.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.981 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 65' ' ' ILE . 43.4 mt-10 -61.65 -35.19 77.22 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.004 0.742 . . . . 1.0 113.004 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -54.33 -25.85 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.394 -0.522 . . . . 1.0 110.945 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.624 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 2.3 t60 -102.21 -39.17 7.36 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.318 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 69' ' ' LEU . 47.9 mt -41.09 -21.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.502 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 68' ' ' HIS . 17.1 tttt 69.46 -6.16 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.733 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 72' ' ' TRP . . . 156.5 -43.47 0.53 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLY . 7.7 m0 -49.7 -176.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 1.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -125.42 143.75 50.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.171 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -56.21 -24.18 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 76' ' ' ARG . 49.6 t0 -60.37 -22.91 63.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.839 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.577 ' O ' ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -15.46 132.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.789 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 76' ' ' ARG . 3.3 mt -11.32 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.781 -0.645 . . . . 1.0 111.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.79 108.12 2.62 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.532 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.7 -53.15 14.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 1.0 110.415 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 9.6 t -52.51 -49.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.54 . . . . 1.0 110.411 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' OE2' ' HB1' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -48.05 -47.43 33.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.422 -0.808 . . . . 1.0 111.561 -179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -51.5 -50.59 59.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -72.54 -42.36 64.81 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.483 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.36 -38.28 80.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.932 -0.576 . . . . 1.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.3 tt -55.79 -46.07 78.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.904 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.547 ' NH1' ' OD2' ' A' ' 62' ' ' ASP . 8.1 mtp85 -60.5 -42.04 95.52 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.335 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.18 -38.09 85.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.261 -179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.518 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -67.19 -47.34 64.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.799 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.784 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.73 -30.85 51.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.772 0.32 . . . . 1.0 110.706 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB1' HG22 ' A' ' 53' ' ' THR . . . -45.07 -42.73 8.88 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.61 ' O ' ' C ' ' A' ' 92' ' ' LEU . 4.6 mp0 -66.53 -58.74 4.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.506 -0.878 . . . . 1.0 111.094 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' C ' ' O ' ' A' ' 91' ' ' GLU . 1.5 mm? -1.26 -87.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.723 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.54 -29.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.258 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -52.11 -40.22 60.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.899 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.3 tp -102.0 -20.44 14.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.254 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 63.15 88.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 1.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.5 t -101.79 176.64 5.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -98.72 -40.85 7.96 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.479 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.27 75.86 78.62 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.092 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.534 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 35.0 Cg_exo -53.98 -34.2 75.92 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.857 2.372 . . . . 1.0 112.713 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.83 -48.36 86.45 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.712 -0.555 . . . . 1.0 111.712 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -71.25 -35.15 71.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.776 0.322 . . . . 1.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -48.76 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.444 -179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.796 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.9 m-85 -54.2 -48.12 71.35 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.069 -0.653 . . . . 1.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -48.01 -52.79 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.525 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.85 -47.81 76.62 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.722 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.73 -45.0 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 104' ' ' PHE . 38.6 t -66.49 -37.03 78.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.547 -0.752 . . . . 1.0 110.416 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 105' ' ' ILE . 4.6 t0 -61.25 -35.89 78.49 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.55 -33.83 74.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.923 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.447 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -65.8 -38.45 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.389 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -51.72 -37.57 51.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.191 0.52 . . . . 1.0 110.671 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -62.52 -45.16 94.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.181 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -93.66 -71.23 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 1.0 111.286 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -78.01 167.79 20.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.88 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.16 155.81 39.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.29 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -62.33 -33.82 75.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.6 -33.53 71.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 1.0 110.123 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.613 ' HB1' ' OE2' ' A' ' 81' ' ' GLU . . . -71.32 -36.17 71.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.72 -0.673 . . . . 1.0 110.198 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.42 -36.3 83.44 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.397 -0.82 . . . . 1.0 111.113 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -45.8 92.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.68 -42.31 99.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.663 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.428 HG23 ' OE2' ' A' ' 81' ' ' GLU . 75.0 t -62.04 -47.61 92.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.137 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -67.56 -51.01 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.799 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.29 -48.22 81.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.286 -0.725 . . . . 1.0 111.286 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 65' ' ' ILE . 2.4 p -67.37 -28.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 1.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.71 85.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.11 0.481 . . . . 1.0 110.012 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 t -61.44 -29.89 70.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -56.54 -38.39 71.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.631 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.598 HD11 HG12 ' A' ' 65' ' ' ILE . 6.1 mt -68.06 -38.79 80.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.28 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -54.35 -49.72 69.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.795 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -40.46 81.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 1.0 110.364 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.908 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.39 -52.69 62.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.029 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -51.94 -30.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.214 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.9 p -85.16 -30.87 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.212 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -73.46 -36.63 65.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.627 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 82.9 p -79.74 161.67 25.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.515 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 148' ' ' GLU . 22.0 tttm -152.6 149.23 28.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -44.74 -31.03 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -166.63 -179.88 5.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -69.91 154.83 94.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.99 154.49 73.09 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.498 2.132 . . . . 1.0 111.84 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 93.0 p -151.77 -131.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.639 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 145' ' ' LEU . 10.1 mp -77.8 -102.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.554 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -145.47 -172.08 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.453 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t 50.29 55.6 9.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.442 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 139' ' ' LYS . 12.3 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.547 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 48.42 41.1 16.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.622 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 4.9 p90 -66.43 -40.17 89.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 1.0 110.407 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.29 -32.32 72.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.673 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -55.59 -36.64 67.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.421 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' THR . . . -73.16 -33.0 59.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.6 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 1.0 110.611 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -74.64 -34.93 62.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' HD13 ' A' ' 110' ' ' LEU . 13.2 t0 -60.48 -46.99 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 1.0 110.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' GLY . 79.9 p -61.75 -20.07 63.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -52.65 -41.62 63.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 1.0 111.614 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -57.48 -48.89 77.99 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.648 -0.421 . . . . 1.0 112.004 -177.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -55.0 -39.52 69.15 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.085 -179.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.58 -43.39 94.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' CD2' HG23 ' A' ' 51' ' ' VAL . 2.3 mm? -61.7 -34.33 75.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -62.48 -40.24 96.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.786 -0.643 . . . . 1.0 109.821 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.86 73.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.751 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -62.38 -34.1 76.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.086 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.0 -33.23 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.8 mp -91.15 -45.73 8.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.492 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.62 -47.39 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.061 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.94 20.62 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.85 133.22 43.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.859 0.361 . . . . 1.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 2.7 m-20 36.85 92.2 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.152 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.99 -17.77 6.68 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.128 . . . . 1.0 112.105 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 -47.49 25.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -59.53 -50.27 74.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 1.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.38 -37.03 69.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.53 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.639 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -55.9 -40.08 72.5 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.963 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -57.67 -33.1 67.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.955 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -71.23 -39.78 71.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 29' ' ' PHE . 2.4 p -74.1 -42.4 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.111 0.411 . . . . 1.0 112.111 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -46.47 -35.71 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -178.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.58 -49.38 73.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.646 -1.161 . . . . 1.0 111.342 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -75.13 -44.47 46.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.744 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -71.43 -3.78 22.8 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.367 -178.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 36' ' ' LYS . 2.7 m120 37.86 44.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 1.0 110.327 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 31.4 mm -33.4 -39.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.674 -0.694 . . . . 1.0 111.237 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 16.6 tttp 79.85 -75.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.626 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -68.43 89.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.405 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -51.23 -34.88 34.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.224 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -53.63 -41.21 66.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.795 0.807 . . . . 1.0 109.303 178.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.49 66.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.212 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.571 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.6 t80 -56.74 -43.14 80.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.439 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -68.76 -46.72 68.06 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -58.9 -37.27 76.22 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.391 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.94 92.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.659 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.942 ' O ' HG12 ' A' ' 51' ' ' VAL . 31.0 ttmt -58.44 -52.46 65.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.546 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -36.62 74.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.621 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.67 -43.01 94.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.874 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 48' ' ' LYS . 6.1 p -65.03 -33.89 66.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.209 -0.597 . . . . 1.0 111.397 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.7 t70 -62.52 -29.06 70.28 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.086 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.44 ' CG2' HD13 ' A' ' 95' ' ' LEU . 90.9 m -58.19 -32.35 68.17 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.64 -42.02 43.67 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.919 -1.491 . . . . 1.0 110.059 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -78.92 -16.38 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.094 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 52' ' ' ASP . 29.1 ttt-85 -53.21 -14.67 0.72 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 13.2 m80 -130.71 -65.9 0.78 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 5.4 mt 84.23 -102.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.163 -0.472 . . . . 1.0 112.119 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.68 -46.07 90.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.977 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -52.28 -37.31 55.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.991 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.819 ' CG2' HG11 ' A' ' 89' ' ' VAL . 8.4 mt -60.16 -49.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.84 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -56.08 -45.64 79.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t -59.75 -43.21 94.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.327 -0.852 . . . . 1.0 109.415 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HG23 ' A' ' 130' ' ' ILE . 17.7 mt -59.53 -36.79 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -69.65 -41.77 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.189 177.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 65' ' ' ILE . 39.7 mt-10 -62.44 -34.85 77.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.402 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -53.98 -25.64 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.689 -0.404 . . . . 1.0 110.474 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.76 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 52.8 t-80 -102.0 -40.31 6.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.416 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 69' ' ' LEU . 56.5 mt -40.63 -21.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.473 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 68' ' ' HIS . 9.1 ttmt 71.03 -62.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.747 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.88 37.16 0.57 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.405 ' CE3' ' NH1' ' A' ' 76' ' ' ARG . 7.9 m0 -130.18 -173.75 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.893 0.378 . . . . 1.0 110.55 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.7 m -125.4 142.85 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.364 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.29 -24.08 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 77' ' ' LEU . 37.3 t70 -63.74 -23.49 67.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.384 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 75' ' ' ASP . 2.6 mtp180 -15.15 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.416 0.447 . . . . 1.0 111.561 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 tp 51.35 168.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.815 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' H ' ' HG ' ' A' ' 77' ' ' LEU . . . 62.7 113.68 0.01 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -73.88 -51.39 16.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 1.0 110.465 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 2.8 t -51.83 -48.85 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.488 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.499 ' CD ' ' HB1' ' A' ' 119' ' ' ALA . 19.6 mt-10 -47.15 -48.27 23.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.28 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 75' ' ' ASP . 11.5 ttp180 -52.22 -51.27 59.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.187 -0.605 . . . . 1.0 111.195 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -73.24 -40.48 64.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.324 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.55 75.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.131 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -54.61 -44.81 73.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.165 -178.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -58.94 -45.51 90.28 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.629 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -36.07 81.04 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.387 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.598 ' HA3' HD11 ' A' ' 127' ' ' LEU . . . -67.74 -47.39 61.61 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.418 -0.896 . . . . 1.0 111.63 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.5 p -64.78 -31.11 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.961 0.41 . . . . 1.0 110.138 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.09 -43.78 9.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 92' ' ' LEU . 22.2 mp0 -70.62 -58.2 3.92 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.492 -0.883 . . . . 1.0 110.397 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -4.4 -82.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.056 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.26 -32.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 1.4 m-30 -53.3 -43.96 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.335 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 95' ' ' LEU . 1.7 tp -101.76 -5.75 24.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 43.87 72.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 1.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.71 151.48 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.87 -23.65 48.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.388 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -135.13 69.95 69.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 32.2 Cg_exo -54.23 -43.2 60.71 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.92 2.413 . . . . 1.0 112.548 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.08 87.17 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -71.45 -35.18 70.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.694 0.283 . . . . 1.0 110.544 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -58.0 -49.06 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.289 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE2' ' O ' ' A' ' 100' ' ' PRO . 3.2 m-85 -54.61 -48.97 71.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.881 -0.728 . . . . 1.0 110.2 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.77 -52.95 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.435 -178.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.87 -48.97 74.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.694 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.83 -43.77 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.119 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 104' ' ' PHE . 96.0 t -68.56 -36.92 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.437 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' ILE . 24.9 t70 -60.65 -34.52 74.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.86 -35.88 75.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.93 -1.032 . . . . 1.0 109.882 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -65.49 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -52.47 -37.62 57.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.261 0.553 . . . . 1.0 110.561 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -67.58 -45.03 76.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.3 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -92.0 -71.39 0.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.389 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 111' ' ' VAL . . . -85.16 161.65 19.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.018 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -56.63 152.67 11.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.984 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.34 -31.66 72.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.158 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.51 -30.99 68.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.614 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' HB1' ' CD ' ' A' ' 81' ' ' GLU . . . -71.11 -36.86 72.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.126 0.488 . . . . 1.0 110.071 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.69 83.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.973 -0.851 . . . . 1.0 110.973 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -61.97 -46.43 89.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -66.21 -43.6 86.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.406 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 119' ' ' ALA . 72.0 t -60.32 -45.15 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.102 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -51.81 41.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.705 -0.398 . . . . 1.0 111.25 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.01 -53.01 48.95 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.472 -0.651 . . . . 1.0 111.472 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.604 HG13 HD21 ' A' ' 85' ' ' LEU . 1.4 p -58.74 -28.51 37.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.853 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.598 HD11 ' HA3' ' A' ' 88' ' ' GLY . 0.2 OUTLIER -62.66 -47.56 83.15 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.571 -0.451 . . . . 1.0 110.409 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.4 m -59.65 -29.9 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.189 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.56 -35.41 70.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.714 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.672 HD11 HG12 ' A' ' 65' ' ' ILE . 6.5 mt -67.21 -38.69 81.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.151 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HB2' HD11 ' A' ' 92' ' ' LEU . 88.3 t80 -54.11 -52.72 60.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.545 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -55.98 -36.68 68.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.481 -0.487 . . . . 1.0 110.315 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 137' ' ' SER . . . -61.72 -40.38 94.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.237 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 134' ' ' TYR . 8.0 t80 -60.57 -27.15 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -98.68 -30.84 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.052 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 20.5 p -87.82 -20.47 26.04 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 133' ' ' ALA . 35.1 t -80.22 -36.37 34.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 1.0 110.377 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.0 t -49.53 100.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.498 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -69.28 107.69 3.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.35 82.69 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -134.82 140.13 45.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.346 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' OE1' ' A' ' 141' ' ' GLU . 11.9 mtpp -69.05 147.25 97.64 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.541 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 144' ' ' SER . 33.3 Cg_endo -65.74 131.41 27.45 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.391 2.061 . . . . 1.0 112.03 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PRO . 4.9 m 41.13 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.645 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.72 -98.04 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.479 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 147' ' ' SER . 52.6 pttt -88.67 -13.39 39.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.494 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 146' ' ' LYS . 70.3 p 48.5 101.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.687 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.963 -1.018 . . . . 1.0 110.529 179.903 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.454 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 3.5 mmt180 -44.42 110.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.302 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 4' ' ' ARG . 3.0 p90 -53.1 -37.29 61.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.468 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.465 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 33.8 ttm180 -57.13 -32.61 66.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.495 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -56.2 -37.28 69.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.404 . . . . 1.0 109.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.07 -48.47 20.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.4 -1.08 . . . . 1.0 110.4 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 1.0 110.283 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -74.74 -43.23 56.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.494 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 110' ' ' LEU . 28.7 t0 -60.2 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.993 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.0 p -61.71 -21.18 64.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.556 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.06 70.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.451 . . . . 1.0 111.415 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -57.72 -48.33 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.919 -178.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.65 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -53.96 -38.23 64.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 1.0 111.042 -178.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.653 ' HB ' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.39 -47.45 92.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 1.0 109.466 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -64.2 -32.45 74.04 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.256 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' ND2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -58.92 -41.39 87.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -34.16 77.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.3 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.408 ' CE2' HD11 ' A' ' 58' ' ' ILE . 68.6 t90 -62.3 -34.27 76.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD2' ' OD1' ' A' ' 83' ' ' ASN . 2.0 m-20 -67.03 -33.55 75.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.824 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -91.74 -45.72 8.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.268 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -98.63 -46.97 5.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.269 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.35 26.15 65.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.08 123.98 26.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.824 0.345 . . . . 1.0 111.096 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 40.81 92.57 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.12 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.73 -26.88 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.211 . . . . 1.0 112.386 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.62 -46.99 29.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.69 -47.01 83.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 1.0 110.288 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mt -55.81 -36.28 67.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.231 -0.895 . . . . 1.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -55.76 -44.52 77.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 34' ' ' GLU . 1.3 tmmt? -57.32 -32.74 67.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.586 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.45 -40.03 70.6 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.549 0.574 . . . . 1.0 112.549 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.47 -42.91 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.904 0.335 . . . . 1.0 111.904 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -46.84 -36.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 2.0 mt-10 -63.65 -45.45 90.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.642 -1.163 . . . . 1.0 110.066 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 32' ' ' VAL . 32.9 mt-10 -74.62 -44.68 49.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.795 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.4 mttm -86.45 124.66 33.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.013 0.435 . . . . 1.0 110.342 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.747 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -70.89 51.05 0.14 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.198 -179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 40' ' ' ASN . 46.7 mm -44.85 84.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 37' ' ' ASN . 14.6 ptpt -61.65 62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.725 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.7 m-20 158.29 87.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.302 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -51.07 -33.76 27.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 1.0 109.773 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.66 -45.37 70.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.882 0.849 . . . . 1.0 109.089 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 47' ' ' ALA . . . -62.52 -47.56 83.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.44 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CG ' HG11 ' A' ' 33' ' ' VAL . 1.4 t80 -55.58 -44.6 77.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.598 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.21 -47.91 63.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -57.54 -38.07 74.12 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.39 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -62.82 -43.48 98.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' O ' HG12 ' A' ' 51' ' ' VAL . 30.7 ttmt -59.08 -52.12 67.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.637 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -57.27 -38.05 73.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -59.17 -46.5 88.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.915 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.653 HG21 ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -65.02 -33.65 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.331 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -62.37 -31.54 72.21 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.993 -0.683 . . . . 1.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.448 ' OG1' HD23 ' A' ' 95' ' ' LEU . 94.0 m -59.73 -31.52 69.69 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -76.44 -40.36 50.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.792 -1.549 . . . . 1.0 110.525 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 51' ' ' VAL . 20.6 t -79.24 -16.26 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.791 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -51.1 -39.35 55.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.053 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 60' ' ' GLU . 1.5 m170 -115.27 -8.61 12.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.065 0.46 . . . . 1.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 59' ' ' GLU . 11.6 tt 21.12 -93.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.461 -0.791 . . . . 1.0 112.993 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.033 ' H ' HG23 ' A' ' 58' ' ' ILE . 29.5 mt-10 -59.51 -46.04 89.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 1.0 111.03 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' HIS . 30.4 tt0 -52.83 -36.68 58.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.406 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.832 ' CG2' HG11 ' A' ' 89' ' ' VAL . 6.3 mt -59.39 -47.98 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.052 -0.659 . . . . 1.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 86' ' ' ARG . 14.1 m-20 -55.14 -45.18 75.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.679 -1.23 . . . . 1.0 107.679 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 t -59.06 -44.95 91.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.222 -0.899 . . . . 1.0 109.342 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.432 ' CG2' HG23 ' A' ' 130' ' ' ILE . 21.6 mt -59.09 -36.87 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -69.25 -42.97 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.259 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' N ' HG22 ' A' ' 65' ' ' ILE . 53.4 mt-10 -61.62 -35.12 76.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.259 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -54.58 -26.12 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.777 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' LYS . 3.5 t60 -102.44 -37.45 8.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' A' ' 69' ' ' LEU . 46.2 mt -40.86 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.794 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 68' ' ' HIS . 65.9 tttt 74.7 -14.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.386 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 69' ' ' LEU . . . 158.2 -36.39 0.52 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.411 ' O ' ' O ' ' A' ' 71' ' ' GLY . 11.1 m0 -51.52 -174.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.018 0.437 . . . . 1.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.8 t -125.35 142.02 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.054 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -56.71 -23.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' LEU . 12.0 t70 -58.05 -24.06 56.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.825 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 37.02 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.884 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' ASP . 43.4 tp -149.69 -65.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.92 144.78 48.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -49.14 25.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 1.0 111.069 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 12' ' ' PHE . 43.4 t -50.81 -49.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 1.0 110.88 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' OE1' HG21 ' A' ' 123' ' ' VAL . 3.8 mm-40 -48.29 -47.88 36.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.27 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -51.93 -50.45 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.936 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.521 ' ND2' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.71 -44.55 66.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 1.0 109.876 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.09 69.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 89' ' ' VAL . 1.4 mp -54.56 -46.24 73.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.279 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -59.85 -44.4 94.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.887 -0.725 . . . . 1.0 110.952 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -65.38 -33.55 76.23 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.44 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.626 ' C ' HD11 ' A' ' 127' ' ' LEU . . . -66.95 -45.49 82.64 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.4 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.832 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.2 p -65.32 -32.24 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.865 0.364 . . . . 1.0 110.21 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -44.88 -41.59 7.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.414 0.626 . . . . 1.0 109.416 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.619 ' O ' ' C ' ' A' ' 92' ' ' LEU . 78.7 mm-40 -71.71 -59.6 2.67 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.971 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -7.35 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.716 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.27 -32.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 1.0 111.591 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.812 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 2.7 m-30 -54.39 -42.5 70.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.359 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -100.11 -20.52 15.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.336 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.6 tttp 55.46 84.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.719 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.7 t -92.44 172.62 8.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.726 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -95.18 -26.18 16.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -131.08 74.3 79.82 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.121 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 50.2 Cg_exo -52.48 -44.22 48.75 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.978 2.452 . . . . 1.0 112.966 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.69 -48.53 85.79 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.71 -35.33 70.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -57.96 -43.87 85.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.466 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.884 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.8 m-85 -68.25 -48.16 65.8 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.561 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -47.66 -52.54 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.396 -178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.66 -49.09 73.85 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 107' ' ' ILE . 3.9 mm -59.15 -43.41 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.065 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 104' ' ' PHE . 30.0 t -68.65 -36.73 75.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.001 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ILE . 31.1 t70 -57.18 -35.73 69.93 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.79 -36.62 77.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.924 . . . . 1.0 109.545 179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -64.22 -40.15 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.075 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -53.5 -37.87 63.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.449 0.642 . . . . 1.0 110.345 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -45.26 74.9 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.026 -0.988 . . . . 1.0 111.23 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -92.01 -70.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.491 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.43 169.28 17.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.264 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -57.89 145.27 36.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.3 mp0 -62.37 -35.3 78.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.09 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -59.8 -35.84 75.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 1.0 110.39 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.771 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -63.54 -35.3 80.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.45 -36.51 77.41 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.1 -46.44 89.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.143 0.496 . . . . 1.0 109.743 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.02 -36.77 80.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.596 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 119' ' ' ALA . 68.2 t -61.91 -45.76 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.254 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.55 -50.94 56.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.239 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.27 -49.14 74.87 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.59 -0.604 . . . . 1.0 111.59 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -64.51 -29.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.848 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.5 OUTLIER -63.05 -47.96 80.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.105 0.479 . . . . 1.0 109.892 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -61.45 -27.86 68.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.356 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 126' ' ' VAL . . . -55.44 -38.43 69.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.25 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 65' ' ' ILE . 32.9 mt -67.69 -39.21 81.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.553 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' ILE . 71.8 t80 -59.36 -52.68 64.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.939 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -42.0 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.451 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 136' ' ' THR . . . -70.04 -33.31 71.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.684 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 136' ' ' THR . 85.8 t80 -62.16 -52.46 63.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.572 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -42.98 -23.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.851 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 133' ' ' ALA . 1.6 t -62.92 -25.71 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.0 110.723 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -74.83 -24.52 58.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.629 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 139' ' ' LYS . 4.1 t 54.69 174.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.419 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 138' ' ' SER . 28.3 ttmt -136.19 138.43 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.391 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 47.57 79.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.455 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -89.14 172.08 9.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -68.87 147.51 97.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.084 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.42 131.46 30.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.236 1.958 . . . . 1.0 111.724 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 m -54.94 177.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.624 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.1 tp -143.7 -12.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.308 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.64 -44.42 0.75 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.34 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m 44.82 35.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.802 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.043 -0.98 . . . . 1.0 110.425 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' H ' ' NE ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 47.5 91.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.727 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 4' ' ' ARG . 22.9 p90 -66.11 -35.26 80.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 1.0 109.982 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' CG ' ' A' ' 3' ' ' TYR . 6.6 ptm180 -56.82 -31.91 65.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 1.0 110.398 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -43.55 76.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 109.95 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.58 -48.93 63.26 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.245 -1.142 . . . . 1.0 110.245 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 -33.78 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 1.0 110.31 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mtt-85 -74.16 -44.6 52.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.033 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -61.09 -47.72 84.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.854 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.1 p -61.97 -20.82 64.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.628 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.69 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.948 0.404 . . . . 1.0 111.776 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.21 -49.06 77.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 1.0 112.094 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.689 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.42 -39.69 67.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.594 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -65.45 -44.89 94.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 179.264 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 51' ' ' VAL . 2.1 mm? -60.44 -34.76 74.45 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.229 -0.896 . . . . 1.0 108.834 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.72 -40.8 98.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.165 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -65.36 -31.08 72.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.082 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -62.12 -33.16 73.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.255 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.566 ' CG ' HH21 ' A' ' 82' ' ' ARG . 83.0 m-20 -66.85 -34.79 78.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -91.85 -45.93 8.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.454 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.463 HH11 ' HB2' ' A' ' 20' ' ' LEU . 8.7 mpt_? -95.93 -47.22 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.402 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 49.59 59.9 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 24' ' ' ASN . 62.2 mt-10 -132.92 173.07 11.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.293 . . . . 1.0 110.844 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -28.66 94.5 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 23' ' ' GLU . 40.0 Cg_exo -54.25 -23.73 31.19 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.533 2.156 . . . . 1.0 112.399 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.538 ' H ' ' ND2' ' A' ' 24' ' ' ASN . . . -65.03 -47.99 76.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.18 -45.98 78.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.244 0.545 . . . . 1.0 110.091 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.93 -37.53 71.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.428 -0.805 . . . . 1.0 111.301 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -65.18 -38.48 90.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.571 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 57.4 mmtt -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.59 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -68.42 -41.14 80.8 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.3 p -73.86 -45.7 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.249 0.462 . . . . 1.0 112.249 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -47.38 -36.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 2.5 mt-10 -59.9 -49.83 76.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.143 -0.935 . . . . 1.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -75.06 -44.76 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.044 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' ILE . 1.3 mttm -88.63 117.09 27.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.049 0.452 . . . . 1.0 110.686 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -67.16 49.91 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.003 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 36' ' ' LYS . 28.0 mm -36.27 -31.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.957 0.408 . . . . 1.0 110.743 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 41' ' ' LYS . 13.2 tptm 62.75 -100.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.777 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 32.6 m-80 -39.12 90.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.734 0.302 . . . . 1.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 39' ' ' LYS . 15.9 tptm -51.36 -34.42 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 1.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.24 -45.12 68.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.863 0.84 . . . . 1.0 108.89 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 40' ' ' ASN . . . -62.56 -46.88 86.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.03 -1.441 . . . . 1.0 111.088 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB2' HG21 ' A' ' 38' ' ' ILE . 10.9 t80 -57.11 -44.54 83.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.723 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.86 -47.07 66.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.64 -37.48 70.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.291 -0.868 . . . . 1.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.17 95.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.649 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -59.13 -51.2 71.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.803 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -35.48 71.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.01 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.42 -43.73 93.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.47 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 55' ' ' VAL . 82.4 t -63.46 -35.28 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 56' ' ' ARG . 20.6 t0 -64.19 -31.39 72.57 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.959 -0.696 . . . . 1.0 110.572 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.631 HG22 ' HB1' ' A' ' 90' ' ' ALA . 70.5 m -58.86 -31.96 69.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -77.01 -41.84 41.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.556 -1.656 . . . . 1.0 110.294 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' VAL . 10.3 t -78.44 -14.49 13.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.353 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 52' ' ' ASP . 9.9 tpt180 -49.73 -13.86 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.267 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.511 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -143.24 -49.97 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.057 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 57' ' ' HIS . 52.8 mt 76.6 -100.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.45 -45.85 90.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.392 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' OE1' ' NE2' ' A' ' 57' ' ' HIS . 37.2 tt0 -52.04 -37.33 53.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.384 -0.526 . . . . 1.0 110.182 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.778 ' CG2' HG11 ' A' ' 89' ' ' VAL . 4.8 mt -60.76 -49.31 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.691 -0.804 . . . . 1.0 109.387 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.28 -45.9 79.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 t -58.88 -43.35 90.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.441 -0.8 . . . . 1.0 109.425 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG23 ' A' ' 130' ' ' ILE . 14.2 mt -59.43 -37.82 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.454 -0.794 . . . . 1.0 109.196 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.694 HG21 ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -70.71 -40.24 76.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.291 177.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . 20.7 tt0 -62.93 -35.88 81.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.118 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -55.5 -25.44 37.22 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.596 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.797 ' CG ' ' HB1' ' A' ' 129' ' ' ALA . 3.2 t60 -100.37 -43.69 6.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.993 -0.283 . . . . 1.0 111.188 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 74' ' ' ILE . 54.1 mt -36.84 -43.72 0.45 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.749 0.309 . . . . 1.0 110.803 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt 56.55 104.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 11.39 8.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -125.86 157.07 38.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.843 0.354 . . . . 1.0 110.528 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -118.18 134.9 54.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.772 ' O ' HD22 ' A' ' 77' ' ' LEU . 2.1 tt -56.03 -23.67 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.49 -22.25 62.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.217 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -76.95 73.36 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.618 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -179.93 -161.98 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.427 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 77' ' ' LEU . . . -66.07 165.55 38.35 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.063 -1.215 . . . . 1.0 110.063 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -74.45 -52.84 10.85 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.821 -0.351 . . . . 1.0 111.466 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 22.0 t -52.39 -49.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 1.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' LEU . 35.2 mt-10 -48.39 -46.26 36.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.184 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.566 HH21 ' CG ' ' A' ' 19' ' ' ASP . 1.5 tmm_? -50.63 -51.29 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.592 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.448 ' CG ' ' N ' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -72.18 -45.47 60.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.457 -0.497 . . . . 1.0 110.434 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 83' ' ' ASN . . . -58.28 -37.89 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.685 -0.688 . . . . 1.0 109.841 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.2 tm? -54.87 -47.5 74.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -60.61 -42.84 97.62 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.155 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -61.37 -37.69 84.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.473 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' N ' ' HG ' ' A' ' 87' ' ' LEU . . . -66.81 -47.36 67.43 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.445 -0.884 . . . . 1.0 111.815 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 61' ' ' ILE . 1.7 p -64.9 -31.63 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.941 0.4 . . . . 1.0 110.724 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.76 ' O ' ' HB2' ' A' ' 94' ' ' PHE . . . -45.8 -43.36 13.18 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.604 ' O ' ' C ' ' A' ' 92' ' ' LEU . 9.2 mp0 -68.48 -58.2 4.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.439 -0.904 . . . . 1.0 110.845 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -3.78 -84.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.966 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 92' ' ' LEU . 1.1 mp -120.15 -30.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.111 0.481 . . . . 1.0 111.417 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.76 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 6.8 m-85 -52.2 -40.7 61.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.968 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.555 HD13 ' OG1' ' A' ' 53' ' ' THR . 8.0 tp -101.56 -20.06 15.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt 61.73 84.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 t -98.47 151.73 20.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.739 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -79.65 -19.5 48.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.367 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -138.77 72.95 41.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.54 ' O ' ' CE2' ' A' ' 104' ' ' PHE . 36.2 Cg_exo -57.8 -43.17 51.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.021 2.481 . . . . 1.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -48.08 88.03 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.276 -0.729 . . . . 1.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -35.03 72.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.694 0.283 . . . . 1.0 110.665 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 104' ' ' PHE . 1.1 t -57.97 -48.74 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.211 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 4.5 m-85 -55.21 -47.8 74.78 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.599 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -47.76 -52.5 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.169 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -55.97 -48.34 75.99 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 87' ' ' LEU . 1.2 mp -58.47 -43.37 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 104' ' ' PHE . 91.7 t -68.57 -37.31 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.382 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 105' ' ' ILE . 45.2 t0 -59.15 -33.79 71.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -60.47 -36.26 77.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.655 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -63.68 -39.24 84.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.174 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -51.8 -37.44 51.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.269 0.556 . . . . 1.0 110.517 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -69.92 -44.76 68.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.245 -0.888 . . . . 1.0 111.264 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -91.73 -70.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.492 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . . . -80.0 -174.15 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.236 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -76.64 152.86 35.68 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.248 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 1.7 mp0 -62.56 -42.77 99.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -60.0 -35.61 75.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . . . -62.87 -38.01 89.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.075 0.464 . . . . 1.0 110.019 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.8 89.54 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.821 . . . . 1.0 111.046 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -61.63 -46.3 90.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 122' ' ' PHE . 26.0 t80 -62.36 -42.68 99.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.964 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 119' ' ' ALA . 91.2 t -59.83 -44.56 94.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.521 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -66.8 -50.48 62.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.592 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.09 93.96 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.463 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.2 -29.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.684 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -59.48 -47.69 84.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.121 0.486 . . . . 1.0 110.17 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 m -63.69 -29.72 70.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.736 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.797 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -57.08 -34.51 68.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.85 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD11 HG12 ' A' ' 65' ' ' ILE . 7.8 mt -67.55 -39.88 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.213 -0.595 . . . . 1.0 109.949 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -55.26 -43.45 74.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.953 ' O ' HD12 ' A' ' 135' ' ' ILE . 1.5 tmtp? -64.65 -37.31 87.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.85 68.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 1.0 110.24 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 136' ' ' THR . 66.7 t80 -62.86 -48.49 78.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.561 -0.745 . . . . 1.0 112.469 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -46.23 -8.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -178.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 135' ' ' ILE . 41.4 p -72.12 -34.27 68.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 1.0 110.477 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.8 m -73.11 -36.07 66.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.36 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.5 m -75.61 142.7 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.417 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.6 mttm 51.36 -120.88 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.495 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 141' ' ' GLU . 57.6 tt0 -166.65 161.14 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.589 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 5.8 mp0 -46.42 160.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.743 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -69.39 150.98 96.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.39 154.67 72.57 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.428 2.086 . . . . 1.0 111.878 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 m -163.65 144.36 8.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -81.85 82.14 7.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.413 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -113.28 -20.85 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.695 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -159.91 119.24 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.689 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.522 179.931 . . . . . . . . 0 0 . 1 stop_ save_